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Abstract 
Introduction:  
Countless children sustain painful burn injuries every year, many requiring hospital 
treatment. Treatment can involve painful wound care procedures, possible surgical 
intervention and the risk of lifelong scarring which can have a multi-faceted effect on the 
child and their family. The current focus of research into paediatric burns lies 
predominantly with severe burn injuries which generally denote long hospital stays and 
worse outcomes (functionally, cosmetically and psychosocially). However in high-income 
countries, the majority of children sustain small partial thickness burns which are treated in 
the outpatient setting with specialized dressings.  
Thesis aim:  
The aim of this study was to provide a holistic and comprehensive exploration of pediatric 
partial thickness burn care. The first phase was to determine the most effective silver 
dressing for reduced wound re-epithelialization time and pain during dressing changes, 
establish the reliability of a new wound measurement tool, assess the scar outcome of 
study participants and complete a cost effective analysis of silver dressings. The second 
phase was to provide an exploration of parent experiences in the outpatient setting. 
Phase 1 Methodology and Results:  
RCT: Ninety-six children (0-15 years) with ≤10% total body surface area partial thickness 
burn injuries were recruited for a randomised controlled trial and received either 1) 
ActicoatTM; 2) ActicoatTM with MepitelTM; or 3) Mepilex AgTM dressings changed every 3-5 
days until full re-epithelialization or skin grafting occurred. When adjusted for burn depth, 
Acticoat™ significantly increased the expected days to full re-epithelialization by 40% (p < 
0.01) and Acticoat™ with Mepitel™ significantly increased days to full re-epithelialization 
by 33% (p = <0.01) when compared to Mepilex Ag™. Pain scores were also significantly 
lower at dressing changes in children who received Mepilex Ag and Acticoat with Mepitel 
compared to Acticoat alone. 
3D photography reliability: Burn wound re-epithelialisation was measured at each dressing 
change using digital planimetry (Visitrak™ system) and stereophotogrammetry (3D 
photography). Wound surface area measurements were complete for 75 participants at the 
first dressing change. Level of agreement between wound surface area measurements 
was excellent (ICC 0.96, 95% CI 0.93, 0.97). Visitrak™ tracings could not be completed in 
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19 participants with 16 aged less than two years. 3D photography could not be completed 
for one participant. Barriers to completing Visitrak™ tracings were: excessive movement, 
pain, young age or wound location. 
Cost-analysis: This study was trial based economic evaluation conducted from a 
healthcare provider perspective. Costs directly related to the management of partial 
thickness burn injuries ≤10% TBSA were collected from March 2013-July 2014 and for a 
one year post re-epithelialization time horizon. Incremental cost effectiveness ratios were 
estimated and dominance probabilities calculated. Costs (dressing, labor, analgesics, scar 
management) were considerably lower in the Mepilex Ag™ group (median AUD$94.45) 
compared to the Acticoat™ (median $244.90) and Acticoat™ with Mepitel™ (median 
$196.66) interventions. There was a 99% and 97% probability that Mepilex Ag™ 
dominated (cheaper and more effective than) Acticoat™ and Acticoat™ with Mepitel™, 
respectively. 
Scar assessment: An assessment of forty-three children participants’ skin appearance was 
conducted at 3 and 6 months post re-epithelialization for children who presented for follow-
ups or sent a photo. Days to re-epithelialization was a significant predictor of skin/scar 
quality at 3 and 6 months (p<0.01). Patient-rated color and observer-rated vascularity and 
pigmentation POSAS scores were comparable at 3 months (color vs. vascularity 0.88, 
p<0.001; color vs. pigmentation 0.64, p<0.001), but patients scored higher than the 
observer at 6 months (color vs. vascularity 0.57, p<0.05; color vs. pigmentation 0.15, p = 
0.60).  Burn depth was significantly correlated with skin thickness (r=0.51, p<0.01). 
Hypopigmentation of the burn site was present in 25.8% of children who re-epithelialized in 
≤2 weeks.  
Phase 2 Methodology and Results:  
This study was a qualitative design using purposive sampling. Ten parents of children 
aged 0 to 5 years with an acute partial thickness burn injury ≤10% TBSA who were 
referred for outpatient treatment were interviewed. Semi-structured interviews were 
conducted on the day of their child’s discharge from the service. Interviews were 
transcribed verbatim and analysed using an inductive thematic analysis method. Themes 
identified included; going into the unknown, facilitation and resilience. 
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Discussion: 
This body of work has provided a comprehensive and holistic overview of pediatric partial 
thickness burn care. Outcomes from this study have resulted in the development of a new 
and more cost-effective dressing protocol for pediatric burn care, which has been 
implemented Queensland-wide and introduced interstate and in New Zealand. 3D 
photography is now being utilized as a non-invasive alternative to digital planimetry when 
completing wound surface area measurements. It has also provided a greater knowledge 
of challenges and outcomes faced by this population of children and their families, which 
can be used to inform future clinical practice so that the burn treatment experience 
includes faster wound re-epithelialization, less pain and reductions in parental stress. 
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Chapter 1. Introduction 
1.1 Background 
Childhood injuries are commonplace around the world and for some; the injuries can be 
more serious and have a multi-faceted impact on the life of the child and their family. Burn 
injuries are one of the most painful and potentially devastating injury types that a child can 
experience. According to the World Health Organization [1], burn injuries are globally the 
fifth most frequent occurrence of non-fatal childhood injuries. Non-fatal burns are also one 
of the main contributors to hospitalization and disability worldwide with burns under 20% 
total body surface area (TBSA) in children aged 0-15 years occurring at a rate of 153 per 
100,000 population [2].  
Burn injuries fall into a spectrum of severity dependent on the level of damage sustained to 
the skin, ranging from superficial (epidermis only) to deep dermal partial thickness (damage 
to the epidermis as well as down to the superficial or deep dermis) and full thickness 
(destruction of all skin layers down to subcutaneous tissue) [3, 4]. Typically only partial and 
full thickness burns require hospital treatment (with full thickness burns almost always 
requiring surgical closure). With advances in treatments and reductions in mortality and 
morbidity, the majority of children with partial thickness burns can now be treated as 
outpatients. 
A study of all burn injuries presenting to the Royal Children’s Hospital, Brisbane in 2013 
noted that 758 children were treated for a burn. Of the children treated as outpatients, 73.2% 
had a superficial partial thickness burn and of all presenting children, 97.3% had a burn less 
than 10% total body surface area [5]. Currently, the focus of research into pediatric burns 
lies overwhelmingly with large, deep burn injuries >10% total body surface area (TBSA) 
which generally result in long hospital stays and worse outcomes (functionally, cosmetically 
and psychosocially). However the fact remains that many children in high-income countries 
sustain small, but significant partial thickness burns ≤10% TBSA which can be treated in the 
outpatient setting [2, 6]. 
There are two main stages of pediatric partial thickness burn care; acute treatment to enable 
wound closure and longer term wound outcome/scar management. Throughout this 
continuum of care, the child and parent experience must be taken into account due to its 
potential impact on care and ultimately the outcome for the child and family. There are 
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substantial research gaps within each of these components, which need to be addressed in 
order to improve outcomes for children who sustain partial thickness burn injuries: 
1.2 Treatment 
Children with partial thickness burns ≤10% TBSA are primarily treated in the outpatient 
setting with dressing changes occurring up to twice weekly [6]. The choice of burn dressing 
in this setting is vital to ensure rapid wound re-epithelialization and thus reduce the risk of 
scarring caused by prolonged re-epithelialization times [7]. The current standard of care in 
Australasia is silver fabric (Acticoat™) or foam dressings (Mepilex Ag®)), with or without a 
silicone interface (Mepitel™) (for atraumatic dressing removal), to promote wound re-
epithelialization [8, 9]. Hydrofibre and alginate dressings are very rarely used for paediatric 
patients in Australasia. Multiple research studies [10-15] have shown silver to be effective 
against a variety of gram positive and negative bacteria. While it is well known that silver 
can be cytotoxic to healthy keratinocytes, prevention of infection, in particular toxic shock 
syndrome, even in small burns, is prioritized over promoting wound re-epithelialization for 
paediatric patients in Australia and New Zealand. As such, it is the standard of care that all 
children in Australia and New Zealand receive silver dressings as their primary treatment. 
A number of studies have been published comparing silver dressings to silver sulfadiazine 
cream. However silver sulfadiazine cream is a poor comparator as it is no longer used in 
pediatrics in Australia due to delays in wound re-epithelialization and painful dressing 
changes [9, 16]. There is a shortage of quantifiable evidence on which silver dressing is 
most effective, with very few direct comparisons of silver dressings in the literature [17].   
In addition there is a need for cost-effective analysis of silver burns dressings. Burns 
dressings are expensive and with a large number of children treated for burns every year, 
this is a significant burden on the healthcare system [18].  A systematic review of burn care 
costs calculated the mean total cost as $3,883 per 1% TBSA burned for burns 0-10% TBSA 
in high income countries [18]. As a comparison to other morbidities, a study on burn care in 
Spain reported that the mean annual cost of burn care was $99,773 compared to $13,826 
in the first year post-stroke for stroke survivors [19]. Economic evaluations for burn care are 
scarce, but greatly needed to ensure that new burns treatments that are implemented into 
the healthcare system are both effective and economical.  
1.3 Outcome 
Wound re-epithelialization time and risk of hypertrophic scarring from burn injuries are 
related, with the risk of scarring increasing with delays in re-epithelialization [7]. Partial 
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thickness burns have been shown in the literature to result in a better scar quality than full 
thickness burns [20]. However there remains a paucity of research on the longer-term skin 
appearance or presence of residual scarring in children who sustain partial thickness burns.  
1.4 Experience 
Finally, while physical/medical treatments and outcomes are often the main focus of burns 
treatment, the psychosocial impact of a burn injury on families is also significant, with parents 
often witnessing the accident, accompanying and supporting the child through painful 
procedures and usually caring for the burn at home [21]. Parents and caregivers have been 
demonstrated to use negative coping reactions such as blame when caring for a burn-injured 
child and experience feelings of guilt [22]. Accordingly, research has also shown that a 
child’s psychosocial recovery can be impacted on by parents’ responses to the burn event 
[23]. There is evidence that parent distress levels are not influenced by the size of the burn 
[24], however the research focus still lies primarily with children who sustain major burn 
injuries. As a result, the experiences of parents and caregivers of children with partial 
thickness burns in the outpatient setting are largely unexplored. 
Therefore there is a need for a comprehensive overview of treatments and outcomes for 
partial thickness burns in children and the impact of such injuries on families in order to 
improve acute care and provide positive long-term results. 
1.5 Thesis Aims 
The aim of this research was to provide a holistic and comprehensive overview of pediatric 
partial thickness burn care. The thesis is split into two parts to address the processes 
involved with burn care and to explore the psychosocial impact of burn injury and care on 
parents. Part One examines the physical treatments and outcomes and Part Two 
investigates parent experiences.  
1.5.1 Part One Aims 
Part One aimed to conduct a clinical trial to determine the most effective silver dressing to 
use in terms of reduced time to wound re-epithelialization and pain during dressing changes, 
assess the scar outcome of study participants, complete an economic evaluation of the silver 
dressing and establish the reliability of 3D photography as a new wound measurement tool. 
1.5.2 Part Two Aims 
Part Two aimed to provide a qualitative exploration of the lived experiences of parents and 
caregivers with children who had sustained ≤10% TBSA partial thickness burns. 
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1.6 Thesis Overview: 
This thesis is presented as eight chapters, with chapters 3-6 based on published and 
submitted manuscripts. Chapter Two is a literature review, exploring and discussing 
research available regarding pediatric partial thickness burn care. Part One of the thesis will 
encompass chapters 3-6: Chapter 3 is the methodology of the silver dressing clinical trial 
(including methodology for assessing scar outcome and cost-analysis), Chapter 4 will 
present the findings from the clinical trial, Chapter 5 is a reliability study of 3D photography 
for wound measurement mapping, Chapter 6 will provide an in-depth cost-effective analysis 
of the silver dressings used in the trial and Chapter 7 discusses the scar outcome of children 
recruited into the clinical trial and Part Two of the thesis is covered in Chapter 8 which 
provides an exploratory qualitative investigation into parent experiences in the outpatient 
setting. Lastly, the final chapter of the thesis, Chapter 9, will provide an in-depth discussion 
of clinical outcomes from the thesis, limitations and how these can be addressed and future 
directions from this research. 
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Chapter 2. Literature Review 
2.1 Pediatric burns epidemiology 
The burden of pediatric burn injuries worldwide is particularly high, with burn injuries less 
than 20% total body surface area (TBSA) in children aged 0-15 years, the fifth most common 
cause of non-fatal childhood injuries worldwide, occurring at a rate of 153 per 100,000 
population of children [2]. According to the Australian Institute of Health and Welfare (AIHW) 
[25], children under the age of four years have the highest rates of hospital admission due 
to burns in Australia with 12,159 hospitalized (inpatients) with a burn or scald between 1999 
and 2004. The majority of burns in this age group were scalds caused by hot beverages, 
food and cooking oil (50.7%). These burn injury rates have remained consistent across high-
income countries in recent years, with American Burn Association data up to 2010 reporting 
that burns in children aged 1-4 years are the eighth most common cause of non-fatal injuries 
in the United States [26].  
Australian pediatric burn centers report that the majority of children present with partial 
thickness burns <10% TBSA [5, 27]. As the mortality rates from burn injuries have decreased 
over time with better treatment options, burns of up to 10% TBSA in children can now be 
managed in the outpatient setting [6]. Data collected by the Burns Registry of Australia and 
New Zealand (BRANZ) from seven burns centers over a one year period (2010-2011), 
stated that the ratio of pediatric outpatient admissions to inpatients was 3.2:1 [28]. 
The cost of burn care is an undeniably expensive endeavor, with a recent systematic review 
calculating mean total burn care costs in high-income countries as approximately $3,883 
per 1% TBSA burned in injuries 0-10% TBSA [18]. The AIHW [25] estimated the costs to the 
Australian healthcare system for burn injuries requiring hospitalization (inpatients) as 
between $37.8 and $40.2 million. The economic burden to the healthcare system of pediatric 
burn injuries treated as outpatients is likely significant, but difficult to quantify due to limited 
research and the over-representation of inpatient data such as in the Burns Registry of 
Australia and New Zealand (BRANZ) which only collects data for patients admitted for longer 
than 24 hours [28]. 
2.2 Burn injury classification  
Burn injuries are classified according to the level of burn damage to the layers of the skin, 
with damage ranging from superficial/erythema only to superficial partial to full thickness [3, 
4, 29]. (Figure 2-1) 
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Superficial burns include damage to the epidermis only and do not extend into the dermis. 
This depth of burn results in redness (erythema) of the affected area, but no blistering (e.g. 
sunburn) [3, 29]. 
Superficial partial thickness burns include damage to the epidermis and the papillary dermis 
resulting in blisters. The underlying skin is wet, pink, painful and, blanches on touch. Re-
epithelialization is usually achieved within 10-14 days, with no scarring [3, 29].  
Deep partial thickness burns extend through the papillary dermis to the reticular dermis and 
have a mottled appearance, with slow capillary refill on touch, and have less sensation than 
more superficial burns. They may take up to 3 weeks or more to re-epithelialize and may 
require surgical closure in the form of skin grafts. These burns will have variable amounts of 
scar tissue laid down depending on many factors including skin type, area of body and age 
[3, 29]. 
Full thickness burns damage the entire dermis, often continuing through into subcutaneous 
tissue. These burns are firm, leathery and white with reduced sensation and no blanching 
on touch, almost always require early excision and grafting to close the wound, and will 
invariably result in hypertrophic scarring [3, 29]. 
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2.3 Assessing burn depth and healing potential 
While clinical assessment of burn depth is most commonly conducted visually, objective 
measurement is required to provide an accurate measurement of burn depth for clinical and 
research use. The use of laser Doppler is currently the only objective measure of burn wound 
healing potential available and is becoming more widely used due to demonstrated 
inconsistencies between clinicians and inaccuracies when assessing the depth of a burn 
[30, 31]. The moorLDI2-BI laser Doppler imager (LDI) assesses the blood flow in burn 
wounds by conducting a 30-second scan which measures the movement of red blood cells 
within the skin [32] (Figure 2-2). The LDI then provides numerical measures of blood 
perfusion units, where a higher level of perfusion units indicates a burn with a greater healing 
potential (i.e. a more superficial burn).   
Numerous studies have examined the validity and reliability of this machine in both pediatric 
and adult burns populations and found laser Doppler to be a reliable measure of burn depth 
[33-36]. A study by Holland et al [31] assessed 57 pediatric burn wounds and found that 
90% of superficial partial thickness burns were correctly predicted by LDI compared to 66% 
by clinical assessment. However, more research is required to determine if LDI can also be 
used reliably in children under the age of three years due to challenges with compliance, as 
children have to remain motionless for 30 seconds with the burn wound exposed.  
Figure 2-1 Burn depth classification 
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Figure 2-2 moorLDI2-BI laser Doppler imager 
 
2.4 Measurement of progressive wound re-epithelialization 
Burn wound re-epithelialization measurement is completed via a process called wound 
mapping. The wound border is traced and areas of re-epithelialization are measured and 
recorded as a percentage of the total wound area. This process can be completed serially 
(i.e. at each dressing change) until full re-epithelialization is recorded.  
There is no gold standard for burn wound mapping. Most burn centres use digital planimetry 
(Visitrak™, Smith and Nephew), as it has been proven to be reliable in the mapping of 
chronic wounds [37, 38]. Digital planimetry involves placing a plastic grid over the affected 
area and tracing an outline of the wound and areas of re-epithelialization. The grid is then 
placed onto the Visitrak device and traced using a digital drawing system (Figure 2-3). 
Previous studies have found digital planimetry to have good intra- and inter-rater reliability 
for the measurement of wound surface area [39]; however, it is limited within the pediatric 
population due to the need for children to remain motionless while the tracing is completed. 
The plastic grid must also be in contact with the wound bed, which can cause anxiety and 
discomfort.  
3D photography is a non-invasive alternative to digital planimetry (Figure 2-3). Whilst there 
is evidence on its use in chronic wounds [40], there is limited research on its potential as a 
burn wound mapping tool in pediatric populations [41]. 3D photography has the potential 
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advantage over digital planimetry due to its ease of use at the bedside, non-invasive point-
and-shoot method, increased accuracy of measurement, and its ability to store wound 
progression photographs. 
 
Figure 2-3 Visitrak device (A) and 3D photography example (B) 
 
2.5 Outpatient management of pediatric partial thickness burns 
There has been a shift from inpatient management of pediatric partial thickness burns with 
daily dressings with the majority now managed in the outpatient setting with specialized 
dressings than can be changed less frequently [6, 16, 42]. By treating these children as 
outpatients, they are able to return to their normal environment and routine thus reducing 
the burden on the healthcare system [16, 43, 44]. 
The main aim of acute pediatric burn care in the outpatient setting is to control infection and 
maintain an appropriate environment for the wound to re-epithelialize at a rapid rate, in order 
to minimize the risk and/or presence of scarring and minimize pain and distress where 
possible [6, 42]. Factors such as infection, wound dressing application, and removal and 
pain can all affect re-epithelialization rates of the wound and all must be considered during 
wound treatment decision-making [45, 46]. 
2.5.1 Pain associated with burn injuries in the pediatric population 
While the presence of scarring presents a long-term psychosocial challenge for children with 
burn injuries, pain and distress during the acute phase of a burn injury can greatly impact 
upon the child [47, 48]. It has been well-documented that burn wound care procedures are 
highly traumatic experiences for children, as burn injuries can often be extremely painful due 
to exposed or damaged nerve endings [48, 49]. Pain and distress during dressing change 
procedures, particularly in pediatric patients, can affect the healing process of a burn [47, 
50]. Stress can be defined as effects of the human body’s inability to appropriately respond 
to threats from their environment (physical or emotional), which can be caused by pain and 
anxiety and may impact on the cascade of wound healing [51]. In the inflammatory stage of 
B A 
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wound re-epithelialization, stress can induce an increase in glucocorticoids and cortisol 
levels in the body [52]. These changes in the inflammatory phase can, as a result, delay 
processes in the proliferation phase of wound re-epithelialization where the recruitment and 
replication of cells required for tissue generation and capillary growth occurs. In turn, the 
entire re-epithelialization process can become delayed [45, 46, 52]. 
2.6 Silver dressings 
Silver has been used for centuries in a range of formulations to treat burn injuries due to its 
antimicrobial properties. Silver sulfadiazine (SSD) was introduced in 1968 as a topical 
treatment in a cream preparation for all types of burns in pediatric and adult populations [9, 
53]. SilvazineTM (Smith and Nephew, Clayton, Australia), a preparation of 1% silver 
sulfadiazine and 0.2% chlorhexidine digluconate, was formulated for use in Australasia in 
1971. Treatment involves daily reapplications after the removal of old cream and the wound 
is cleaned [9]. Various SSD cream products are used in many countries worldwide as the 
front-line treatment for burn injuries, given their low cost, availability and anti-microbial 
properties [10].  
A recent systematic review and meta-analysis of non-silver treatments compared to silver 
sulfadiazine in the treatment of paediatric partial thickness burns [54] found shorter healing 
times for non-silver treatments and no significant difference in the incidence of wound 
infection compared to those treated with silver. The majority of studies however, had 
methodological shortcomings and a high risk of bias, rendering it difficult to accurately draw 
conclusions from these findings. 
Given the potential risk of infection, even in small, clean partial thickness burns, Australasian 
paediatric burns centres have continued to use silver to treat burns. The paediatric burns 
centre where this trial was conducted has a 0% toxic shock syndrome (TSS) rate for all 
burns (outpatient and inpatient). This is in comparison to a survey of UK burns centres 
demonstrating that in burns centres where incidences of TSS were reported, 2.5% of 
children admitted showed symptoms of TSS [55]. Numerous research studies have 
demonstrated challenges with the use of SSD including: delays in burn re-epithelialization 
(due to cytotoxicity of SSD to keratinocytes); and painful and numerous, resource-intensive 
dressing changes [9, 16, 43]. Therefore the standard of care in burns dressings for small to 
medium partial thickness burns has changed in the last 10-15 years in an attempt to resolve 
these challenges. Currently, silver–impregnated fabric, foam, hydrofibre and alginate 
dressings are commonly used to manage the bio-burden of a wound in high-income 
countries. There are many of these dressings currently available on the market [9].  These 
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dressings are impregnated with different types of silver compounds, which are released in 
varying amounts from the dressing [10, 56]. A survey of paediatric burns centres in Australia 
and New Zealand conducted as part of this thesis found that the most commonly used silver 
dressings are Acticoat™ and Mepilex Ag™. The standard of care in Queensland for 
paediatric partial thickness burns is Acticoat™ with the addition of Mepitel™ (a silicone 
interface dressing) (Table 2-1). Due to a lack of rigorous research studies on effective silver 
dressings, hydrofibre and alginate silver dressings are rarely used in Australia and New 
Zealand. 
ActicoatTM (a three-day dressing) and Acticoat7TM (a seven-day dressing) (Smith and 
Nephew, Hull, UK) are antimicrobial barrier dressings impregnated with nanocrystalline 
silver [13]. ActicoatTM consists of three layers: an absorbent middle core of rayon and 
polyester between two outer layers of nanocrystalline silver-coated, low-adherent 
polyethylene mesh. Acticoat7TM has one additional absorbent and one silver layer. 
Acticoat™ dressings are required to be moistened with sterile water to promote the release 
of silver onto the burn wound.  
In comparison, Mepilex AgTM (Mölnlycke Healthcare, Mikkeli, Finland) is an antimicrobial 
silver-sulphate-impregnated foam pad with a polyurethane backing film that incorporates 
Safetac™ silicone technology. Silver particles are released from Mepilex AgTM when it is 
moistened from direct contact with wound exudate. Mepilex Ag™ is indicated to be changed 
every three to seven days.  
2.6.1 Silicone interface dressings 
Dressings that are adherent to the wound can cause trauma on removal and promote skin 
stripping which may increase pain and delay re-epithelialization [57]. The use of a low 
adherent interface such as silicone has advantages, particularly for pediatric patients [58-
60]. The SafetacTM technology (Mölnlycke Healthcare) is a new development in dressings 
and is comprised of soft silicone. It is proposed to adhere to normal, intact skin remaining in 
situ on the surface of a wound but not adhere to the wound bed, maintaining a moist wound 
environment while providing a less traumatic and painful removal and subsequently less 
epidermal damage [8, 61]. This technology may be of great use in the pediatric burn 
population, where pain during dressing change procedures has been found to be detrimental 
to the child in terms wound of re-epithelialization [45-47, 62]. ActicoatTM silver dressing can 
be used in conjunction with non-stick interface dressings such as MepitelTM (Mölnlycke 
Healthcare, Mikkeli, Finland) or on its own. MepitelTM is a silicone-coated nylon grid product 
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that utilizes non-stick SafetacTM technology to reduce dressing adherence to the wound and 
subsequent damage to the wound on dressing removal [57].  
The majority of evidence available regarding SafetacTM technology is in the form of 
observational and case studies, with small sample sizes and the presence of bias. A recent 
study has been conducted in pediatric patients with a variety of burn, traumatic and surgical 
wounds, investigating the effect of a SafetacTM foam dressing on pain during dressing 
application and removal and healing [60]. While this study noted that the Safetac technology 
dressing was associated with lower levels of pain in pediatric patients compared to 
hydrocolloid, film and foam dressings they were previously being treated with, it was an 
observational study, non-specific to burns and used a non-silver dressing. Although 
SafetacTM technology is relatively new and evidence is limited, it shows promise as a 
dressing property that could improve dressing change procedures in the pediatric 
population. 
2.6.2 Antimicrobial properties of silver dressings 
A number of studies have been conducted into the efficacy and antimicrobial properties of 
ActicoatTM for use in a burns population. ActicoatTM has been found in a number of in vitro 
trials to be effective against a broad spectrum of Gram positive and Gram negative bacteria 
[10-15]. Furthermore, Acticoat™ when used to treat patients with burn injuries was found to 
be significantly associated with a lower rate of adverse events (colonizations or infections) 
than those participants treated with the SSD or other non-silver dressings and applications 
[11, 12]. 
A small number of studies have reviewed the evidence regarding the antimicrobial properties 
of Mepilex Ag on a variety of wound types, including acute wounds such as burns and 
chronic wounds in adult patients [8, 63, 64]. While they have provided positive evidence 
regarding the effective antimicrobial action of the silver component in Mepilex AgTM on a 
variety of bacteria compared to other fabric and foam silver dressings, these are only case 
and observational studies. Additionally the results reported in the paper by Chadwick et.al 
[8] may be subject to bias, as the study was funded by Mölnlycke Healthcare and conducted 
by its employees. 
Despite the effective antimicrobial utility of silver products for managing the bio-burden of 
burn wounds, in-vitro studies have shown silver products to be cytotoxic to healthy 
keratinocytes in the wound bed which can delay re-epithelialization [14, 15, 65, 66]. SSD 
was found to be particularly cytotoxic to keratinocytes which result in delayed burn wound 
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re-epithelialization. ActicoatTM has also been found to be cytotoxic to keratinocytes, albeit 
not to the extent of SSD, with in vitro studies showing that SSD is significantly more cytotoxic 
than ActicoatTM  [66]. A fine balance is needed between managing infections in burn wounds 
and promoting re-epithelialization of the wound. Although silver-impregnated dressings have 
been found to be cytotoxic, they remain effective in managing a broad spectrum of bacteria 
and the sequelae resulting from infection, such as Toxic Shock Syndrome which can be fatal 
in pediatric patients. For this reason, preventing infection is often prioritized over wound 
closure [67, 68]. 
2.6.3 Evidence for the use of silver dressings on acute, pediatric burns 
A multi-national survey of burn specialists was conducted by Selig et.al [69] in 2012 
regarding the ideal properties of a burns dressing. The survey found that 100% of specialists 
surveyed wanted pain-free dressing changes, 94.2% wanted a dressing that was easy to 
remove, 87.5% wanted a dressing with a lack of adhesion to the wound bed and 83.5% 
wanted an antimicrobial dressing. However, the survey also found that 92% of the specialists 
who responded felt that a dressing which meets all of these criteria did not yet exist on the 
market, despite the large range available.  
The large range of dressings available has also impacted on dressing choices in pediatric 
burns centers in Australia and New Zealand. A survey completed in 2013 as part of this 
thesis found that ActicoatTM is used across the majority of centers and the use of Mepilex 
AgTM is also quite common. However, across all seven centers, none used the same 
dressing protocol (Table 2-1). Decision-making regarding burns dressing choice is largely 
influenced by research studies; however, current evidence does not provide a clear-cut 
answer as to the most appropriate dressing for pediatric patients.
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Table 2-1 Australian and New Zealand pediatric burn center dressing protocols for partial thickness burns
 Dressing choice Dressing change frequency 
Royal Children’s Hospital, 
Brisbane 
Acticoat™ 3 or 7 with a Mepitel™ interface Every 3-7 days 
Royal Hobart Hospital,  
Hobart 
First 24-48hrs (if silver not required): Hydrofibre, alginate or foam 
dressings 
After 48hrs: Foam or hydrocolloid or silver dressings (Acticoat™ 3 or 
Allevyn Ag Gentle Border) 
Wound review at 24-48hrs post-injury 
Then dressing change every 3-4 days 
Princess Margaret Hospital, 
Perth 
Inner face and peri-orbital: Emollient ointment and chlorsig ointment 
Non-circumferential burns: Acticoat™ with Intrasite Gel interface, 
DuoDERM® covering 
Circumferential: Acticoat™ with Intrasite Gel underneath 
Face care: Every 4hrs 
Other burns: Dressing changes after 
48hrs 
Westmead Children’s Hospital,  
Sydney 
Superficial partial thickness: Mepilex™ or Mepilex Ag™ or Comfeel® 
Mid-dermal: Acticoat™ 7 or Mepilex Ag™ 
Deep dermal partial thickness: Acticoat™ 7 or Biobrane with Acticoat™ 
7 covering 
Acticoat™ every 7 days 
Mepilex Ag™ every 5 days 
Comfeel® every 3 days 
Women’s and Children’s 
Hospital,  
Adelaide 
Acticoat™ 3 or 7 or Mepilex Ag™ 
Intrasite interface under Acticoat™ if particularly dry 
Dressings changed as often as 
clinically indicated 
Royal Children’s Hospital, 
Melbourne 
Acticoat™ 3 or 7 (up to 3 weeks) 
Unhealed at 3 weeks change to Mepilex Ag™ or Xeroform 
Acticoat™ every 3 or 7 days 
Mepilex Ag™ every 7 days 
Xeroform every 3 days 
Middlemore Hospital,  
Auckland, New Zealand 
<1% total body surface area: Acticoat™ 3 
>1% total body surface area: Biobrane (applied under general anesthetic) 
Experimental with Mepilex Ag™ 
Wound reviewed at 48hrs 
Dressing change every 3 days 
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A Cochrane review by Wasiak et.al [17] reviewed all randomized controlled trials that 
investigated dressings used for the treatment of superficial and partial thickness burns. The 
authors included 26 of these studies for analysis in the review on the basis they reported 
outcome measures including time to wound re-epithelialization, number of dressing 
changes, dressing cost, pain associated with dressing removal and application, patient 
satisfaction with the dressing and incidence of infection. Wasiak et.al [17] noted that the 
majority of randomized controlled trials evaluating burns dressings had poor methodology 
reporting and poor measurement of outcomes; in particular, there was inconsistent and non-
objective assessment of burn depth. Only three randomized controlled trials were found to 
investigate silver-impregnated dressings (ActicoatTM only) [70-72], and all three trials 
compared ActicoatTM with SSD, despite existing evidence reporting that SSD can delay 
wound re-epithelialization and is painful to remove and apply. Each of these articles reported 
that mean re-epithelialization times in the Acticoat™ groups were significantly shorter than 
SSD groups. Groups treated with ActicoatTM also reported lower levels of pain than SSD 
treated groups during dressing changes; however, these results were not statistically 
significant. A systematic review by Aziz, Abu and Chong [73] evaluating trials of silver-
containing dressings and topical silver applications for burn injuries also noted that the 
majority of these trials did not differentiate between pediatric and adult populations and 
depths of burn injuries, which makes extrapolation to a pediatric population with 
predominantly partial thickness burn injuries difficult.  
Since publication of the above Cochrane review, two studies have been published which 
compare silver dressings in partial thickness burn injuries [74, 75]. The first investigated the 
use of Acticoat™ versus the hydrofibre silver dressing Aquacel Ag® in a combined adult 
and pediatric population with partial thickness burns up to 40% TBSA [74]. The study found 
that the two dressings resulted in comparable re-epithelialization times, but that Aquacel 
Ag® was significantly more comfortable for patients and more cost-effective than Acticoat™. 
This study did not differentiate between adult and pediatric populations and included large 
TBSA burns which were treated in the inpatient setting. The second study was the only one 
to compare silver dressings in a purely pediatric population with partial thickness burns ≤
10% TBSA [75]. The study compared Acticoat™ and Aquacel Ag® and similarly found no 
statistically significant differences in re-epithelialization between groups at day 10 post-burn, 
but that Aquacel Ag® required fewer dressing changes. 
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The evidence regarding the use of Mepilex AgTM on burn injuries in pediatric or adult 
populations is relatively limited given its recent development [76-78]. Two randomised, 
prospective studies investigating the use of Mepilex AgTM in a burn-specific population have 
been published [77, 78]. Both studies examined the use of Mepilex AgTM for combined adult 
and pediatric burns populations in comparison to the standard care of SSD in terms of pain 
on application and removal and efficacy with regards to re-epithelialization. Patients treated 
with Mepilex AgTM were found to have comparable re-epithelialization rates to those treated 
with SSD, however, patients treated with Mepilex AgTM reported lower levels of pain on 
application and while wearing the dressing compared to SSD. Treatment costs were also 
significantly lower using Mepilex AgTM [78] and both studies reported significantly less 
dressing changes were required for Mepilex Ag™ compared to SSD [77, 78]. These were 
comprehensive studies, however both were limited given their use of SSD as the comparator 
dressing and neither objectively measured burn depth. The combined adult and pediatric 
populations used for each study also makes it difficult to gauge the appropriateness of this 
dressing for the specific needs of a pediatric population.  
The literature on the use of Acticoat™ and Mepilex Ag™ for burn injuries has indicated that 
there remains a lack of comprehensive research investigating the use of these dressings on 
partial thickness burns in the pediatric population. Therefore, there is a need to identify which 
of these dressings is the preferred choice for pediatric patients and which best meet the 
current challenges of burn wound management in this population.
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2.7 Burn scarring and predicting outcome for pediatric partial thickness burns 
2.7.1 Evidence around partial thickness burn outcomes 
The prevention or management of scarring is of prime importance in the pediatric population, 
and there is evidence to support the association between burn re-epithelialization time and 
hypertrophic scarring [7, 79]. A study by Cubison and colleagues [7] on pediatric scald burns 
in Caucasian children (n=337), reported that for burns which re-epithelialized in 10-14 days, 
only 2% had a hypertrophic scar compared to 94% of children who had burns which took 
more than 3 weeks to re-epithelialize. While this research has contributed a significant 
amount of knowledge to scarring in children it is limited by its inclusion of only children with 
scald injuries (i.e. other burn mechanisms are excluded). The study was conducted 
retrospectively and only assessed the presence of hypertrophic scarring and did not 
comprehensively examine potential confounding variables such as burn characteristics or 
objectively assess skin pigmentation or skin thickness changes. 
Anecdotally there is a wealth of clinical experience with long term burn scar outcome for 
children; however, there is a lack of long term clinical research on such outcomes, in 
particular for children who sustain partial thickness burns which re-epithelialize 
conservatively within 3 weeks. In the literature, deep partial thickness and full thickness 
burns in children which require skin grafting and/or scar management therapy are the 
primary focus of research as these burns often require management until a child reaches 
adulthood and beyond. Partial thickness burns (including superficial and deep partial) are 
largely under-researched despite this being the most common type of burn injury in children 
from high-income countries. An observational study by van der Wal [20] compared the 
outcomes of full thickness and partial thickness burns (in adults and children) and noted the 
scar maturation patterns were different with regards to the depth of burn, with those 
sustaining full thickness burns experiencing a worse result. While this has highlighted a 
difference between these burn types, there is still no comprehensive overview of longer term 
burn outcomes from partial thickness burns with regards to the resolution of original skin 
appearance, skin color and return to original color and skin thickness. 
Clinical trials of burn dressings are also important in determining if acute dressings impact 
the scar outcome of the child. Knowledge of longer-term outcomes in addition to acute 
wound re-epithelialization can assist with treatment decision-making when choosing a 
dressing. A recent systematic review of the optimal treatment for partial thickness burns [80] 
noted that of all randomized controlled trials included in the review, only one included a 
longer term follow-up phase of patients  [80]. The follow-up phase of this RCT, however, 
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only consisted of the review of a small number of children (exact number not stated) at 3 
months post re-epithelialization [81]. Furthermore, external to the systematic review, 
Mabrouk et al. [82] compared Aquacel® Ag to the moist, open dressing MEBO and 
conducted three and six month follow-ups, however, age range was broad (children and 
adults), only partial thickness facial burns were included, and follow-up numbers were again 
not stated. The need remains for a high-level clinical trial comparing silver burns dressings 
which also includes a longer-term scar outcome follow-up of trial participants. 
2.8 Burn scar assessment tools 
2.8.1.1 Patient and Observer Scar Assessment Scale 
There are a number of burn scar assessments utilized and the Patient and Observer Scar 
Assessment Scale (POSAS) and the Modified Vancouver Scar Scale (MVSS) are the most 
commonly used. The inter-rater reliability of the POSAS total scores has been established 
in burn scars of participants aged 15-73 years between four observers (ICC 0.92) and the 
inter-rater reliability on individual items of the POSAS is also reasonable [83, 84]. These 
reliability scores have also been confirmed via Rasch analysis [85] and high inter-reliability 
is reported to also encapsulate strong test re-test reliability [86], indicating it is appropriate 
for use longitudinally. [84] While the Modified Vancouver Scar Scale (MVSS) can be 
considered for use in children aged 2-17 years [87], POSAS has been shown to have a high 
quality reliability and superior overall performance compared to the MVSS [84]. Furthermore, 
POSAS is recommended for use when investigating patient opinions of scar in children, 
despite not being valid for children under 12 years, as the evidence for MVSS is even lower 
quality and a Rasch analysis has not yet been completed for this scale [87]. The POSAS 
was also the standard scar assessment scale used in the burns unit at the time of the trial 
conducted for this thesis and as the majority of children treated are under the age of 3, scar 
assessment is completed by parents. 
The POSAS is a two-part assessment scale (observer scale and patient scale) utilized to 
assess burn scars [83] (see Appendix 1). Scars are assessed by the observer (occupational 
therapist or physiotherapist) using visual evaluation and palpation of the scar. The scales 
assess the scar on six items and an overall opinion score. All items are given a score out of 
10, with a score of 10 equal to the ‘worst imaginable scar’:  
Observer scale: Vascularity, pigmentation, thickness, pliability, relief and surface area  
Patient scale: Itch, pain, thickness, color, stiffness, irregularity 
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2.8.1.2 Objective burn scar measures 
Longitudinal burn scar quantification has made a gradual move from subjective to objective 
assessment in recent years as new technology has developed and improved. There is an 
increased interest in quantifiably measuring skin and scar characteristics and examining the 
changes to the skin as scar tissue matures over time. Two devices which have come to 
prominence are 3D photography and ultrasound.  
2.8.1.3 3D photography 
3D photography (or 3D stereophotogrammetry) has been shown to be reliable and valid in 
the mapping of chronic wounds and some pediatric burn wounds [40, 41].This device also 
has the ability to measure the height, surface area and volume of burn scars. Previous 
research has found that 3D stereophotogrammetry is a reliable and valid technique for the 
measurement scar surface area (ICC 0.99) and volume (ICC 0.99) in burn, keloid and linear 
scars in combined adult and pediatric populations [88, 89]. Given the non-invasive method 
of the camera and ease of operation, it is hypothesized that this technique may be suitable 
for burn scar assessment in the pediatric population where compliance during procedures 
is challenging. 
2.8.1.4 Ultrasound 
As clinical evaluation of burn scars is typically completed through visual assessment and 
palpation of the scar, objective measurement of scar thickness, scar progression over time 
and the level that scar tissue may extend internally is of interest. Data concerning skin 
thickness of children at varying ages and by anatomical area is extremely limited. One study 
of ultrasound measured skin thickness in children aged 2-13 years indicated that skin 
thickness in children is approximately 1.0-2.0mm which increases with age and can vary 
depending on the anatomical area of the body (e.g. soles of feet compared to the face) [90] 
- however, this data has yet to be confirmed via biopsy and/or histological examination.  
There is limited research on the use of ultrasound to measure skin and scar thickness and 
little information regarding the most appropriate device for a pediatric population. Available 
research on the use of ultrasound for the evaluation of burn scars is primarily focused on 
the Dermascan C device (Cortex Technology, Denmark). This device is a high frequency 20 
MHz echogenic ultrasound which uses a water-filled transducer to produce high resolution 
soft tissue images at a depth of 15mm [91, 92]. Dermascan C has been found to be a reliable 
in the measurement of burn scar thickness in adult burn scar populations [91, 92]. The 
device is, however, clinically reported to have a lengthy and complex set-up process (for 
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example, the precise application of film over the transducer head) and is cumbersome to 
transport and use, which may not be logistically appropriate for a pediatric population. 
Only one paper has investigated ultrasound assessment of burn scars in children [93]. This 
study used the GE LOGIQ 500 (GE Healthcare) with a 5-10 MHz transducer head and found 
that ultrasound measurement of skin thickness correlated with clinical estimation; however, 
it did not determine if this device was a reliable and valid option for pediatric scar 
assessment. This study was conducted 15 years ago and new ultrasound devices have 
since become available that may be more suitable and can scan at a higher frequency. 
An appropriate ultrasound device with a high clinical utility for use in pediatric burn scar 
populations has not yet been identified. The Venue 40 MSK ultrasound (GE Healthcare, 
Australia) (Figure 2-4) is one of many recently developed ultrasound devices for pediatric 
burn scar assessment which has simple set-up process, fast scan time and is low profile 
and easily transportable. This ultrasound device utilizes a higher frequency (compared to 
the GE LOGIQ 500) 8-18 MHz hockey stick probe and can provide soft tissue images to a 
penetration depth of 20mm below the surface of the skin. The clinical utility of this device 
has yet to be established, but will be initially assessed in this thesis. 
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Figure 2-4 Venue 40 MSK Ultrasound (GE Healthcare) 
 
2.8.2 Psychosocial impact of partial thickness burn scarring 
In comparison to the high risk of hypertrophic scar development in children with severe burns 
requiring skin grafting, the long term outcome for pediatric partial thickness burns is less 
complex, with the majority of children discharged at the point of wound re-epithelialization, 
without requiring scar management therapy. Partial thickness burn sites are clinically 
reported to return to normal skin appearance and pigmentation within six months post-
wound re-epithelialization, but there is very limited research-based evidence to support this.  
Changes in skin pigmentation and appearance as a result of partial thickness burns are at 
the lower end of the spectrum in terms of clinical significance, as many of these changes 
are assumed to be temporary with resolution in 6-12 months. However, there is the capacity 
for such appearance changes to negatively impact on the psychosocial functioning of 
children and their families, particularly for children with darker skin types where pigmentation 
may take a longer amount of time to return. Studies in children and adolescents with ‘visible’ 
burn scars or skin pigmentation conditions such as vitiligo have shown that children and 
adolescents experience negative psychosocial sequelae such as depression, anxiety, low 
self-esteem and reductions in health-related quality of life [94-97]. 
2.9 Parent experience of pediatric outpatient burn care 
The child-parent relationship is an important aspect of burn care with many burn patients 
under the age of five years reliant on parental support and care during treatment. Parents 
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often witness the burn accident and subsequently accompany the child through painful 
wound care procedures and assist with managing the burn wound at home, all of which can 
influence stress levels [21]. The relationship of parent distress and the impact on child 
distress is well-researched with numerous studies reporting that a child’s distress can be 
influenced by parents’ responses to the traumatic event [23, 98, 99]. Studies have found 
that parent behaviors related to situational distress and anticipation of child distress can 
influence the child’s response and psychological recovery from a burn injury [23, 98, 99].  
Parent experiences of pediatric burn care reported in the literature are largely confined to 
large, severe burns requiring lengthy inpatient hospitalization periods. Qualitative studies of 
parents found that many reported experiencing negative coping reactions such as guilt, 
blame and hopelessness during their child’s hospitalization. In addition, watching their child 
in pain or enduring painful procedures was a major stressor [100-102]. While outpatient burn 
care is a different environment and a more short-lived experience for parents, it remains 
unexplored in the literature despite evidence that post-traumatic stress symptoms in parents 
may not be confined to burn injuries at the serious end of the spectrum [24]. 
2.10 Summary 
This review has identified major gaps in the literature for pediatric partial thickness burn care 
in the outpatient setting; with respect to dressing choice, objective wound and scar 
assessment tools, partial thickness burn scar outcomes and parent experiences. The aim of 
this thesis is to therefore provide a holistic and comprehensive overview of pediatric partial 
thickness burn care to address these discrepancies in the literature. 
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Chapter 3. Quantitative Methodology 
 
This chapter is based on a published paper in Trials journal. 
Citation: Gee Kee E, Kimble RM, Cuttle L, Stockton K. Comparison of three different 
dressings for partial thickness burns in children: study protocol for a randomized controlled 
trial. Trials. 2013;14:403
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3.1 Chapter foreword  
The dressings applied to acute burn wound injuries in children are a major and vital 
component of burn care, given the propensity for functional and psychosocial implications 
associated with delayed wound re-epithelialization time and possible surgical intervention. 
Specialised burns dressings containing silver for partial thickness burns up to 10% TBSA in 
children are continually evolving and improving, thus, the requirement for high quality 
research also increases.  
Despite the prevalence of partial thickness burns in children, well-conducted clinical trials of 
topical applications and dressings for these injuries are lacking [17]. While there is evidence 
available supporting the use of silver dressings for the management of burn injuries in adults 
and children, there are significant limitations in the methodologies of many of these studies. 
Previous systematic reviews have noted that many randomized controlled trials evaluating 
burns dressings available in the literature contained poor methodology reporting (e.g. trials 
insufficiently powered to find statistical significance in data, combined adult and pediatric 
populations, large TBSA ranges) and poor measurement of outcomes (e.g. no formal or 
objective assessment of burn depth) [17, 80]. 
As the literature review indicated, a rigorous clinical trial, which also included a follow-up 
scar assessment phase and economic evaluation, was needed to identify the most effective 
silver dressing to use for children. This chapter is based on the publication titled ‘Comparison 
of three different dressings for partial thickness burns in children: study protocol for a 
randomized controlled trial’ and details the methodology for two of the quantitative sections 
in the thesis. This encompasses a randomized controlled trial of silver dressings in children 
with partial thickness burns, and a scar assessment of the same group of children. A brief 
overview of the economic evaluation is presented in this chapter, with a detailed 
methodology along with results and discussion to follow in Chapter 6. This methodology 
chapter was developed to address methodological and outcome measurement limitations 
identified in previous trials and provide a solid base for a clinical trial which would allow for 
translation of research findings to clinical practice. 
3.2 Abstract 
3.2.1 Background 
In the pediatric population, pain and distress associated with burn injuries during wound care 
procedures remains a constant challenge. Although silver dressings are the gold standard 
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for burn care in Australasia, very few high level trials have been conducted which compare 
silver dressings to determine which will clinically provide the best level of care. Therefore, 
for pediatric patients in particular, identifying silver dressings that are associated with lower 
levels of pain and rapid wound re-epithelialization is imperative.  This study will determine if 
there is a difference in time to re-epithelialization and pain and distress experienced during 
wound care procedures between ActicoatTM, ActicoatTM combined with MepitelTM and 
Mepilex AgTM dressings for acute, pediatric partial thickness burns. 
3.2.2 Methods/Design 
Children aged 0 to 15 years with an acute partial thickness (superficial partial to deep partial 
thickness inclusive) burn injury and a burn total body surface area of ≤10% will be eligible 
for the trial. Patients will be randomized to one of the three dressing groups 1) ActicoatTM or 
2) ActicoatTM combined with MepitelTM or 3) Mepilex AgTM. A minimum of 28 participants will 
be recruited for each treatment group. Primary measures of pain, distress and healing will 
be repeated at each dressing change until complete wound re-epithelialization occurs or 
skin grafting is required. Additional data collected will include infection status at each 
dressing change, physical function, scar outcome and scar management requirements, cost 
effectiveness of each dressing, and staff perspectives of the dressings. 
3.2.3 Discussion 
The results of this study will determine the effects of three commonly used silver and silicone 
burns dressing combinations on the rate of wound re-epithelialization and pain experienced 
during dressing procedures in acute, pediatric partial thickness burns injuries. 
3.3 Trial registration 
Australian New Zealand Clinical Trials Registry ACTRN12613000105741. 
3.4 Keywords 
Child, burn injuries, partial thickness, silver dressings, healing, pain, distress, randomized 
clinical trial
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3.5 Background 
The ultimate goal of burn wound healing is to promote early closure, as this has considerable 
influence on the long term quality and appearance of a hypertrophic scar. It has been 
demonstrated that even scars considered small in size can contribute to negative 
psychosocial outcomes for children, hence the importance of effective wound healing 
techniques [103, 104]. The relationship between scar formation and time taken to re-
epithelialize in children is well understood by burns clinicians. According to Cubison et.al [7], 
partial thickness burns that re-epithelialize within the optimal time period of 10-14 days 
generally do so without scarring, and those taking more than three weeks will invariably 
scar. Burns re-epithelializing between two and three weeks will have variable amounts of 
scar tissue laid down depending on many factors including skin type, anatomical location of 
the burn and age of child [7]. 
Children whose burn wounds re-epithelialize after the three weeks post-injury are at a high 
risk of residual or hypertrophic scarring [7]. Scar management therapy facilitated by 
occupational therapists to manage and prevent hypertrophic scarring currently involves of 
the use of various types of silicone contact media, pressure garments and splints. 
Engagement in scar management therapy typically occurs for 18 months or until scars reach 
maturity. While these scar management techniques are successful for some children in 
managing scars, there are inevitably children who require ongoing treatment of their scar 
tissue as they grow older.  Scars generally do not grow with the child, and if situated around 
a joint, can lead to joint contracture and loss of function, resulting in ongoing scar 
reconstruction to keep up with the child’s growing body [105]. Therefore, the initial care of 
the burn wound and choice of burn dressing is vital in creating the ideal healing environment 
to ensure rapid re-epithelialization of the wound and to avoid the possibility of hypertrophic 
scarring.   
In the past 30-40 years, children with burns were treated with daily baths, dressing changes 
and antiseptic or topical silver sulfadiazine-based creams; however, even with appropriate 
pain relief these procedures were often very distressing and painful for children [106]. It has 
been well documented that burn wound care procedures are highly traumatic for children 
and the resultant stress has been shown to interrupt and delay the cascade of wound healing 
[47]. Decreasing the pain and distress experienced during a dressing change procedure can 
have positive implications psychosocially for the child as well as encouraging re-
epithelialization of the wound within the optimal healing timeframe [50]. Therefore, in the 
pediatric population, careful attention also needs to be made concerning choosing a 
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dressing that can be applied and removed with minimal pain and stress to the child. A 
dressing which requires infrequent reapplication also has obvious benefits by decreasing 
the number of dressing change procedures the child has to undergo. 
Small- to medium-sized partial thickness burns are mainly managed in the outpatient setting 
using specialized dressings which promote moist wound healing and prevent wound 
infection [73]. Unfortunately the antibacterial agents in burns dressings are also cytotoxic to 
keratinocytes: therefore, a fine balance is required between the prevention of a wound 
infection and the promotion of wound healing [11]. Despite the known cytotoxic effects of 
antibacterial dressings, they help prevent not only infections (which can delay the rate of re-
epithelialization) but also the possibility of toxic shock syndrome (TSS), which is most likely 
to occur in the first three days post-burn injury and if left untreated can be fatal [65-67].  
The standard of care in burns dressings for small to medium partial thickness burns has 
changed in the last 10-15 years. Currently silver–depositing fabric and foam dressings are 
the gold standard used to manage the bio-burden of a wound, with or without a silicone skin 
interface [9]. ActicoatTM (Smith & Nephew, Hull, UK) has been available since the 1990s and 
is the most widely used silver dressing in the developed world. It is required to be moistened 
with sterile water to promote the release of silver onto the burn wound and can be left on for 
3-4 days. ActicoatTM may be used alone or in combination with a MepitelTM dressing 
(Mölnlycke Healthcare, Mikkeli, Finland), which acts as a non-stick interface between 
ActicoatTM and the burn wound. MepitelTM is a silicone-coated nylon grid product that utilizes 
non-stick SafetacTM technology to reduce the pain and trauma experienced by children 
during dressing changes and the amount of silver in direct contact with the wound.  Mepilex 
AgTM (Mölnlycke Healthcare, Mikkeli, Finland) has been available since 2007 and is a soft 
foam, silver-impregnated dressing that absorbs exudate and maintains a moist wound 
environment [63]. Silver particles are released from Mepilex AgTM when it is moistened from 
direct contact with wound exudate. It also has a silicone SafetacTM interface layer 
incorporated within its design that in a similar way to the MepitelTM, serves to promote easy 
removal of the dressing and reduce pain and trauma during dressing changes [63]. 
Many trials have been conducted regarding the efficacy of silver dressings for treating burn 
injuries, using topical silver sulfadiazine applications as the control or comparator dressing. 
However, these silver sulfadiazine applications have been shown to delay re-
epithelialization and are painful to apply and remove, indicating the possibility of bias in the 
results of these trials [17].  Additionally, despite the large number of silver-impregnated 
burns dressings that have become available on the market, very few high level trials have 
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been conducted which compare these dressings in pediatric or adult patients. For pediatric 
patients in particular, identifying silver dressings that are associated with lower levels of 
pain, require fewer reapplications and promote a fast rate of re-epithelialization is vital.  
The aim of this study is to then determine whether one of three silver and silicone containing 
burns dressings—ActicoatTM, ActicoatTM combined with MepitelTM or Mepilex AgTM—will be 
more effective in terms of pain experienced and the rate of re-epithelialization of acute, 
partial thickness burns in children.  
The following protocol for this study has been reported as per CONSORT guidelines [107]. 
3.6 Methods 
3.6.1 Ethics Approval 
This study is registered with the Australian New Zealand Clinical Trials Registry 
(ACTRN12613000105741) and approved by the Queensland Children’s Health Services 
(Royal Children’s Hospital) Human Research Ethics Committee and The University of 
Queensland Ethics Committee. 
3.6.2 Study Design 
This study is a prospective, randomized controlled trial. Participants will be randomized to 
receive one of three commonly used dressings for burn wounds (1) ActicoatTM (2) ActicoatTM 
and MepitelTM combined or (3) Mepilex AgTM, in order to determine the effects of the 
dressings on pain and the rate of re-epithelialization in acute, partial thickness burns in 
children. It is hypothesized that silver dressings with a silicone interface, compared to no 
silicone interface, will decrease the time to re-epithelialization of a burn injury and decrease 
the amount of pain and distress experienced during dressing changes within a pediatric 
population. The design of data collection is displayed in Figure 3-1. 
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Figure 3-1 Data collection flowchart: The chronological timing and order of data collection within the burn 
wound care procedure framework 
 
 
 
Assessed for eligibility  
Excluded   
♦   Not meeting inclusion criteria  
♦   Declined to participate 
♦   Other reasons 
Allocated to ActicoatTM dressing  
φ Dressing change every 3-4 days 
until re-epithelialization or graft 
φ Pain and distress measures 
φ Visitrak tracing and 3D 
photograph 
Enrolment 
Randomization 
3 month follow-up 
6 month follow-up 
Allocated to ActicoatTM and 
MepitelTM dressing 
φ Dressing change every 3-4 days 
until re-epithelialization or graft 
φ Pain and distress measures 
φ Visitrak tracing and 3D 
photograph 
Allocated to Mepilex AgTM dressing  
φ Dressing change every 3-4 days 
until re-epithelialization or graft 
φ Pain and distress measures 
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3.6.3 Study setting 
Participants for this study will be recruited from the Royal Children’s Hospital, Brisbane, 
Australia. Children presenting to the Department of Emergency (DEM) from March 2013 will 
be screened on presentation by a surgical registrar for eligibility to this study.   
3.6.4 Participants 
3.6.4.1 Inclusion criteria 
Children who are aged 0 to 15 years with an acute partial thickness (superficial partial to 
deep dermal partial thickness inclusive) burn injury and a burn total body surface area of ≤
10%, presenting at the DEM within the first 72 hours post-injury will be considered for 
inclusion in this study. 
3.6.4.2 Exclusion criteria 
Children will be excluded from this study if they present >72 hours post burn; have received 
silver dressings prior to presentation at the Royal Children’s Hospital; have sustained a 
superficial (erythema only) or full thickness burn; have sustained a chemical or friction burn; 
present with cold, flu or viral symptoms (e.g. upper respiratory tract infection); have received 
inappropriate first aid (e.g. dirty water); have a known reaction to silver products; are non-
English speaking; have a cognitive impairment; or are currently involved with Department of 
Communities (Child Safety).  
Additionally, any children who have burn wounds requiring grafting, contract an infection or 
need to change dressing type during the course of their treatment will only have data 
collected up until that point in time (as per intention to treat protocol), as these changes in 
clinical care will void the intervention they have been randomized into for the study. 
Apart from the dressings received, children participating in this study will receive the same 
standard medical care as those children not participating in the study.  
3.6.5 Recruitment 
A surgical registrar will be notified of a patient with a burn injury by DEM staff and will then 
determine patient’s eligibility according to study criteria. The potential participants and their 
parents/caregivers will be notified of their eligibility to participate in this study by the registrar. 
Parents/caregivers will then be asked if a member of the research team can speak to them 
about the study. Informed caregiver consent and child assent (for children 6 years and 
above) will be gained by an investigator on the study after a discussion with the child and 
their caregiver regarding the information in the Patient Information Sheet. Once consent is 
gained, the investigator will randomize the patient to one of the three dressing treatment 
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arms. Randomization will be completed using a computerized random number generator 
and randomizations will be enclosed in sealed, opaque envelopes by an independent party. 
All dressings will be carried out by staff experienced in burns dressing application. Baseline 
measures (pain and behavioral scores from child, nurse and parent, pulse rate and 
respiratory rate) will be recorded by the primary investigator prior to and after the dressing 
is applied. The patient will then present at our burns center every 3-4 days for subsequent 
dressing changes. Any analgesia given to the patient will be recorded. 
The first three days post-burn injury often have the highest risk of Toxic Shock Syndrome, 
which is potentially fatal if left untreated [67, 108].While the incidence rate of Toxic Shock 
Syndrome at our burns center is extremely low to non-existent, phone calls will be made to 
each participant by the primary investigator within this period. A set of standardized 
questions will be used to screen for any Toxic Shock Syndrome symptoms and to assess 
how the child and their parents or caregivers are managing the dressing and all responses 
will be recorded. 
3.6.6 Intervention 
The intervention will be one of either ActicoatTM, ActicoatTM combined with MepitelTM or 
Mepilex AgTM dressing arms that the participant is randomized into on presentation. This 
dressing will then be used to treat the burn wound and will be replaced every 3-4days at 
each dressing change until re-epithelialization occurs or grafting is required. The dressings 
will be applied according to manufacturer’s instructions. 
3.6.7 Data collection 
Demographic information and clinical details will be obtained from the caregiver and the 
patient’s chart regarding: mechanism of the burn injury, the site of the injury, total body 
surface area of the burn and first aid the patient received. Children over the age of 4 years 
will be given the DittoTM (virtual reality) device (Diversionary Therapy Technologies, 
Queensland, Australia) to engage in the “Bobby got a Burn” procedural preparation story at 
their first dressing change. These children may also engage in a choice of games or stories 
on the DittoTM during all dressing changes.  At the first dressing change only, each 
participant will have their burn/s scanned using the LDI2-BI (VR) Laser Doppler Imager (LDI) 
(Moor Instruments, Axminster, Devon, UK), which measures wound depths (in blood 
perfusion units) as a percentage of total wound area. The Laser Doppler Imager scan will 
provide an objective assessment of burn depth to enable a comparison of treatment group 
demographics [109]. Participants who have burn wounds on different body parts will have 
separate scans completed for each body part involved. If burn wounds are circumferential 
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or across curved areas, more than one scan will be taken at frontal, lateral and medial 
aspects to obtain an accurate scan. In addition, blinded photo reviews of burn depth will be 
undertaken by a panel of burns specialists (consultants and nursing staff). 
At each dressing change appointment, pain, behavior and physiological measures (pulse 
rate and respiratory rate) will be taken before and after dressing removal and before and 
after the re-application of a new dressing. The time taken for the dressing removal, cleaning 
and re-application procedure, the number of nurses required to complete the entire 
procedure, quantity of dressings used and analgesia given to the participant will be 
recorded. A tracing of the wound using VisitrakTM grids (Smith & Nephew, Hull, UK) and a 
photograph using the 3D LifeViz Camera (Quantificare, Cedex, France) will be taken. 
Nursing staff treating the child will be surveyed on a 5-point Likert-scale regarding the ease 
of use of the dressing for that particular child. Parents or caregivers and children over the 
age of 8 years will be surveyed on a 5-point Likert-scale regarding their physical function 
while wearing the dressing. 
All participants in the study will have their dressings changed every 3-4 days at our burns 
center as a standard measure. This protocol will be followed until full re-epithelialization of 
the wound occurs or grafting of the wound is required [110]. After full re-epithelialization 
occurs, participants will be followed-up at 3 months and then 6 months time to assess skin 
appearance and/or the presence of scarring. 
3.6.8 Primary outcome measures 
3.6.8.1 Days to re-epithelialization 
The number of days from the burn injury date until wound re-epithelialization occurs, surface 
area of the wound, and percentage of wound re-epithelialization will be calculated by four 
methods: 1) clinical judgement from the consultant; 2) use of VisitrakTM grids; 3) 3D camera 
photographs and analysis on specialist computer software; and 4) blinded review of the 3D 
photographs by a panel of burns specialists (consultants and nursing staff). 
3D photographs and VisitrakTM tracings will be taken of a participant’s burn wound at every 
dressing change. A ruler will be included in all 3D photographs for measurement calibration 
in the associated software package DermapixTM (Quantificare, Cedex, France). The 3D 
photographs will be analyzed by the primary investigator on the DermapixTM software 
program to calculate burn wound surface area and area of re-epithelialization of the wound 
from each dressing change. The VisitrakTM will also be used to trace around total burn area 
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and re-epithelialized areas of the burn wounds at each dressing change, in order to calculate 
wound surface area and percentage of re-epithelialization.  
A blinded review of the 3D photographs will be undertaken by a panel of burn wound 
specialists (consultants and nursing staff), who will assess the progress of re-
epithelialization and appearance of each participant’s burn wound after data collection has 
been completed. 
3.6.8.2 Pain  
Pain and distress will assessed by obtaining: 1) the participant’s self-report of pain intensity 
using the Faces Pain Scale-Revised (FPS-R) (if participant is aged 3 years or over) [111]; 
2) the parent’s report of the participant’s pain intensity using a Visual Analogue Scale-Pain 
(VAS-P) (alternatively, if participants are aged 8 years or over they will complete the VAS-P 
in lieu of the caregiver) [112]; 3) the nurse’s observational rating of the participant’s pain and 
distress using the Face, Legs, Activity, Cry, Consolability (FLACC) scale [113]; and 4) pulse 
and respiratory rates of the participant.. All four of these measures will be taken before and 
after dressing removal and before and after dressing application. Heart and respiratory rates 
will be recorded once at each time point to provide an objective measure of pain and distress 
in participants, as increases in these physiological measures have been shown to be 
indicative of pain and distress [47, 52]. Heart rate will be measured using a pulse oximeter 
and respiratory rate will be measured by visually counting the number of breaths taken per 
minute. Any analgesic and/or sedative medication administered to the participant at each 
dressing change will also be recorded. 
Face scales are particularly useful for obtaining self-report pain scores from younger 
children as they have been reported to be easier to follow than other types of self-report 
scales and are well-validated measures [114]. The FPS-R is clinically valid for a pediatric 
population and was chosen over other faces pain scales due to its psychometrically sound 
characteristics, including the exclusion of smiling faces or tears, thus eliminating the possible 
confusion of pain intensity and affect by children [111]. The VAS-P is a valid and reliable 
self-report measure of acute pain in children over the age of 8 years [112]. The VAS-P is 
not valid for children under the age of 8, but is valid as a parent-report measure of pain; 
therefore, parents and caregivers of the children in this study will instead score their child’s 
pain level [112]. The FLACC scale is a valid and reliable behavioral observer-report (nurse 
or health professional) measure of a child’s pain. Self-reports of pain intensity can be difficult 
to ascertain and inaccurate when a child is receiving sedative and analgesic medications or 
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is too young to verbalize their pain level, therefore the use of the FLACC scale can be a 
suitable and accurate alternative [113].  
3.6.9 Secondary outcome measures 
3.6.9.1 Physical function 
A self report of the participants’ ease of movement while wearing the dressing will be 
obtained using a 5-point Likert-scale question from children over the age of 8 years or their 
caregiver at the first dressing change [78].  
3.6.9.2 Grafting 
A note will be recorded if a participant’s wound requires grafting. Data collection will cease 
on that date for the participant as different dressings are used for wounds which are grafted, 
however, all data preceding that point will be included for analysis. 
3.6.9.3 Infection 
At each dressing change, the wound will be assessed clinically by the consultant. If the 
consultant deems an infection to be present, a swab will be taken from the wound for 
confirmation and identification. 
3.6.9.4 Cost-effectiveness of dressings 
At each dressing change, nursing time to apply the dressing, the amount and size of each 
dressing used and any other resources required will be recorded and a cost-analysis will 
then be calculated. Additionally, dressings required for scar management will also be 
recorded and analyzed. 
3.6.9.5 Scar assessment 
If further scar management treatment is required after full re-epithelialization of the burn 
injury occurs, a referral will be made by the treating consultant to the scar management 
clinic. At 3 months following full re-epithelialization of the burn injury, a face-to-face follow-
up will be completed with all participants to conduct a skin and/or scar review in conjunction 
with Occupational Therapy. An ultrasound scan (BT12 Venue 40 MSK, GE Healthcare) [109] 
will be taken of the burn area to measure the height of the scar, and digital and 3D 
photographs will also be taken. The Patient and Observer Scar Assessment Scale will also 
be completed with the child (if over the age of 6 years) and/or caregiver. All scar 
management resources used with the participant will be recorded for cost-analysis. At 6 
months post-full re-epithelialization, the same measures will be repeated. 
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3.6.9.6 Burns center staff perspectives on dressings 
Nursing staff, consultants and occupational therapists from our burns center will be surveyed 
regarding their opinions of the three dressings prior to the commencement of data collection. 
The survey questions will be standardized and consist of Likert scales, tick boxes with a 
selection of responses and additional space for comments regarding the dressings. Nursing 
staff will be surveyed again using the same questions after data collection has ceased, to 
examine any changes in their perceptions of the dressings after using all three for an 
extended period of time. 
3.6.10 Blinding 
The dressing used for each participant cannot be completely masked, as the ActicoatTM 
dressing stains the healthy skin around a burn wound brown. The expert panel of burn 
wound specialists will be blinded where possible, however, the primary investigator and 
expert panel may still be able to deduce what dressing a participant received. The primary 
investigator will also be present when dressings are being applied and removed to obtain 
pain scores from the participant, caregiver and nursing staff, and will see which dressing is 
being used on the child. Wherever possible during data collation and analysis, treatment 
groups will be de-identified. 
3.6.11 Discontinuation/adverse events 
The infection of the burn wound is a potential adverse effect of any of the burns dressings. 
Infection rates at our burn center are extremely low, however, if any adverse effects such 
as infection occur, participants will only have data collected up until that point in time 
analyzed, as clinical care (including dressing type) may change to address the adverse 
event. Additionally, if a consultant feels that a particular dressing is not appropriate for a 
participant’s care, they may change to a different dressing. If this occurs, data collection for 
the participant will cease from this date. All data preceding this date will be included for 
analysis. 
3.6.12  Statistics 
3.6.12.1 Sample size 
The primary outcome measure will be days until wound re-epithelialization. Previous data in 
pediatric burns patients demonstrated re-epithelialization within 15 (SD = 4) days and a 
minimally clinically important difference is 3 days [47]. Thus sample size was calculated at 
28 per group at 80% power with an α of 0.05. Allowing for 20% loss to follow up, a total of 
100 participants will be required. The burn center treats 800 children per year with burns so 
recruitment for this study should be achievable within one year. This sample size will also 
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be adequate to find a significant difference in data collected from pain scores, powered on 
data from a previous study [47]. 
3.6.12.2 Data analysis 
All statistical analyses will be conducted using SPSS 21 (IBM Corporation, Armonk, NY, 
USA). Generalized linear models, estimating variance appropriately for repeated measures, 
will be used to determine whether there are differences between the ActicoatTM group, the 
ActicoatTM combined with MepitelTM group and the Mepilex AgTM group in primary and 
secondary outcomes. Changes in the intervention effects will be examined with burn depth, 
burn total body surface area, mechanism of injury, anatomical location of burn, skin type, 
ease of dressing removal and application, and physical function considered a priori to be of 
potential interest. All data will be analyzed as intention to treat and on a per protocol basis, 
with the intention to treat analysis being the primary approach for this trial. Any missing data 
will be handled using the multiple imputation method. All tests will be two-tailed and only 
those with a p value <0.05 will be considered statistically significant. 
3.6.13  Data storage 
Data will be securely stored in a locked filing cabinet in a secure area of Queensland 
Children’s Medical Research Institute, The University of Queensland. Data will be entered 
into an SPSS spreadsheet and any incomplete data will be coded as missing, unknown or 
not applicable. The full dataset will be cleaned and checked before being locked for analysis. 
On completion of the study, data will be kept for a period of 15 years in accordance with 
NHMRC guidelines. 
3.7 Discussion 
Pain and distress during dressing change procedures remains a major challenge when 
treating acute pediatric burn injuries and can have a negative effect on healing [47]. Although 
silver dressings are the gold standard for burn care in Australasia, very few high level trials 
have been completed comparing the clinical utilities of these dressings, particularly in 
relation to pain and rates of re-epithelialization in pediatric burns patients. Additionally, the 
majority of trials that are available on these dressings only show the benefits of using these 
silver dressings in comparison with silver sulfadiazine creams for burn injuries, and are not 
specific to pediatric or adult patients [9, 17, 108]. Therefore, for pediatric patients in 
particular, identifying silver dressings that are associated with lower levels of pain and rapid 
wound re-epithelialization is imperative not only for clinical care, but also to facilitate further 
evidence based practice in this field.  
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A clear link has been established between the rate of re-epithelialization of a burn wound 
and the risk of hypertrophic scarring. Partial thickness burn injuries that heal within 10-14 
days are at a very low risk of developing hypertrophic scarring, whereas wounds that re-
epithelialize within two to three weeks will inevitably produce some scar tissue, and those 
wounds taking more than three weeks to heal are likely to result in hypertrophic scarring [7]. 
Given this knowledge, if there is a silver dressing that is associated with a reduced time for 
a burn injury to re-epithelialize, there is a possibility that partial thickness burns can be 
healed within the optimal time period of 10-14 days which could subsequently reduce the 
risk of hypertrophic scarring and the need for reconstructive surgery in pediatric patients 
with this depth of burn. 
The associated pain experienced during dressing removal and re-application by pediatric 
patients is a significant problem for health professionals. Previous studies have shown that 
an increase in pain, anxiety and distress during various types of wound care procedures can 
have a negative effect on the healing cascade [47, 50, 52]. This negative effect on the rate 
of re-epithelialization in pediatric patients with burn injuries may increase the likelihood of 
hypertrophic scarring as a result of the injuries not healing in the optimal time period. It is 
therefore imperative to identify a silver dressing that promotes a fast rate of re-
epithelialization and that induces the least amount of pain and discomfort on removal and 
application for pediatric patients. Dressings that are comfortable, easy to move in, and which 
require infrequent changes are also beneficial for the pediatric population. 
While every precaution possible will be taken for this study, there still may be some 
limitations involved with data collection. All children recruited into the study will have a Laser 
Doppler Imager scan taken of their burn wound [109]. Although the scan can be completed 
for children of any age, children are required to remain still for a period of time with their 
wound exposed to the air and free of dressings while the scan is being taken. Given that 
this study is recruiting all children under the age of 16 years, completing these scans may 
be difficult if not impossible in some circumstances due to the age of the child and associated 
pain from the exposed wound. Thus, to compensate for this limitation, a blinded photo review 
of burn depth by a panel of burns specialists will also be undertaken. Additionally, completing 
VisitrakTM tracings on some children may be a challenge, as they are again required to 
remain still and may experience pain or discomfort when the VisitrakTM grid is in direct 
contact with their wound.  
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3.8  Significance of study 
In Australasia, the standard of care in burns dressings for small to medium partial thickness 
burns has changed over the past 10-15 years. Currently, silver containing dressings are 
used as the gold standard of burn care to prevent infection and promote healing. However 
despite the large number of silver burns dressings available on the market, very few high 
level trials have been conducted in pediatric or adult patients. This study aims to determine 
the effect of ActicoatTM, ActicoatTM combined with MepitelTM and Mepilex AgTM burns 
dressings on the rate of re-epithelialization of partial thickness burn wounds and pain and 
distress levels during the treatment of these injuries in the pediatric population.  
3.9  Trial status 
This study commenced recruitment on March 18, 2013. Completion of participant 
recruitment is planned by December 2013 and data collection is likely to continue to June 
2014 (with data collection continuing until six months post re-epithelialization of participant’s 
burns).   
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3.15  Chapter conclusion 
This chapter has described the methodology for the randomized controlled trial and scar 
assessment follow-up phase in addition to a short summary of the economic evaluation.  
In addition to these three sections, a reliability and clinical utility analysis of the 3D LifeViz™ 
system (3D camera) was also undertaken with wound surface area measurements taken 
during the randomized controlled trial using the 3D camera and Visitrak™ tools. Previous 
trials measuring wound surface area have used invasive measures such as the Visitrak™, 
which involves placing a plastic grid onto the wound to measure the area. However, the 3D 
camera is a new, non-invasive alternative to Visitrak™ and use of this tool clinically in the 
acute, pediatric population would be of great benefit. A detailed methodology and 
presentation of results on this additional section will be provided separately in Chapter 5. 
As this methodology was published as a trial protocol, publications included in this thesis 
will follow the exact scheme of data collection and data analysis as detailed in this chapter 
for accuracy and consistency. The following chapters will be separated out into the 
randomized controlled trial, 3D camera and Visitrak™ reliability, scar assessment and 
economic evaluation respectively. Each chapter will include further elucidation of 
methodological details where required and detailed results and discussion sections.   
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Chapter 4. Randomized controlled trial 
of silver dressings for pediatric partial 
thickness burns 
 
This chapter is based on a published paper in Burns journal. 
 
Citation: Gee Kee, E. L., Kimble, R. M., Cuttle, L., Khan, A., & Stockton, K. A. (2015). 
Randomized controlled trial of three burns dressings for partial thickness burns in children. 
Burns, 41(5), 946-955. doi: 10.1016/j.burns.2014.11.005 
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4.1 Chapter foreword  
A survey of burns surgeons worldwide reported that the essential or desirable features of an 
‘ideal’ burns dressing were; lack of adhesion to the wound bed, pain-free dressing changes, 
ease of dressing removal, antimicrobial activity of the dressing and twice weekly dressing 
changes [69]. However, importantly it was noted that a burns dressing which possesses all 
of these properties has not yet been developed. Therefore treatment choice is reliant on 
research evidence to discern which dressing/s from those available on the current market 
best meet ideal dressing characteristics. 
Silver dressings are currently the most common dressing used for pediatric partial thickness 
burns in Australia and New Zealand. The ideal or most effective silver dressing to use for 
this population though is a point of contention, as high-level research is not currently 
available for clinicians to assist in treatment decision-making. A survey of pediatric burns 
units in Australia and New Zealand (Table 2-1) concluded that no two units have the same 
silver dressing treatment protocol. Many units use Acticoat™ as their primary dressing of 
choice, based on research purporting its effectiveness over silver sulfadiazine cream. 
However treatment regimes in some of these centers, for example in Brisbane, have evolved 
through clinical trial and error, with the use of silicone interface dressings such as Mepitel™ 
under Acticoat™ to assist with removal. Other burns units use Mepilex Ag™, which 
combines the benefits of both Acticoat™ and Mepitel™ in a single dressing.  
Hence the aim of the clinical trial presented in this chapter was to provide a solid evidence 
base for clinical treatment decision-making regarding the use of silver dressings and to 
improve clinical outcomes for children with partial thickness burns. This chapter is based on 
the publication titled ‘Randomized controlled trial of three burns dressings for partial 
thickness burns in children’ and follows on from the study protocol presented in Chapter 2. 
Results from the trial will be presented along with a detailed discussion of the trial outcomes 
and implications for clinical practice.  
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4.2 Abstract 
4.2.1 Background 
This study compared the effects of three silver dressing combinations on small to medium 
size acute partial thickness burns in children, focusing on re-epithelialization time, pain and 
distress during dressing changes.  
4.2.2 Method 
Children (0-15 years) with clean, ≤10% Total Body Surface Area (TBSA) partial thickness 
burn injuries who met the inclusion criteria were included in the study. Children received 
either 1) ActicoatTM; 2) ActicoatTM with MepitelTM; or 3) Mepilex AgTM dressings. Measures 
of burn re-epithelialization, pain, and distress were recorded at dressing changes every 3-5 
days until full re-epithelialization occurred.  
4.2.3 Results 
One hundred and three children were recruited with 96 children included for analysis. No 
infections were detected for the course of the study. When adjusted for burn depth, 
Acticoat™ significantly increased the expected days to full re-epithelialization by 40% (IRR 
= 1.40; 95% CI: 1.14-1.73, p < 0.01) and Acticoat™ with Mepitel™ significantly increased 
the expected days to full re-epithelialization by 33% (IRR = 1.33; 95% CI 1.08-1.63, p <0.01) 
when compared to Mepilex Ag™. Expected FLACC scores in the Mepilex Ag™ group were 
32% lower at dressing removal (p = 0.01) and 37% lower at new dressing application (p = 
0.04); and scores in the Acticoat™ with Mepitel™ group were 23%  lower at dressing 
removal (p = 0.04) and 40% lower at new dressing application (p <0.01), in comparison to 
the Acticoat™ group. Expected Visual Analogue Scale-Pain (VAS-P) scores were 25% 
lower in the Mepilex Ag™ group at dressing removal (p = 0.04) and 34% lower in the 
Acticoat™ with Mepitel™ group (p = 0.02) at new dressing application in comparison to the 
Acticoat™ group. There was no significant difference between the Mepilex Ag™ and the 
Acticoat™ with Mepitel™ groups at all timepoints and with any pain measure.  
4.3 Conclusion 
Mepilex AgTM is an effective silver dressing, in terms of accelerated wound    re-
epithelialization time (compared to Acticoat™ and Acticoat™ with Mepitel™) and decreased 
pain during dressing changes (compared to Acticoat™), for clean, <10% TBSA partial 
thickness burn injuries in children. 
4.4 Keywords 
Child, burn injury, partial thickness, silver dressing, re-epithelialization, pain 
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4.5 Introduction 
Small to medium sized partial thickness burn injuries are a common occurrence for children 
in high income countries [42]. Scarring remains the biggest problem for pediatric burn 
centers, contributing to negative physical and psychosocial outcomes for children [94]. 
Therefore the initial care of the burn wound and choice of burn dressing is vital in creating 
the ideal healing environment to ensure rapid re-epithelialization of the wound and to reduce 
the possibility of hypertrophic scarring.  Currently, ≤ 10% TBSA partial thickness burns in 
children are predominantly managed in the outpatient setting using specialized dressings 
which promote moist wound healing and prevent wound infection [73]. The standard of care 
for burns of this size in children has changed in the last 10-15 years. Currently silver–
depositing fabric and foam dressings are the most commonly used treatment to manage the 
bio-burden of a wound, with or without a silicone skin interface [9].  
Many trials have been conducted regarding the efficacy of silver dressings for treating burn 
injuries, using topical silver sulfadiazine applications as the control or comparator dressing. 
However, the use of silver sulfadiazine as the comparator treatment needs to be 
reconsidered, as silver fabric dressings have been shown to promote faster wound  re-
epithelialization rates, are associated with lower levels of pain during burn care procedures 
and do not require daily changes [9, 17, 115].   Despite the large number of silver-
impregnated burns dressings now on the market, very few high level trials have been 
conducted which compare these dressings in pediatric or adult patients [17]. To date, only 
one randomized controlled trial has been conducted comparing the use of silver dressings, 
in a combined adult and pediatric population [74]; however none have been conducted 
specifically in a pediatric population. Therefore there is a need to identify the silver 
dressing/s which best meet the current challenges of burn wound management in the 
pediatric burns population. 
The aim of this study was to determine whether one of three silver dressings - ActicoatTM, 
ActicoatTM combined with MepitelTM or Mepilex AgTM - would be more effective in terms of 
reduced pain during change of dressings and the re-epithelialization rate of acute, partial 
thickness burns in children. ActicoatTM, Mepitel™ and Mepilex AgTM were selected for the 
trial as all are commonly used within pediatric burn centers in Australia and New Zealand. It 
was hypothesized that silver dressings with a silicone interface, compared to no silicone 
interface, would hasten the re-epithelialization of a burn injury and decrease the amount of 
pain and distress experienced during dressing changes within a pediatric population. 
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4.6 Methods/Design 
This study was a prospective, randomized controlled trial. This study is registered with the 
Australian New Zealand Clinical Trials Registry (ACTRN12613000105741) and was 
approved by the Queensland Children’s Health Services (Royal Children’s Hospital) Human 
Research Ethics Committee and The University of Queensland Ethics Committee. A 
protocol paper has been published for this trial; please refer to the article for a more detailed 
summary of the methods [116]. This trial was completed as per the published protocol. 
4.6.1 Intervention 
The intervention was randomized to be one of either: ActicoatTM; ActicoatTM combined with 
MepitelTM; or Mepilex AgTM dressings (See Figure 4-1). Each dressing was replaced every 
3-5 days until re-epithelialization occurred or grafting was required.  
Acticoat™ was moistened with sterile water and applied over the entire wound, with a 
nasogastric tube placed on top of the dressing, (with the capped end of the tube left 
unsecured outside the border of the dressing) before the entire dressing was secured with 
self-adhesive tape. A dry absorbent pad dressing was then applied over the Acticoat 
dressing and secured with tape. For the Acticoat™ with Mepitel™ intervention, Mepitel™ 
was cut to the identical size of the Acticoat™ and was placed onto the wound first, after 
which Acticoat™ was applied as per the previous protocol. Nasogastric tubes were used to 
assist in the moistening of the dressing between changes. Depending on the size of the 
wound, tubes were placed approximately 10cm apart over the Acticoat™, and 1-2ml of 
sterile water was then inserted via plastic syringe through the tubes 3 times a day by parents 
at home until the next dressing change. Mepilex Ag™ was applied to the wound and secured 
with self adhesive tape as per manufacturer instructions.  
 
 
 
 
 
Figure 4-1. Acticoat™ dressing with nasogastric tube attached (A); Mepitel™ dressing in situ beneath 
Acticoat™ (B); Mepilex Ag™ dressing (C) 
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4.6.2 Participants 
Eligible patients were recruited from the Department of Emergency Medicine and the Stuart 
Pegg Pediatric Burns Centre (SPPBC) at the Royal Children’s Hospital (RCH), Brisbane, 
Australia between March 2013 and January 2014. Once informed consent was gained, the 
patient was randomized to one of three dressing treatment arms. 
Children aged 0 to 15 years with an acute partial thickness (superficial partial to deep partial 
thickness inclusive) burn injury and a burn total body surface area (TBSA) of ≤10% who 
presented within the first 72 hours post-burn injury were considered for inclusion in this 
study. Children were excluded from the study if they had received silver dressings prior to 
presentation at RCH; had sustained a superficial (erythema only), full thickness, chemical 
or friction burn; presented with cold, flu or viral symptoms (e.g. upper respiratory tract 
infection); had received potentially unclean water as first aid (e.g. non-treated dam or tank 
water); had a known reaction to silver products; were non-English speaking; had a cognitive 
impairment; or were currently involved with the Department of Communities, Child Safety 
and Disability Services. 
4.6.3 Primary outcome measures 
4.6.3.1 Days to re-epithelialization 
The number of days from the burn injury date until wound re-epithelialization, surface area 
of the wound and percentage of wound re-epithelialization were calculated via four methods: 
1) clinical judgment from the consultant; 2) use of VisitrakTM grids (Smith & Nephew, Hull, 
UK); 3) 3D camera photographs (3D LifeViz system) and analysis on the Dermapix™ 
software program (Quantificare, Cedex, France). Visitrak™ and the 3D camera are both 
reliable and valid methods of calculating wound surface area [41]. 4) Blinded review of 
photographs by a panel of 3 burns surgeons. The surgeons were asked to rate the 
percentage of wound re-epithelialization at each dressing change. Burn wounds were 
considered fully re-epithelialized when rated as 95% re-epithelialized or more. The inter-
rater reliability was also calculated. 
4.6.3.2 Pain  
Pain and distress were assessed by obtaining: 1) the participant’s self-report of pain intensity 
using the Faces Pain Scale-Revised (FPS-R) (if participant was aged 3 years or over) [111]; 
2) the nurse’s observational rating of the participant’s pain and distress using the Face, 
Legs, Activity, Cry, Consolability (FLACC) scale [113]; 3) the participant’s self report (if aged 
over 8 years) or the parent’s report of the participant’s pain intensity using a Visual Analogue 
Scale-Pain (VAS-P) [112]; 4) pulse rate; and 5) respiratory rate of the participant, taken 
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immediately prior to and after dressing changes. Any analgesic and/or sedative medications 
administered to the participant at each dressing change were also recorded. 
4.6.4 Secondary outcome measures 
Nursing staff were surveyed on their views of the three dressings using a set of standardized 
questions and Likert scales. Surveys were completed pre and post data collection. 
Participants’ physical function while wearing the dressing (first dressing change) was 
obtained on a 5-point Likert scale (1= extremely easy to move; 5= not at all easy to move). 
The ease of removing and applying the dressing was obtained from the treating nurse on a 
5-point Likert scale (1= extremely easy to remove/apply; 5= not at all easy to remove/apply) 
at each dressing change. At each dressing change, wounds were assessed clinically by the 
consultant. Nursing time to remove and apply the dressing, amount and size of dressings 
used and other resources required were also recorded at each dressing change. This data 
will be utilized in a future paper of dressing cost-analysis.  
4.6.5 Procedures 
All participants in the study had their dressings changed every 3-5 days until full re-
epithelialization of the wound occurred or grafting of the wound was required [116].  
Demographic information and clinical details were obtained from the caregiver and the 
patient’s chart regarding: mechanism of the burn injury, the site of the injury, TBSA and first 
aid the patient received. Burn injuries with a TBSA of <1% are difficult to quantify as a 
percentage clinically, therefore as a standard rating, all burns <1% were recorded as 0.5% 
TBSA for this study. Burn depth was categorized by laser Doppler Imager (LDI) scan, 
treating consultant review at the first dressing change (day 3-5) as either ‘superficial partial 
thickness only’, ‘mixed depth’, or ‘deep dermal partial thickness only’ and blinded photo 
reviews of burn depth were also performed. Whilst LDI is the gold standard for burn depth 
analysis, it is technically difficult in the pediatric population and was not possible to complete 
in all participants, thus burn depth ratings were clinically judged by the treating consultant. 
At each dressing change appointment, pain and distress measures were taken before and 
after dressing removal and before and after the re-application of a new dressing. A tracing 
of the wound using VisitrakTM grids and a 3D photograph were also taken.   
The investigators in this trial could not be completely blinded to the dressing used for each 
participant as the ActicoatTM dressing stains the healthy skin around a burn wound brown. 
Additionally, the primary investigator was present when dressings were applied and 
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removed to obtain pain scores and therefore saw what dressing was used on the child; 
however data was coded for analysis.  
4.6.6 Discontinuation/adverse events 
If an adverse event (e.g. infection, reaction to the dressing) occurred during the trial, 
participants only had data collected up until that point in time analyzed, as clinical care 
(including dressing type) was changed to address the adverse event. If a consultant felt that 
a particular dressing was not appropriate for a participant’s care, they were able to change 
to a different dressing. If this occurred, data collection for this participant was ceased from 
that date. All data preceding that date was included for analysis as per intention to treat 
protocol.  
4.6.7 Statistical Analysis 
All statistical analyses were conducted using SPSS 21 (IBM Corporation, Armonk, NY, USA) 
and Stata 12 (StataCorp LP, College Station, TX, USA). All data was analyzed as intention 
to treat and on a per protocol basis, with the intention to treat analysis being the primary 
approach for this trial. All tests were two-tailed and only those with a p-value <0.05 were 
considered statistically significant. Inter-rater reliability of burn depth and burn re-
epithelialization ratings between burn surgeons was calculated using intra class correlation 
coefficients (ICC 2,1).  
4.6.7.1 Sample size 
Previous data in pediatric burns patients demonstrated re-epithelialization within 15 (SD = 
4) days and a minimally clinically important difference is 3 days [47]. Thus sample size for 
this trial was calculated at 28 per group at 80% power with an α of 0.05. Allowing for 20% 
loss to follow up, a total of 100 participants were required. This calculated sample size was 
also determined to be adequate to find a significant difference in data collected from pain 
scores. 
4.6.8 Primary outcome measures 
Days to burn re-epithelialization data was analyzed using a negative binomial regression 
model, with burn depth, burn total body surface area, mechanism of injury, anatomical 
location of burn, age and gender considered a priori to be of potential interest. Pain data 
was analyzed with multilevel generalized linear mixed-effects modeling with a log link 
function and gamma distribution to determine differences between the treatment groups at 
timepoints and over time.  
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4.6.9 Secondary outcome measures 
Dressing application and removal time, dressing ease of use and physical function rating 
data were not normally distributed or were Likert-scale ratings, therefore a non-parametric 
Kruskal-Wallis test was used to analyze the data from the three groups. If a significant 
difference between the groups was found, post-hoc analyses were then conducted using 
the Mann-Whitney U tests to determine which groups were significantly different from each 
other.  
4.7 Results  
4.7.1 Sample and demographic characteristics 
The CONSORT diagram [107] illustrates that a total of 285 children were assessed for 
eligibility into this trial (See Figure 4-2). One hundred and three children were randomized 
into the study and as per intention to treat protocol, 96 children were included for analysis. 
Groups were similar with respect to baseline variables (age, gender, clinically rated burn 
depth, mean and minimum wound perfusion units, TBSA, mechanism of burn injury, 
anatomical location of the burn injury) (Table 4-1). Participants in all three groups had their 
dressings changed every 3-5 days until re-epithelialization or grafting occurred. At the first 
dressing change, the median number of days between date of injury and first dressing 
change was 3 days (IQR 3-4 days) and there was no statistically significant difference 
between the groups (p = 0.79). 
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Figure 4-2 CONSORT diagram of study participant
Assessed for eligibility (n=285) 
Excluded (n=182) 
♦ Received unclean water first aid (n=3) 
♦ Unwell at time of injury (n=2) 
♦ Not meeting remaining inclusion criteria 
(n=121) 
♦ Declined to participate (n=8) 
♦ Missed (n= 48) 
 
 
 
 
Allocated to ActicoatTM dressing 
(n=33) 
 
Enrolment 
Randomised (n = 103) 
Follow-up 
Analysis 
Allocated to ActicoatTM and 
MepitelTM dressing (n=34) 
 
 
Allocated to Mepilex AgTM 
dressing (n= 36) 
 
♦ Lost to follow-up  
o Failed to attend first 
appointment (n=1) 
o Failed to attend last 
appointment (n=2) 
♦ Discontinued intervention due to:   
o Unwell at first appointment 
(illness not present at 
recruitment) (n=1) 
o Skin graft  (n=2) 
 
 
 
♦ Lost to follow-up  
o Failed to attend first 
appointment (n=1) 
o Failed to attend last 
appointment (n=1) 
♦ Discontinued intervention due to: 
o Incorrect dressing applied 
on first presentation (n=1) 
o Child protection involvement 
unknown at recruitment 
(n=1) 
 
 
 
 
Analysed (n=31) 
♦ Excluded from analysis (n=2) 
o Incorrect dressing applied 
on first presentation (n=1) 
o Failed to attend first 
appointment (n=1) 
 
Analysed (n=32) 
♦ Excluded from analysis (n=2) 
o Failed to attend first 
appointment (n=1) 
o Unwell at first 
appointment (n=1) 
Analysed (n=33) 
♦ Excluded from analysis (n=3) 
o Incorrect dressing 
applied on first 
presentation (n=1) 
o Failed to attend first 
appointment (n=1) 
o Child protection 
involvement (n=1) 
♦ Lost to follow-up 
o Failed to attend first 
appointment (n=1) 
♦ Discontinued intervention due to:  
o Incorrect dressing applied 
on first presentation (n=1) 
o Pain/distress during 
dressing change (n=1) 
o Skin graft (n=2) 
 
Allocation 
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4.7.2 Burn depth classification 
LDI scans were successfully completed in 35 out of the 96 participants, with an even number 
of participants in each group (See Table 4-1). Both the minimum value of perfusion units 
(deepest part of the burn) and the mean value were recorded for each scan.  The majority 
of scans were abandoned due to high participant pain and distress levels or excessive 
movement. A number of scans were completed on participants, but were affected by 
artefacts (blurring of the image) due to movement during the scan, to be utilized for 
measurements. Of the 61 participants who did not have a successful scan, 75.4% of these 
were ≤ 2 years of age. Blinded photo review burn depth ratings by three consultants were 
analyzed using intraclass correlation coefficients (two-way random effects model for 
absolute agreement). The level of agreement on burn depth between burn consultants was 
low (ICC 0.34, 95% CI 0.212, 0.47).  
Due to a lack of reliable LDI scans and the low agreement for burn depth consensus, clinical 
judgment of burn depth by the treating consultant only at day 3-5 post-burn was used. 
Clinical judgment of burn depth encompasses the evaluation of patient health, mechanism 
of injury and first aid received in addition to reviewing the appearance of the wound, 
therefore it was deemed appropriate to use this classification of burn depth for statistical 
analyses. The burn depth ratings from clinical judgment for each group were: Acticoat™ 
(‘superficial partial thickness only’ n= 24; ‘mixed depth’ = 7), Acticoat™ with Mepitel™ 
(‘superficial partial thickness only’ n= 23; ‘mixed depth = 9) and Mepilex Ag™ (‘superficial 
partial thickness only’ n= 30; ‘mixed depth’ n =3). The baseline differences in burn depth 
between the groups was not statistically significant (p = 0.33).  
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Table 4-1 Study demographics 
  Acticoat™ (n=31) 
Median (IQR) 
Acticoat™ & Mepitel™ (n=32) 
Median (IQR) 
Mepilex Ag™ (n=33) 
Median (IQR) 
p-value 
Age (years)  1.0 year (1.0-5.0 
years) 
1.0 year (1.0-4.0 years) 1.0 year (1.0-4.0 years) 
 
0.59 
TBSA  1.0% (0.50-3.0%) 
 
1.0% (0.50-3.0%) 0.50% (0.50-2.0%) 0.33 
  n (%) n (%) n (%)  
Gender Male 
 
18 (58.1) 21(65.6) 16 (48.5) 0.38 
MOI Scald 
Contact 
Flame 
Electrical 
18 (58.1) 
11 (35.5) 
1 (3.2) 
1 (3.2) 
 
20 (62.5) 
11 (34.4) 
1 (3.1) 
0 (0) 
18 (54.5) 
14 (42.4) 
0 (0) 
1 (3.0) 
0.91 
 Burn Site Head/neck 
Hand/fingers 
Upper limb 
Foot/toes 
Lower limb 
Torso (front and back) 
Abdomen 
Perineum 
3 (9.7) 
9 (29.0) 
4 (12.9) 
6 (19.4) 
1 (3.2) 
6 (19.4) 
2 (6.5) 
0 (0) 
5 (15.6) 
7 (21.9) 
6 (18.8) 
4 (12.5) 
4 (12.5) 
4 (12.5) 
1 (3.1) 
1 (3.1) 
3 (9.1) 
10 (30.3) 
3 (9.1) 
4 (12.1) 
5 (15.2) 
7 (21.2) 
0 (0) 
1 (3.0) 
 
0.83 
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Burn depth  Superficial partial 
thickness only 
Mixed partial thickness 
24 (77.4) 
 
7 (22.6) 
23 (71.9) 
 
9 (28.1) 
30 (90.9) 
 
3 (9.1) 
0.15 
   
(n= 12) 
Mean (SD) 
 
(n= 12) 
Mean (SD) 
 
(n= 11) 
Mean (SD) 
 
LDI Mean PU  1110.46 (235.70) 1396.05 (457.40) 1161.02 (306.80) 0.12 
LDI Min PU  361.42 (191.70) 340.92 (207.80) 279.27 (145.60) 0.55 
SD = standard deviation; TBSA = total body surface area; MOI = mechanism of injury; LDI = laser Doppler image; PU = perfusion units 
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4.7.3 Primary Outcomes 
4.7.3.1 Days to full re-epithelialization  
Burn wounds were classified as ≥95% re-epithelialized by the treating consultant, through 
measurement from 3D photographs and Visitrak™ tracings and by consultants during blind 
photo reviews. Visitrak™ measurements could not be used as tracings were unable to be 
completed in 22% of children due to pain and an inability to remain still. However 3D 
photographs and wound measurements were successfully completed for all participants in 
the study.  The level of agreement between consultants from blinded photo review 
classification of ≥95% re-epithelialization was excellent, ICC 0.92 (95% CI 0.88, 0.94) and 
therefore ratings of days to ≥95% re-epithelialization by the treating consultant were used 
for the analysis.  Table 2 shows the raw data for days to ≥95% re-epithelialization between 
the three dressing groups as classified by the treating consultant. 
4.7.3.2 Negative binomial regression  
The variance of the days to full re-epithelialization (28.28) was nearly 3 times greater than 
the corresponding mean (9.66). Given this over-dispersion of the data, a negative binomial 
regression model was used to compare the differences in the treatment groups, after 
adjusting for the effects of any potential confounding variables. Four variables (gender, age, 
burn depth, TBSA) were considered for their potential contribution to the days to re-
epithelialization outcome and entered individually into the regression model. Burn depth was 
the only variable found to have a significant (p <0.05) impact on days to re-epithelialization 
and was included in the final regression model. Two outliers, one from the Acticoat™ group 
and one from the Mepilex Ag™ group, were excluded from the final model due to their 
unusually large residual values (i.e. high number of days to full re-epithelialization compared 
to the whole cohort). Data was calculated as an incidence rate ratio in the final model. 
When adjusted for burn depth, receiving the Acticoat dressing compared to Mepilex Ag™ 
significantly increased the expected days to full re-epithelialization by 40% (95% CI: 1.14-
1.73, p < 0.01; see Table 4-2). Similarly, receiving the Acticoat™ with Mepitel™ dressing 
compared to Mepilex Ag™ significantly increased the expected days to full re-
epithelialization by 33% (95% CI 1.08-1.63, p = 0.01). There was no statistically significant 
difference between Acticoat™ and Acticoat™ combined with Mepitel™.  
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Table 4-2 Days to full re-epithelialization between dressing groups 
N = number of participants; IQR = Inter-quartile range; IRR = incidence rate ratio; CI = confidence interval 
4.7.3.3 Pain during the dressing change procedure 
Multilevel generalized linear mixed-effects modeling with a log link function and gamma 
distribution was used to analyze the data from each of the 5 pain measures (See Table 4-3). 
Four variables (gender, age, burn depth, TBSA) were considered as potential confounders 
for modeling each of the pain measures (FPS-R, FLACC, VAS-P, pulse rate, respiratory 
rate). Data were analysed after dressing removal, at new dressing application and overall 
(all timepoints at all dressing changes). Results were presented as odds ratios and their 
95% confidence intervals. 
Modeling was not completed for the FPS-R due to a large amount of missing data (the 
majority of children in the study were too young to use this scale). For respiratory rate, there 
was no statistically significant difference between the three dressing groups overall, after 
dressing removal or application.  Additionally, at all timepoints and for all pain measures, 
there was no significant difference between Acticoat™ with Mepitel™ and Mepilex Ag™. 
Raw Data N Median IQR 
Acticoat™ 28 9.50 7.00-14.00 
Acticoat™ with Mepitel™ 28 10.00 8.00-13.00 
Mepilex Ag™ 32 7.00 4.00-8.00 
Adjusted for Depth IRR 95% CI p-value 
Acticoat™ vs. Mepilex Ag™ 1.40 1.14, 1.73 <0.01 
Acticoat™ with Mepitel™ vs. Mepilex Ag™ 1.33 1.08, 1.63 0.01 
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Table 4-3 Multilevel mixed-effects modeling for pain and distress measures 
 Pain or 
distress 
measure 
Dressing comparison OR 95% CI p-value 
After 
dressing 
removal 
FLACC 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.77 0.60-0.98 0.04 
Acticoat™ vs. Mepilex Ag™ 
 
0.68 0.50-0.91 0.01 
VAS-P 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.76 0.56-1.02 0.07 
Acticoat™ vs. Mepilex Ag™ 
 
0.75 0.56-0.99 0.04 
Pulse rate 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.92 0.87-0.97 <0.01 
Acticoat™ vs. Mepilex Ag™ 
 
0.93 0.89-0.98 0.01 
After 
dressing 
applicati
on 
FLACC 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.60 0.44-0.83 <0.01 
Acticoat™ vs. Mepilex Ag™ 
 
0.63 0.41-0.97 0.04 
VAS-P 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.66 0.46-0.94 0.02 
Acticoat™ vs. Mepilex Ag™ 
 
0.70 0.48-1.01 0.06 
Pulse rate 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.93 0.88-0.99 0.02 
Acticoat™ vs. Mepilex Ag™ 
 
0.91 0.84-0.99 0.03 
Overall 
FLACC 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.80 0.66, 0.97 0.02 
Acticoat™ vs. Mepilex Ag™ 
 
0.78 0.64, 0.95 0.01 
VAS-P 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.79 0.65-0.95 0.02 
Acticoat™ vs. Mepilex Ag™ 
 
0.83 0.68-1.01 0.06 
Pulse rate 
Acticoat™ vs. Acticoat™ with 
Mepitel™ 
0.92 0.88-0.97 <0.01 
Acticoat™ vs. Mepilex Ag™ 0.93 0.89-0.98 <0.01 
FLACC = faces, legs, activity, cry, consolability scale; VAS-P = visual analogue scale-pain; OR = odds ratio; CI = confidence interval 
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4.7.3.4  After dressing removal 
Receiving the Acticoat™ with Mepitel™ and Mepilex Ag™ dressings significantly decreased 
the expected FLACC score after dressing removal by 23% and 32% compared to receiving 
the Acticoat™ dressing (p = 0.04; p = 0.01). Receiving the Mepilex Ag™ dressing 
significantly decreased the expected VAS-P score after dressing removal by 25% (p = 0.04) 
compared to receiving Acticoat™. There was no statistically significant difference in VAS-P 
scores between the Acticoat™ and Acticoat™ with Mepitel™. Receiving the Acticoat™ with 
Mepitel™  and Mepilex Ag™ dressings significantly decreased the expected pulse rate after 
dressing removal by 8% and 7% respectively compared to receiving the Acticoat™ dressing 
(p = <0.01; p = 0.01).  
4.7.3.5  After dressing application 
Receiving the Acticoat™ with Mepitel™ and Mepilex Ag™ dressings significantly decreased 
the expected FLACC score after dressing application by 40% and 37% compared to 
receiving the Acticoat™ dressing (p = <0.01; p = 0.04). Receiving the Acticoat™ with 
Mepitel™ dressing significantly decreased the expected VAS-P score after dressing 
application by 34% compared to receiving the Acticoat™ dressing (p = 0.02). There was no 
statistically significant difference in VAS-P scores between the Acticoat™ and Mepilex Ag™. 
Receiving the Acticoat™ with Mepitel™ and Mepilex Ag™ dressings significantly decreased 
the expected pulse rate after dressing application by 7% and 9%  respectively compared to 
receiving the Acticoat™ dressing (p = 0.02; p = 0.03).  
4.7.3.6  Overall 
Receiving the Acticoat™ with Mepitel™ and Mepilex Ag™ dressings significantly decreased 
the overall expected FLACC score by 20% and 22% compared to receiving the Acticoat™ 
dressing (p = 0.02; p = 0.01). Receiving the Acticoat™ with Mepitel™ dressing significantly 
decreased the overall expected VAS-P score by 21% compared to receiving the Acticoat™ 
dressing (p = 0.02). There was no statistically significant difference in VAS-P scores 
between the Acticoat™ and Mepilex Ag™. Receiving the Acticoat™ with Mepitel™ and 
Mepilex Ag™ dressings significantly decreased the overall expected pulse rate by 8% and 
7% compared to receiving the Acticoat™ dressing (p <0.01; p = <0.01).  
4.7.4 Secondary Outcome Measures 
4.7.4.1  Analgesia 
On the first dressing change, 78% of participants received a narcotic analgesia combination 
of paracetamol (dosage by body weight, 15mg/kg) and Oxycodone™ (dosage by body 
weight, 0.1 to 0.2 mg/kg) according to standard practice for the SPPBC. The remainder of 
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participants received paracetamol only or no analgesic medication as determined by clinical 
judgment (i.e. burn injury very minor, child too young for Oxycodone™). Three participants 
in the Acticoat™ group and one participant in the Acticoat™ with Mepitel™ group required 
a rescue dose of Oxycodone™ (dosage of 0.1mg/kg in addition to the initial paracetamol 
and Oxycodone™ dose) during their first dressing change procedure. All three participants 
in the Acticoat™ group who were administered an Oxycodone™ rescue dose also required 
inhaled Entonox™ (nitrous oxide/oxygen combination) at the first dressing change. One 
participant in the Acticoat™ group also required Entonox™ (in addition to standard 
paracetamol/Oxycodone™ dose) for the second and third dressing changes. 
4.7.4.2  Dressing removal and application times 
Removal and application times were analyzed between the three dressing groups on the 
first dressing change.  Comparison of dressing removal, application and cumulative dressing 
removal/application time are presented in Figure 4-3. Cumulative dressing removal and 
application time on the first dressing change was significantly faster in the Mepilex AgTM 
group (5:03 minutes, IQR 2:48 – 7:53 minutes) compared to both the ActicoatTM (10:17 
minutes; IQR 7:38 – 21:58 minutes; p <0.01) and ActicoatTM combined with MepitelTM (10:03 
minutes; IQR 6:21 – 16:47 minutes; p <0.01) groups. 
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Figure 4-3 Comparison of dressing removal, application and cumulative dressing time at the first dressing 
change. Removal and application was significantly faster in Mepilex Ag compared to Acticoat (p < 0.001) and 
Acticoat with Mepitel (p < 0.01). 
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4.7.4.3 Dressing ease of removal and application 
Dressing ease of removal and application ratings were analysed between the three dressing 
groups on the first dressing change. Likert scale ratings regarding ease of dressing removal 
and application are represented in Figure 4-4Aand B.  
For dressing removal (Figure 4-4A), the Acticoat™ group was rated as significantly more 
difficult to remove than both the Mepilex Ag™ group (p <0.01) and the Acticoat™ with 
Mepitel™ group (p < 0.01). There was no significant difference between Acticoat™ with 
Mepitel™ and Mepilex Ag™ (p = 0.20). 
For dressing application (Figure 4-4B), the Acticoat™ group was rated as significantly more 
difficult to apply than both the Mepilex Ag™ group (p = 0.03) and the Acticoat™ with 
Mepitel™ group (p < 0.01). There was no significant difference between Acticoat™ with 
Mepitel™ and Mepilex Ag™ (p = 0.62).
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Figure 4-4 Ease of dressing removal at the first dressing change (A) and Ease of dressing application at the 
first dressing change (B). The treating nurse used a Likert scale where: 1 = extremely easy, 2 = very easy, 3 
= somewhat easy, 4 = not very easy, 5 = not at all easy Acticoat was significantly more difficult to remove 
than Mepilex Ag (p < 0.01) and Acticoat with Mepitel (p < 0.01). Acticoat was also significantly more difficult 
to apply than Mepilex Ag (p=0.03) and Acticoat with Mepitel (p<0.01).
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4.7.4.4 Nursing staff experience with dressing use 
In a pre and post study surveys, nursing staff from the SPPBC rated the three dressings for 
their perceived or observed ease of removal and application when used on hands or feet 
and flat surfaces (i.e. chest).  Nursing staff rated that Acticoat™ with Mepitel™ and Mepilex 
Ag™ were the easiest to remove from both hands or feet and flat surfaces. Acticoat™ with 
Mepitel™ was rated as the easiest to apply to hands or feet and flat surfaces, with Mepilex 
Ag™ the hardest to apply to hands or feet. Acticoat™ was rated as the hardest to apply to 
flat surfaces and hardest to remove from all areas. All nursing staff specified that Mepilex 
Ag™ was the hardest to apply to hands or feet in very young children (under the age of 3 
years) as the dressing is the thickest of the three dressings and difficult to conform to very 
small fingers and toes.  
4.7.4.5 Physical function  
There was no significant difference between the groups regarding physical function when 
wearing the dressings. 
4.7.5 Adverse events  
No infections were recorded for the course of the study in any of the three groups. Nursing 
staff noted that the Acticoat™ dressing often dried into the wound, despite parents or 
caregivers being instructed to regularly irrigate the dressing. Additionally, many Acticoat™ 
dressings were difficult to remove, even after nursing staff soaked the dressing with sterile 
water, and many children who received this dressing were observed to have bleeding from 
the wound after the dressing was removed. One child in the Acticoat™ group with a scald 
burn injury to the face discontinued Acticoat™ use (as per instruction from the treating 
doctor) due to a high level of pain, distress and bleeding from the wound at dressing 
changes. The child then received ActicoatTM and MepitelTM (the standard treatment for the 
burns unit) for the remainder of their treatment and had an uneventful recovery.  
4.8 Discussion  
Effective wound healing treatments are vital to diminish the physical and psychosocial 
challenges children experience after a burn injury, therefore high level evidence is required 
to identify the most appropriate silver dressing for pediatric burn injuries. Whilst silver fabric 
dressings demonstrate improved re epithelialization and reduced pain compared to SSD 
cream [9, 16], there is a lack of high level trials comparing silver dressings to each other in 
the pediatric burns population [17]. The results of this study demonstrated that clean, <10% 
TBSA, partial thickness burn injuries in children aged 0-15 years, when dressed with Mepilex 
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Ag™, re-epithelialized significantly faster than those dressed with Acticoat™ or Acticoat™ 
with Mepitel™.   
The results have shown advantages in using a dressing with a silicone interface (Mepilex 
Ag™) compared to a dressing without (Acticoat™). Dressings that are silicone or have 
silicone interfaces, adhere to normal, intact skin and remain in situ on the surface of a wound 
but don’t adhere to it, maintaining a moist wound environment while providing a less 
traumatic removal and subsequently less epidermal damage [8, 60]. Comparatively, 
dressings that can adhere to wound beds, such as Acticoat, potentially cause trauma on 
removal, increase pain and promote skin stripping which has been found to delay wound re-
epithelialization [58]. In addition to slower re-epithelialization rates, clinical observations of 
bleeding from the wound bed dressing removal in participants who received the Acticoat™ 
dressing further emphasized the benefits of using a dressing with silicone interface for 
pediatric burn injuries.  
Although both dressings had a silicone interface, the difference in re-epithelialization 
between Mepilex Ag™ and Acticoat™ with Mepitel™ was unexpected and may be due to 
other factors such as the cytotoxicity or release of silver from the dressings. Silver products 
are an effective antimicrobial utility for managing the bio-burden of burn wounds and in-vitro 
studies have shown Acticoat™ can be cytotoxic to healthy keratinocytes which can delay 
healing [66].  However there has yet to be any published research with respect to the 
cytotoxicity of the silver used in Mepilex Ag™. In terms of silver release from dressings, an 
in vitro study by Rigo et al. [10] demonstrated that over a period of 7 days, the silver release 
from Mepilex Ag™ occurred within the first hour of contact with human serum substitute, 
whereas Acticoat™ Flex had a sustained silver release over the same 7 days. This 
difference in silver release rate between the two dressings could account for the difference 
in re-epithelialization rates, due to the continual release of silver from Acticoat™ over time. 
Additionally, there could also be an infection risk if Mepilex Ag is left on for 7 days but has 
released all its silver within the first day of application. It should be noted that the amount of 
silver released from Acticoat™ with the addition of Mepitel™ has yet to be reported in the 
literature. Laboratory research would be of major importance to evaluate the cytotoxicity of 
Mepilex Ag™ in comparison to Acticoat™, the antimicrobial effect of Mepilex Ag™ on dirty 
wounds and when worn for 7 days or more and the effect of Mepitel on silver release from 
Acticoat™.  
This study also proved that dressings with silicone interfaces were associated with lower 
pain scores after dressing removal and application and across time in comparison to 
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Acticoat™ alone. Pulse rate was a significant indicator of pain, however may have little 
significance clinically due to the relatively small differences found between the groups. 
Respiratory rate was difficult to record in the children in this study due to excessive 
movement and crying and the results reflect that it is not a useful indicator of pain or distress 
in this instance. Given the difference in days to re-epithelialization between the Acticoat™ 
and Mepilex Ag™ groups and the subsequent difference in pain levels between these two 
groups, the results from this study sit well within the existing literature. Previous studies in 
this population have also demonstrated that higher levels of pain during burn care 
procedures are associated with delays in wound re-epithelialization [45, 47]. The reduced 
levels of pain associated with Acticoat™ with Mepitel™ and Mepilex Ag™ in this study, in 
conjunction with significantly faster re-epithelialization in the Mepilex Ag™ group has 
provided evidence to strongly consider the utilization of dressings with added-on or in-built 
silicone interfaces to manage acute burn injuries in the pediatric population. 
The significant differences noted between the three dressings in this study with regard to re-
epithelialization rates and pain levels, have provided sufficient justification to conduct this 
trial in children with burn injuries >10% TBSA.  It would also be of benefit to explore the rate 
of wound re-epithelialization when changing these dressings at 3 versus 7 days to determine 
if fewer stressful dressing changes will have an effect on re-epithelialization rates and pain 
levels in children. 
Conducting research in a pediatric population can be difficult and this trial was not without 
its own difficulties as the majority of children recruited were under the age of three years. 
Visitrak™ tracings in this study cohort were a challenge due to its invasive nature and many 
tracings could not be completed, whereas 3D photographs were taken for all children. 
Stockton et al. [41] noted that 3D photography is a non-invasive and accurate method for 
calculating wound area for children over the age of 3 years and should be considered for 
future use in children of this age over other methods such as the Visitrak™. Further research 
comparing Visitrak™ and 3D photography in children under the age of 3 years is required 
to extrapolate the results to the population examined in this study.  
The most accurate method of burn depth classification for the pediatric population also 
remains problematic. Completing LDI scans in young children was a challenge in this study 
with many scans unable to be completed those under the age of 3 years.  Challenges 
associated with LDI scanning in very young children have been documented in the literature 
with other researchers acknowledging the difficulty of interpreting scans affected by 
movement artifacts, with some decreasing resolution and scan times to accommodate for 
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such occurrences [31, 33]. However the fact remains that many studies reporting the 
success of LDI scan as an accurate, objective measure of burn wound healing potential 
included children with a mean age of three years or older [34, 36, 117]. Therefore the validity 
and reliability of LDI use in very young children (under the age of three years) is required for 
future studies in this population. Alternatively, recently developed Laser Speckle Contrast 
Imaging has potential as a promising research tool and substitute to LDI scans in the 
pediatric population, with a scan time of 2 seconds and higher resolution images, however 
the reliability and validity of this measure has yet to be established in children [118]. In 
addition to difficulties with LDI scans, the low agreement between medical staff regarding 
burn depth classification is widely acknowledged in the literature [30] and the similar result 
from this study was not unexpected. This study has demonstrated that while viewing a photo 
alone is appropriate for judgment of wound re-epithelialization, it is unsuitable for use in burn 
depth analysis.  
4.9 Conclusion  
Mepilex AgTM has been shown to be an effective silver dressing in regards to wound re-
epithelialization time, pain during dressing changes, dressing removal and application time 
and ease of use in clean, <10% TBSA partial thickness burn injuries in children. The use of 
dressings with silicone interfaces should be strongly considered for use in the pediatric 
population to reduce pain and wound trauma during dressing changes. 
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4.11 Chapter conclusion 
The randomized controlled trial presented in this chapter has demonstrated that  Mepilex 
Ag™  is a more effective dressing for small to medium partial thickness burns in children 
than Acticoat™ and Acticoat™ with Mepitel™ in terms of wound re-epithelialization time, 
dressing time and ease of application and removal. Dressings with silicone interfaces – 
Mepilex Ag™ and Acticoat™ with Mepitel™ - were associated with significantly lower pain 
and distress levels during dressing changes compared to Acticoat™. At the time of 
publication, this study was the only randomised controlled trial available in the literature 
comparing silver dressings in children with partial thickness burns ≤10% TBSA. Since 
publication, one other study comparing Aquacel® Ag and Acticoat™ silver dressings has 
been published in a similar population of children with partial thickness burns [75]. This study 
demonstrated that while there was no difference between the dressings in terms of wound 
re-epithelialization rates or adverse events (e.g. infection), Aquacel® Ag required less 
distressing dressing changes, indicating that it may be more appropriate for a pediatric 
population compared to Acticoat™. Aquacel® Ag is commonly used in European countries, 
but rarely used in Australasia, however such results may warrant further research into this 
dressing in the future. 
The results from the trial presented in this chapter enabled a clinical change in practice in 
December 2014 from the current regime of Acticoat™ with Mepitel™ to Mepilex Ag™ for 
pediatric partial thickness burns ≤10% TBSA at the Pegg Leditschke Children’s Burns 
Centre (PLCBC) at the Lady Cilento Children’s Hospital (LCCH) in Brisbane, Australia. This 
undertaking has been a major achievement from this body of work. It has seen collaboration 
from LCCH burns unit medical and nursing staff to provide assistance in developing a new 
evidence-based burns dressing treatment protocol which has been made available via 
Queensland Health (See Appendix). As the PLCBC is the main tertiary pediatric burns 
center in Queensland, the new treatment protocol has been successfully rolled out to all 
other metropolitan, regional and rural hospitals and medical centers state-wide. Educational 
seminars and inservices have been provided to all burns unit and emergency department 
clinicians within LCCH in addition to clinicians in external centers. Results of the trial have 
also been presented to clinicians at international burns and emergency nursing conferences. 
A recent and extremely important accomplishment has seen the introduction of the new 
treatment protocol at the Royal Children’s Hospital in Melbourne and Middlemore Hospital 
in New Zealand. The uptake of this protocol in the remaining Australasian pediatric burns 
centers in the near future would be an ideal outcome from this research. 
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Chapter 5. Reliability of 3D 
photography compared to digital 
planimetry 
 
This chapter is based on published paper in Burns journal. 
Citation: Gee Kee, E. L., Kimble, R. M., & Stockton, K. A. (2015). 3D photography is a 
reliable burn wound area assessment tool compared to digital planimetry in very young 
children. Burns, 41(6), 1286-1290. doi: 10.1016/j.burns.2015.01.020 
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5.1 Chapter foreword 
Burn wound re-epithelialization is measured as a percentage of the total wound area, with 
re-epithelialization >95% taken as being representative of full wound closure. Clinically, 
wound re-epithelialization is often assessed via visual examination from the treating 
consultant. Comparatively, in research studies, wound mapping tools are often utilized to 
provide a quantifiable measure of wound re-epithelialization to ensure the accurate reporting 
of wound progression [39]. Wound mapping is conducted by measuring the total surface 
area of the wound (i.e. tracing the wound border), as well as measuring the areas that have 
re-epithelialized at each timepoint. The gold standard for wound mapping at the 
commencement of this thesis was digital planimetry using the Visitrak™ device (Smith & 
Nephew Medical Limited, England). At the commencement of this research however, 
recently developed technology in the form of stereophotogrammetry (3D photography) 
became available within the PLCBC using the 3D LifeViz™ System (Quantificare, Sophia 
Antipolis, France). This new tool was seen as a potential non-invasive alternative to 
Visitrak™ which could provide an increased ability to obtain objective and accurate 
measurements of wound re-epithelialization in the pediatric burns population. 
While wound mapping is imperative to recording re-epithelialization, completing such 
measures in the acute, pediatric burn population can be a challenging endeavour. Burn 
wound care procedures can be painful, distressing and uncomfortable for children and even 
more so for those too young to comprehend the experience. As a consequence of pain, 
distress and age, compliance during wound care and assessment procedures is an ongoing 
struggle, particularly with children under the age of 3 years. This was highlighted in the 
previous chapter with the low completion rate of laser Doppler imaging to assess burn depth. 
Therefore there is a need to utilize wound mapping tools which provide not only an accurate 
measurement of wound re-epithelialization over time but can be used in a non-invasive 
manner to diminish the trauma experienced by children with burn injuries. 
This chapter is based on the publication titled ‘3D photography is a reliable burn wound area 
assessment tool compared to digital planimetry in very young children’. The chapter will 
present an analysis of the clinical utility of the 3D camera compared to Visitrak™ based on 
data collected in the randomized controlled trial. Detailed methods and results will be 
presented, along with a discussion of clinical implications associated with integrating 3D 
photography within pediatric burns practice. 
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5.2 Abstract 
5.2.1 Background 
Reliability and validity of 3D photography (3D LifeViz™ System) compared to digital 
planimetry (Visitrak™) has been established in a compliant cohort of children with acute 
burn injuries. Further research is required to investigate these assessment tools in children 
representative of the general pediatric burns population, specifically children under the age 
of three years. 
5.2.2 Aim 
To determine if 3D photography is a reliable wound assessment tool compared to Visitrak™ 
in children of all ages with acute burn injuries ≤10% TBSA.  
5.2.3 Method 
Ninety-six children (median age 1 year 9 months) who presented to the Royal Children’s 
Hospital Brisbane with an acute burn injury ≤10% TBSA were recruited into the study. 
Wounds were measured at the first dressing change using the Visitrak™ system and 3D 
photography. All measurements were completed by one investigator and level of agreement 
between wound surface area measurements was calculated. 
5.2.4 Results 
Wound surface area measurements were complete (i.e. participants had measurements 
from both techniques) for 75 participants. Level of agreement between wound surface area 
measurements calculated using an intra-class correlation coefficient (ICC) was excellent 
(ICC 0.96, 95% CI 0.93, 0.97). Visitrak™ tracings could not be completed in 19 participants 
with 16 aged less than two years. 3D photography could not be completed for one 
participant. Barriers to completing tracings were: excessive movement, pain, young age or 
wound location (e.g. face or perineum).  
5.2.5 Conclusion 
This study has confirmed 3D photography as a reliable alternative to digital planimetry in 
children of all ages with acute burn injuries ≤10% TBSA. In addition, 3D photography is more 
suitable for very young children given its non-invasive nature. 
5.3 Keywords 
Child, burn, reliability, wound area 
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5.4 Introduction 
Measurement of wound area, particularly in burn care, is valuable in clinical and research 
settings in terms of visually recording wound progression and re-epithelialization [39].  For 
children with acute burn injuries, the wound care procedure can be a painful and distressing 
experience. Therefore, while there are many different methods of wound measurement 
available, consideration must be taken to choose a method that is not only reliable, but limits 
the amount of distress experienced by the child.  
Many types of wound measurement techniques are available with the most commonly used 
being digital planimetry using a wound measurement system called Visitrak™ (Smith & 
Nephew Medical Limited, England) (see Figure 1).  Visitrak™ is a valid method of wound 
measurement and is more accurate than the use of a ruler to measure the wound [119]. The 
Visitrak™ system uses a clear, plastic film grid which is placed on the wound, the wound 
border is traced and wound surface area can be calculated using the Visitrak™ digital 
device.  Visitrak™ is widely used to measure burn wounds; however is limited by the 
requirement of direct contact of the grid with the wound bed and for the patient to remain 
still while the tracing is completed. This can be challenging for a pediatric population thus a 
less invasive method of wound measurement may be more appropriate and cause less 
discomfort for children. 
Stereophotogammetry has recently emerged as a non-invasive, alternative method to 
Visitrak™ for wound area measurement. This technique analyzes images and provides a 
3D image from which various wound measurements can be calculated [40]. The 3D 
LifeVizTM system (Quantificare, Sophia Antipolis, France) consists of a high-definition 
camera with two lenses at slightly different angles (See Figure 5-1). Images taken with the 
camera are loaded onto a computer and merged to create a 3D figure of the wound. Wound 
area and volume can be calculated using DermaPix® software (Quantificare, Sophia 
Antipolis, France). 
Preliminary research has found excellent inter-rater reliability in patients with chronic 
wounds [40]. Additionally, a recent paper by Stockton et al. [120] established the validity and 
reliability of 3D photography as a measure of acute burn wound surface area in children with 
acute burn injuries compared to the clinical gold standard digital planimetry (Visitrak™).  The 
study by Stockton et al. [121] included a small, compliant cohort (n=25) of children with a 
median age of over three years in order to have a group of children who could tolerate both 
assessment techniques. However further research is required to investigate these two 
techniques in a larger group of children who represent the general pediatric burns 
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population, where the age of children is more commonly under the age of three years and 
compliance during wound care procedures is not always guaranteed. Therefore the aim of 
this study was to determine if 3D photography was a reliable wound assessment tool 
compared to Visitrak™ in a large group of children aged 0-15 years with acute burn injuries 
≤10% TBSA.  
5.5 Method 
5.5.1 Participants 
Children aged 0 to 15 years with an acute partial thickness (superficial partial to deep partial 
thickness inclusive) ≤10% TBSA burn injury, who presented to the Royal Children’s Hospital, 
Brisbane within the first 72 hours post-burn injury. Children were excluded from the study if 
they had a chemical or friction burn; were non-English speaking; had a cognitive impairment; 
or were currently involved with the Department of Communities, Child Safety and Disability 
Services.  
5.5.2 Ethics 
This study was an extension of a randomized controlled trial investigating burns dressings 
[116]. The trial is registered with the Australian New Zealand Clinical Trials Registry 
(ACTRN12613000105741) and was approved by the Queensland Children’s Health 
Services (Royal Children’s Hospital) Human Research Ethics Committee 
(HREC/12/QRCH/219) and The University of Queensland Ethics Committee. 
5.5.3 Recruitment 
Eligible patients were recruited into the larger trial from the Department of Emergency 
Medicine and the Stuart Pegg Pediatric Burns Centre (SPPBC) at the Royal Children’s 
Hospital (RCH), Brisbane, Australia between March 2013 and January 2014. Informed 
consent and child assent was obtained at first presentation. Recruited children then 
presented to the SPPBC outpatient clinic for a dressing change at day 3-5 post burn-injury. 
5.5.4 Measurement techniques 
5.5.4.1 Visitrak™ method 
To measure the wound, the plastic Visitrak™ tracing grid was placed over the wound so that 
the entire wound was included within the grid border, and the perimeter of the wound traced. 
For larger wounds, two or more grids were joined together in order to encompass the entire 
wound area. At a later date, the tracing grid was placed on the Visitrak™ analysis pad 
device. The device stylus was used to the trace around the wound outline on the grid and 
the device automatically calculated wound surface area.  
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5.5.4.2 3D photography method 
When using the 3D LifeViz System, the camera was held 60cm above the wound until the 
two lens lights aligned and a photo was taken. A ruler was included in all photos for 
measurement calibration as per manufacturer instructions. The photo was directly loaded 
onto the specialist computer software program Dermapix™. The wound outline was 
manually traced using the software and a 3D image of the wound was generated. Wound 
surface area was then automatically calculated from the 3D image.  
Figure 5-1 The two wound measurement techniques used. (A) The 3D LifeViz™ System (Quantificare, Sophia 
Antipolis, France), and an example of wound tracing using the DermaPix® software (B) The Visitrak™ analysis 
pad device (Smith & Nephew Medical Limited, England) 
 
5.5.5 Measurement procedure 
At the first dressing change, each child had their burn wound measured using two 
techniques: Visitrak™ tracing and 3D photography. Measurements were completed after the 
dressing was removed and the wound was cleaned. There was no specified order in which 
the measurements were taken. The measurements from each technique were recorded and 
then analyzed at a later date. Measurements were recorded in cm2 units. Where a child had 
multiple wound sites, these were analyzed separately and combined for a total 
measurement. When circumferential wounds were present, 3D photographs were taken in 
sections which were then analyzed separately using anatomical landmarks as border 
markers and individual measurements were combined for a total measurement. Some 
circumferential wounds also required multiple Visitrak™ grids to be taped together to cover 
the whole wound. Grids were then analyzed separately and combined for a total 
measurement. 
5.5.6 Statistical analysis 
All statistical analyses were conducted using SPSS 21 (IBM Corporation, Armonk, NY, USA) 
and Graph Pad Prism 6 (Graph Pad Software, La Jolla, CA). Demographic data (age, 
gender, burn mechanism) are presented as median and interquartile range (IQR) or 
percentage where appropriate. Level of agreement between wound surface area 
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measurements from the 3D photography and Visitrak™ methods was calculated using an 
intra-class correlation coefficient (2,1) and the Bland-Altman method to allow for a visual 
inspection of the data, bias and level of agreement (LOA) was calculated 
5.5.7 Data storage 
Data was securely stored in a locked filing cabinet in a secure area of Queensland Children’s 
Medical Research Institute, The University of Queensland. Data was entered into an SPSS 
spreadsheet and any incomplete data was coded as missing, unknown or not applicable. 
The full dataset was cleaned and checked before being locked for analysis.  
5.6 Results 
5.6.1 Demographics 
Ninety-six children (55 male/41 female) with a median age of 1 year 9 months (IQR 1 year 
3 months – 5 years) who presented to the Royal Children’s Hospital with acute burn injuries 
were recruited into the study. Sixty-eight percent of children were aged three years or 
younger. Children had partial thickness burns ≤10% TBSA with 57.3% being scald burn 
injuries and 38.5% being contact burn injuries. The remaining burn injuries were flame burns 
(2.1%) and electrical burns (2.1%). 
5.6.2 Agreement between measurements 
Wound surface area ranged from 0.15cm2 to 246.90cm2. The wound surface area 
measurements at the first dressing change were complete (i.e. participants had 
measurements from both techniques) in 75 cases and were analyzed using an intra-class 
correlation coefficient (2, 1). The level of agreement between the two methods of wound 
surface area measurement was excellent (ICC 0.96, 95% CI 0.93, 0.97). Agreement 
between the two techniques was also visualized by comparing average wound area of the 
two techniques to the difference in wound area using Bland-Altman plots (See Figure 5-2). 
The plot demonstrated a heteroscedascity of the data and a greater variability between the 
two techniques in wounds of larger size, with a bias of 1.86 (LOA -15.86 – 19.58) cm2. The 
two outliers above the top LOA line were circumferential wounds where mapping was 
technically difficult for both techniques and there was a greater difference in measurements. 
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Figure 5-2 Bland-Altman plot comparing average Visitrak™ and camera calculated wound area to difference 
of Visitrak™ and camera area. Bias 1.86 (LOA -15.86 – 19.58) cm2. 
 
5.6.3 Missing data 
Visitrak™ tracings could not be completed in 19 participants with 16 of those participants 
aged 2 years or under. Excessive movement in participants, due to pain, young age or 
wound location (e.g. face), made it difficult to complete tracings or trace accurately, with 
many tracings completed as quickly as possible to minimize trauma to the child. As wounds 
were seen acutely at the first dressing change, condensation forming on the Visitrak™ grid 
also made it difficult to distinguish wound borders. Completing tracings quickly also often 
meant a rough, inaccurate drawing and in some cases, small sections of the wound were 
missed. Visitrak™ tracings where only a small section of wound area was missed were still 
used and extra areas captured by photography were not used in the analysis. One 
participant (aged 11 years) refused a 3D photograph due to wound location (perineum).  
5.7 Discussion 
This study has confirmed that 3D photography is a reliable alternative to digital planimetry 
(Visitrak™) to measure wound surface area in children with burn wounds ≤10% TBSA, with 
an intra-class correlation coefficient demonstrating excellent agreement between the two 
techniques. The burn wound care procedure can be a stressful and traumatic time for 
children, particularly for those under the age of three years and care must be taken to avoid 
additional distress to the child. Despite excellent wound measurement agreement between 
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the two techniques, 3D photography was demonstrated to be more appropriate for use in a 
young, pediatric population than Visitrak™.  
While the 3D photography method in this study had a 99% completion rate, Visitrak™ 
tracings could not be completed for 19 children, with 16 of those under the age of two years. 
Stockton et al. [41] also compared Visitrak™ and 3D photography in children with acute burn 
injuries, and recorded a 100% completion rate of tracings. However children in the study 
were a compliant group with a median age of 3 years 7 months compared to the median 
age of 1 year 9 months for this study. 3D photography has previously been established to 
be easier and quicker to use than Visitrak™ at the bedside for children due to its simple 
point and shoot method and non-invasive technique [120]. Visitrak™ tracings comparatively, 
involve direct contact of the film with the wound which can cause pain or anxiety and require 
the child to remain still for a prolonged period of time. Barriers to completing Visitrak™ 
tracings in this study included high pain and distress levels, excessive movement during the 
tracing and wound location (e.g. face). Higher levels of pain and distress during wound care 
procedures in children have been found to be associated with delays in wound re-
epithelialization [45]. Thus the use of wound measurement methods that involve direct 
wound contact or take a prolonged amount of time, such as the Visitrak™ system, should 
be re-considered for all children, especially those under the age of three years. 
Despite its demonstrated clinical utility in the pediatric population, use of 3D photography 
does present some minor drawbacks. Due to the technological limitations of 3D 
photography, wounds that extend over curved areas (e.g. ankle, wrist) can be difficult to 
visualize in 3D and the edges of the image can become distorted, slightly altering the true 
measurement. In particular, fingers and toes in very young children are especially difficult to 
map due to the small size of the digits and wounds often extending around the edges of 
digits. It should also be noted that the angle at which a photo is taken or the angle at which 
a body part is positioned (e.g. extension vs. flexion) can slightly alter surface area 
measurements and care should be taken to ensure consistency when photographing a 
wound over multiple timepoints.  
Again, difficulties were experienced mapping large circumferential wounds using both 
techniques. Four large circumferential wounds required multiple Visitrak™ grids to be joined 
together and it was challenging applying the stiff film sheets around a leg or arm and to 
complete an accurate tracing in these children who were in pain or distressed.  Similarly, 
mapping these wounds using the 3D photography software was difficult as serial 
photographs were taken to capture the entire wound and anatomical landmarks were used 
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to mark borders on each photograph. To counter this, the software does have the ability to 
stitch multiple, serial photographs together, but this is technically difficult and has limited 
clinical utility. While these limitations exist, it should be noted that the majority of children 
seen in this clinical setting have discrete burn injuries <1% TBSA and large, circumferential 
burn wounds are an uncommon occurrence [121]. Therefore this study has shown that 3D 
photography is a reliable measurement technique for smaller, discrete burn wounds and can 
be utilized clinically for this population.  
Photographs produced from the 3D LifeViz™ system are of a high definition and quality. In 
addition to wound area measurement, photographs taken at multiple timepoints have been 
utilized successfully for visual judgment of wound re-epithelialization by clinicians. The 
additional benefits gained from the photographs have strengthened the clinical utility of this 
system for the acute, pediatric burns population. 
5.8 Conclusion 
This study has confirmed 3D photography as a reliable alternative to digital planimetry in 
children of all ages with acute burn injuries ≤10% TBSA. It has also been established that 
3D photography is more clinically appropriate to use for young children given its fast and 
non-invasive nature. 
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5.11 Chapter Conclusion 
The research study presented in this chapter has shown 3D photography to be a reliable 
and non-invasive alternative to Visitrak™ for the mapping of wound surface area in children 
with acute, partial thickness burns. Technological limitations continue to exist in the mapping 
of larger and also circumferential wounds, but it is hoped that this will become less 
problematic as technology develops and users of the camera software become more skilled 
in the complex task of stitching photos together. The 3D LifeViz™ system however remains 
a device that can be successfully utilized for small to medium size burn wounds in children.  
As a result of this study, the 3D LifeViz™ system is now employed as the primary 
measurement method for burn wound mapping in all research studies conducted at the 
PLCBC. The camera’s quick point and shoot method at the bedside, non-invasive nature 
and ability to produce high-quality images, along with the capability of the Dermapix™ 
program to store progressive wound photographs for multiple patients, has rendered it an 
invaluable tool within the burns unit.  
3D photography using this device also has the capacity to measure volume and height of 
areas on the skin and has been identified as a potential tool for pediatric and adult burn 
scars and infantile hemangiomas. As a result, I have been extensively involved in research 
studies external to this thesis, which are currently underway examining the clinical utility and 
reliability of 3D photography to objectively measure burn scar height and volume and the 
volume of infantile hemangiomas over time. It is anticipated that results from these studies 
will demonstrate that the 3D LifeViz™ system is a versatile tool that can provide a multitude 
of benefits to the pediatric burns and vascular anomalies populations.  
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Chapter 6. Cost-effectiveness of silver 
dressings for pediatric partial thickness 
burns 
 
This chapter is based on a submitted paper (‘Cost-effectiveness of silver dressings for 
pediatric partial thickness burns: an economic evaluation from a randomized controlled trial’ 
in Burns journal (submission date: 08/03/2016). 
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6.1 Chapter foreword 
As previously described in Chapter 4, silver dressings are commonly used to treat pediatric 
partial thickness burns, however, research evidence regarding the most appropriate 
dressing to use is lacking. In addition to examining the efficacy of silver dressings, 
understanding the costs involved is also necessary to determine the burden on the 
healthcare system. Burn care in the outpatient setting is expensive with children often seen 
up to twice a week for dressing changes until the wound re-epithelializes, approximately 2-
3 weeks later. Scar management therapy and surgery for skin grafting can drastically 
increase the costs even further. Therefore, care is required to choose a dressing which is 
not only effective but which also reduces financial burden on the healthcare system. 
Despite the expense of burn care in the pediatric setting, very few comprehensive economic 
evaluations have been conducted for burns dressings in the pediatric outpatient population, 
with the majority continuing to combine adult and pediatric populations with severe burns 
requiring inpatient hospitalization. Consequently, there is very little information available to 
clinicians to allow them to choose a silver dressing which is a cost-effective option to use to 
treat pediatric partial thickness burns ≤10% TBSA. 
Hence, the aim of the economic evaluation presented in this chapter was to provide a 
detailed cost-effective analysis of the silver dressings included in the RCT presented in 
Chapter 4, to assist in decision-making for healthcare providers. This chapter is based on 
the submitted manuscript titled ‘Cost-effectiveness of three silver dressings for pediatric 
partial thickness burns: an economic evaluation from a randomized controlled trial’. Detailed 
methodology and results from the economic evaluation will be presented along with a 
discussion of the implications for clinical practice. 
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6.2 Abstract 
6.2.1 Background 
Partial thickness burn injuries of up to 10% total body surface area (TBSA) in children are 
common injuries primarily treated in the outpatient setting using expensive silver-containing 
dressings. However, economic evaluations in the pediatric burns population are lacking to 
assist healthcare providers when choosing which dressing to use. The aim of this study was 
to conduct a cost-effectiveness analysis of three silver dressings for partial thickness burns 
≤10% TBSA in children aged 0-15 years using days to full wound re-epithelialization as the 
health outcome. 
6.2.2 Method 
This study was trial based economic evaluation (incremental cost effectiveness) conducted 
from a healthcare provider perspective. Ninety-six children participated in the trial 
investigating Acticoat™, Acticoat™ with Mepitel™ or Mepilex Ag™. Costs directly related to 
the management of partial thickness burn injuries ≤10% TBSA were collected during the trial 
from March 2013-July 2014 and for a one year post re-epithelialization time horizon. 
Incremental cost effectiveness ratios were estimated and dominance probabilities calculated 
from bootstrap resampling trial data. Sensitivity analyses were conducted to examine the 
potential effect of accounting for infrequent, but high cost, skin grafting surgical procedures. 
6.2.3 Results 
Costs (dressing, labor, analgesics, scar management) were considerably lower in the 
Mepilex Ag™ group (median AUD$94.45) compared to the Acticoat™ (median $244.90) 
and Acticoat™ with Mepitel™ (median $196.66) interventions. There was a 99% and 97% 
probability that Mepilex Ag™ dominated (cheaper and more effective than) Acticoat™ and 
Acticoat™ with Mepitel™, respectively. This pattern of dominance was consistent across 
raw cost and effects, after a-priori adjustments, and sensitivity analyses. There was an 82% 
probability that Acticoat™ with Mepitel dominated Acticoat™ in the primary analysis, 
although this probability was sensitive to the effect of skin graft procedures.  
6.2.4 Conclusion 
This economic evaluation has demonstrated that Mepilex Ag™ was the dominant dressing 
choice over both Acticoat™ and Acticoat™ with Mepitel™ in this trial-based economic 
evaluation and is recommended for treatment of pediatric partial thickness burns ≤10% 
TBSA. 
6.3 Keywords 
Child, partial thickness burn injury, silver dressings, economic evaluation 
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6.4 Introduction 
In children aged 0-15 years, burn injuries of less than 20% total body surface area (TBSA) 
are the fifth most common cause of non-fatal childhood injuries worldwide, occurring in 153 
per 100,000 population of children [2]. As the mortality rates from burn injuries have 
decreased over time with better treatment options, burns of up to 10% TBSA in children can 
now be managed in the outpatient setting and consequently there has been a significant 
drop in inpatient admissions [42]. According to data collected by the Burns Registry of 
Australia and New Zealand (BRANZ) from seven burns centers over a one year period 
(2010-2011), the ratio of pediatric outpatient admissions to inpatients was 3.2:1 [28].  
In recent years, burns dressing applications for partial thickness burns ≤10% TBSA in 
children have changed from daily silver sulfadiazine cream (SSD) applications to the use of 
silver impregnated dressings which can be changed up to twice weekly in the outpatient 
setting [9]. The wound re-epithelialization process using dressings can take 2-3 weeks or 
occasionally more [29]. More than 800 children are typically treated for a burn injury in the 
city of Brisbane, where the present study was conducted, each year [122]. Outpatient 
treatment approaches (the majority of cases) are cheaper than admitted cases, but the costs 
associated with silver dressings utilized, and the health professional labor time consumed 
during the management of these burn injuries are substantial.  
A systematic review of burn care costs calculated the mean total cost as $3,883 per 1% 
TBSA burned for burns 0-10% TBSA in high income countries [18]. Thus, choosing a silver 
dressing which can promote a rapid re-epithelialization time (therefore decreasing the need 
for scar management and surgical intervention), and which is also less costly than other 
silver dressings on the market, has the potential to greatly reduce the resource consuming 
burden on the health system from pediatric burn injuries.  
Economic evaluations of silver burns dressings are warranted among clinical populations in 
order to assist decision making for healthcare providers. However, there is a paucity of cost-
effective studies among pediatric clinical populations with burn injuries. Notably, despite 
silver dressings being the treatment of choice for pediatric burns in high-income countries, 
there has yet to be a rigorous cost-effectiveness study comparing silver burns dressings in 
a pediatric outpatient population. 
A systematic review of the costs of burn care published in 2014 [18] noted that the majority 
of cost studies available in this area had numerous inconsistencies in study methodology. 
The majority were combined adult and pediatric populations, there was unreliable 
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measurement and reporting of TBSA in patients, severe burns requiring inpatient stays were 
largely the focus of studies and many studies which included direct medical costs often only 
recorded dressing costs. Cohort studies were most commonly reported (n = 107), while a 
small number were randomized controlled trials (n = 24). From the 153 studies included in 
the review, only three were identified as complete economic evaluations comparing burns 
dressings using cost effectiveness analyses, the remainder being cost studies only. One 
study investigated non-standard burns treatments [123] and the remaining two studies 
included either Aquacel Ag® [124] or Mepilex Ag™ [78] silver dressings however both were 
compared to SSD which is no longer a standard treatment in high-income countries for 
children.  
Since publication of this systematic review, a comprehensive cost-utility analysis of silver 
dressings (Mepilex Ag™ and Aquacel Ag®) compared to SSD in partial thickness burns 
≤20% TBSA was published [125]. This study among adults with burn injuries incorporated a 
cost-utility analysis and concluded that silver dressings were cost effective over a wide 
complication (e.g. infection) range in comparison to SSD among that sample.  
The most comprehensive economic evaluation currently in the literature of pediatric burn 
care is an incremental cost-effective analysis examining the use of a non-pharmacological, 
procedural preparation and distraction intervention (Ditto™) compared to standard practice 
in the pediatric burns outpatient setting and the effects on wound re-epithelialization [126]. 
While this study does not evaluate burn wound treatments, it was conducted from a societal 
perspective in the same setting as the current study (Royal Children’s Hospital, Brisbane) 
and has provided a detailed overview of cost estimations associated with pediatric burns 
managed as outpatients.  
6.5 Study Objective 
The aim of this study was to conduct an economic evaluation (incremental cost-
effectiveness analysis) of three silver dressings for partial thickness burns ≤10% TBSA in 
children aged 0-15 years using a reduction in days to full wound re-epithelialization (days to 
re-epithelialization saved) as the health outcome. 
6.6 Method 
6.6.1 Design 
A trial based economic evaluation (incremental cost-effectiveness analysis) was conducted 
from the perspective of a healthcare provider alongside a three-parallel arm randomized 
controlled trial [127]. This perspective was chosen to inform healthcare decision making for 
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health service personnel deciding which dressing to use in their service for partial thickness 
burns (≤10% TBSA) in children aged 0-15 years to minimize days until re-epithelialization. 
The time horizon for the study included wound and scar management for (up to) one year 
post-wound re-epithelialization (although most patients with these burns typically complete 
their wound management regimen in less than 6 months). Therefore, the investigators did 
not consider discounting for costs or effects to be warranted in this investigation due to the 
time-frames involved typically being less than 1-year. 
6.6.2 Participants and setting 
This study examined children aged 0-15 years (n = 96) presenting to the former Royal 
Children’s Hospital, Brisbane, Australia from March 2013-January 2014 within 72 hours of 
sustaining a ≤10% total body surface area (TBSA) partial thickness burn (superficial partial 
to deep partial inclusive). Children were recruited into a randomized controlled trial 
investigating silver burns dressings and were randomized to receive one of three silver 
dressings (Acticoat™, Acticoat™ with Mepitel™ or Mepilex Ag™) until the burn re-
epithelialized or skin grafting was required.  
This study was registered with the Australian New Zealand Clinical Trials Registry 
(ACTRN12613000105741) and approved by the Queensland Children’s Health Services 
(Royal Children’s Hospital) Human Research Ethics Committee and The University of 
Queensland Ethics Committee. 
6.6.3 Health outcome 
Days to re-epithelialization was the health outcome of interest for this evaluation. Prolonged 
re-epithelialization time for a burn injury can lead to an increased risk in the development of 
hypertrophic scarring [7]. Burns which re-epithelialize in 14 days or less are at a very low 
risk of developing residual scarring and children are often discharged upon wound re-
epithelialization. Burns which take longer than 14- 21 days to re-epithelialize or those 
requiring skin grafting generally develop hypertrophic scarring [7]. Hypertrophic scarring can 
have significant and life-long implications to the physical, psychosocial and emotional 
functioning of a child [94]. The presence of hypertrophic scarring typically requires long-term 
scar management therapy to treat and minimize scarring. As scar tissue grows at a slower 
rate than unaffected skin, this can lead to the need for multiple reconstructive surgeries until 
the child reaches adulthood. Scar management therapy (including the use of pressure 
garments and topical silicone), skin grafting and reconstruction are extremely expensive and 
can increase the cost of treating a burn dramatically in comparison to the cost of a burn 
treated conservatively and discharged without further follow-up.  
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6.6.4 Intervention 
Use of silver dressings can have a direct impact on the re-epithelialization time of the wound, 
for example, by prevention of infection (which can prolong time to re-epithelialization). The 
three silver dressings investigated in the randomized controlled trial were Acticoat™ (Smith 
and Nephew), Acticoat™ combined with Mepitel™ (Molnlycke Healthcare) and Mepilex 
Ag™ (Molnlycke Healthcare). All three dressings are presently used in healthcare services 
to treat pediatric partial thickness burns in Australasia. Both Acticoat™ and Mepilex Ag™ 
are stand-alone dressings, while Mepitel™ is a silicone interface dressing which is often 
placed underneath Acticoat™ to assist with dressing removal. A detailed explanation of each 
dressing has been previously described [127]. Prior to the present trial, the usual standard 
of care for pediatric burns in Brisbane, Australia was Acticoat™ with Mepitel™. All three 
dressings were changed every 3-5 days during the trial and this regime continued until burn 
wound re-epithelialization occurred or skin grafting was required.  
6.6.5 Intervention effect (on re-epithelialization) 
During the randomized trial, days to wound re-epithelialization was recorded for each 
participant and analyzed using a negative binomial regression adjusting for burn depth and 
TBSA [127]. Mepilex Ag™ was found to be the most effective dressing with regard to days 
to re-epithelialization, and Acticoat™ and Acticoat™ with Mepitel™ found to have a  40% (p 
<0.01) and 33% (p< 0.01) longer time until re-epithelialization respectively.  
6.6.6 Resources and costs 
Resource and cost data directly related to the partial thickness burn injury ≤10% TBSA was 
collected prospectively from March 2013-July 2014 during the trial. In addition, any further 
resource use relating to scar management and skin grafting requirements after the trial 
dressing intervention had ceased was collected from patient medical records for the first 
year post wound re-epithelialization. Costs for this study were applied in (2014) AUD$. (See 
Appendix 5) for a full breakdown of costs. 
6.6.6.1 Resource use 
Resource utilization data collected prospectively for each participant during their trial 
intervention included number of dressing changes required, time taken per dressing change 
and the nursing staff time (in minutes) required for each dressing change. Nursing time was 
inclusive of time taken to remove the dressing, clean the wound and apply a new dressing. 
Dressing type, size and quantity were also recorded at each dressing change. Analgesia 
administered to the child at each dressing change was also recorded. Amount of analgesic 
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medication was calculated by weight, with standard of care being Oxycodone (0.1mg/kg) 
and Paracetamol (15mg/kg).  
Labor time for dressing, wound or scar-related management was also recorded for 
occupational therapists and treating medical or surgical consultants. Labor resource usage 
was accrued for these professionals as; occupational therapy (30 minutes per scar 
management therapy appointment), treating medical or surgical consultant (15 minutes per 
dressing change appointment) for each participant. The investigators considered skin 
grafting to be an infrequent, but potentially important consideration for resource use. 
Therefore if participants required a skin grafting procedure and /or scar management 
therapy, this was also documented. 
6.6.6.2 Valuation of costs 
Labor time was costed at the appropriate award rates for these respective health 
professionals working in state-based health facilities and consistent with the participating 
hospital’s wage rates. This included use of three state-based award rates (Nursing [128], 
Health Practitioner for occupational therapists [129], and Medical [130]). Labor costing for 
this trial included an additional 25.85% for associated on-costs (e.g. for leave accrual). Costs 
for dressings and scar management products were obtained from the participating hospitals’ 
Finance and Materials Management Information System consumables pricing list which had 
prices at market rates. Dressings were individually packaged and price per individual 
dressing was used. Silicone products for scar management included topical silicone gels 
and sheets and silicone moulds. Silicone gels were priced per tube prescribed to the patient 
and silicone sheets as per individual sheet prescribed. Price per silicone mould was 
calculated from the price of a whole container of putty and then an estimation of number of 
moulds per container made (from the participating health professionals). Pressure garments 
for scar management were specifically tailored to each child; therefore price per garment 
was taken from each child’s garment order form. Consistent with the time-horizon for this 
study, scar management resources were only recorded for the first year post wound re-
epithelialization. 
The cost of a skin graft was included as the theatre cost and the cost of a negative pressure 
wound therapy dressing to the graft for 7 days (standard care). Skin grafting theatre cost 
was estimated from Queensland Health Diagnosis-Related Groups theatre costing where 
each child was given a DRG procedure code with a corresponding cost [131]. Price for a 
negative pressure wound therapy dressing encompassed the cost of gauze dressing, 
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dressing film and the lease of a negative pressure wound therapy canister and machine for 
a one week period.  
6.6.7 Incremental cost effectiveness using randomized trial data  
Incremental cost-effectiveness ratios (ICERs) were used to examine the cost per (one less) 
day to re-epithelialization for each paired comparison of the three intervention arms. The 
investigators considered it important to investigate each of the three possible between group 
incremental cost-effectiveness comparisons in order to inform a decision maker choosing 
between any two of these dressings which may be available to them. This meant that three 
separate incremental cost effectiveness ratios were estimated for this economic evaluation 
based on the equations displayed below where Cost was expressed as (2014) AUD$ and 
Effect as (‘days to re-epithelialization’). The three ICER equations represent:  
a) Acticoat™ with Mepitel™ versus Acticoat™  
 
b) Mepilex Ag™ versus Acticoat™  
 
c) Mepilex Ag™ versus Acticoat™ with Mepitel™. 
 
Potential exclusions and model adjustments for the primary cost-effectiveness analysis were 
consistent with the primary trial protocol [127]. This principally meant that the small number 
of patients that required a skin grafting (n=4) were excluded from the primary analysis of 
both costs and effects to avoid the risk of the findings being unduly influenced by a small 
number of potential outliers. However, participants who required a skin graft were included 
in sensitivity analyses to examine their potential impact.  
The difference in cost for each paired comparison was estimated from the adjusted 
regression coefficient derived from a multiple regression that included adjustment for burn 
depth and TBSA. Similarly, the difference in effect for each paired comparison was 
ICER 
(Cost Mepilex Ag™ group )  – (Cost Acticoat™ with Mepitel™ group )   
(Effect Mepilex Ag™ group )  – (Effect Acticoat™ with Mepitel™ group ) = 
ICER 
(Cost Mepilex Ag™ group )  – (Cost Acticoat™ group ) 
(Effect Mepilex Ag™ group )  – (Effect Acticoat™ group ) = 
ICER 
(Cost Acticoat™ group )  – (Cost Acticoat™ with Mepitel™ group ) 
(Effect Acticoat™ group )  – (Effect Acticoat™ with Mepitel™ group ) = 
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estimated from the regression coefficient derived from a multiple regression that included 
adjustment for burn depth and TBSA.  
Bootstrap resampling (2000 replications of the original sample) was used to calculate 95% 
confidence intervals (for between group differences in the cost of treatment and days to full 
re-epithelialization) and 95% confidence ellipses for the ICER estimates (cost per day (less) 
to full re-epithelialization). The ICER estimates and 95% confidence ellipse were plotted on 
cost-effectiveness quadrants with lower cost and fewer days to re-epithelialization 
(dominance) represented in the bottom-right quadrant (Figure 6-1). From these data, the 
probability that each intervention was less costly and more effective than each of the two 
respective alternatives was calculated. All statistical analyses for this economic evaluation 
were completed using Stata 14 (StataCorp, College Station, Texas) and Microsoft Office 
Excel 2010 (Microsoft Pty Limited, North Ryde, NSW, Australia).  
6.6.8 Sensitivity analyses 
Sensitivity analyses focused on examining the impact of inclusion of patients with a skin 
graft on the findings of the economic evaluation. As split skin grafting is seen as ‘man-made’ 
wound closure and the day of the grafting procedure in theatre can vary (e.g. three days 
post-burn to two weeks post-burn) due to factors such as burn depth or theatre availability, 
it is difficult to obtain a true ‘days to re-epithelialization’ equivalent time estimate for these 
patients. As such, two separate sensitivity analyses were conducted using two alternative 
approaches to assigning a ‘days to re-epithelialization’ value for the four participants who 
received a skin graft. The first, and least conservative approach, was to use the day of the 
skin graft as an artificial proxy of the day of re-epithelialization. The second approach was 
to use a dummy value of one day longer than the maximum days to re-epithelialization 
recorded for any non-skin graft participant in the trial. The participant who had the longest 
time to successful re-epithelialization without skin graft had the same burn depth as those 
that were grafted. In both sensitivity analyses, the cost of skin grafting and subsequent 
management of the four skin graft cases was included in the cost component of the equation.  
6.7 Results 
The demographics and clinical characteristics of the participants in the trial have previously 
been reported [127]. In summary, participants (n=96) had a mean (standard deviation) age 
of 3.01 (3.51) years, and 55 (57.3%) were male. Patient outcomes for participants in each 
of the three groups are summarized in Table 6-1. Overall, participants in the Mepilex Ag 
group required fewer days to re-epithelialization than the other groups. Four participants 
(4%) required split skin graft surgery.  
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6.7.1 Costs 
Costs were considerably lower in the Mepilex Ag™ group compared to the Acticoat™ and 
Acticoat™ with Mepitel™ interventions (Table Table 6-2). The median total cost (excluding 
skin grafting) for those who received Mepilex Ag™ was $94.45, compared to $196.66 for 
Acticoat™ with Mepitel™ and $244.90 for Acticoat™. Differences in costs were attributable 
to both the higher item cost of both Acticoat™ and Mepitel™ (in particular when the two are 
combined) as well as the additional costs associated with a large number of dressing 
changes required for Acticoat™ and Acticoat™ with Mepitel™ due to the longer times to re-
epithelialization. Two patients in each of the Acticoat™ with Mepitel™ and Acticoat™ groups 
required grafting that was estimated at $1731 in each case which substantially increased 
the mean total cost for those groups (Table 6-2). In summary, costs were lowest in the 
Mepilex Ag™ group with or without consideration of skin graft costs.  
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Table 6-1 Patient outcomes for each treatment group 
 
 
 
 
 
 
 
Grouping Acticoat™ Acticoat™ + Mepitel™ Mepilex Ag™ 
Total number of patients 31 32 33 
Healed ≤2 weeks 22 24 29 
Healed 2-3 weeks 4 4 2 
Healed >3 weeks 2 0 1 
Drop outs (failed to attend dressing change) 1 2 1 
Split skin graft surgery 2 2 0 
Scar management therapy 5 2 1 
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Table 6-2 Costs accumulated for each treatment group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
+Total acute costs (excluding skin grafting) = dressings, staff labor, analgesia medication, scar management therapy 
Surgical skin grafting costs = surgical cost of a skin graft and cost of negative pressure wound therapy for 1 week 
Scar management costs = all scar resources (consumables costs and staff labour) 
Grouping Acticoat™ Acticoat™ + Mepitel™ Mepilex Ag™ 
Group median (IQR) in AUD$    
Total acute costs (excluding skin grafting)+ 244.87 (109.22-386.80) 196.66 (134.54-393.87) 94.45 (55.21-137.62) 
   Dressing costs 69.71 (38.30-183.28) 98.68 (56.70-198.33) 25.20 (16.80-50.45) 
   Staff labor costs 112.41 (67.85-175.30) 104.99 (72.30-145.53) 67.68 (38.65-74.33) 
   Analgesia costs 0.40 (0.21-0.63) 0.40 (0.26-0.73) 0.32 (0.20-0.47) 
   Scar management costs+ 0 (0,0) 0 (0,0) 0 (0,0) 
Group mean (SD) in AUD$    
Total acute costs (excluding skin grafting)+ 373.30 (428.94) 341.37 (414.16) 116.80 (84.03) 
   Dressing costs 125.97 (133.17) 164.46 (156.55) 39.05 (34.10) 
   Staff labor costs 134.06 (92.17) 114.36 (60.36) 76.34 (54.51) 
   Analgesia costs 0.59 (0.71) 0.54 (0.44) 0.36 (0.27) 
   Scar management costs+ 103.46 (282.43) 41.35 (165.35) 2.94 (16.91) 
Cost estimate per surgical skin grafting case 17131 17131 Nil cases 
Group mean (SD) (including skin grafts) 1478.52 (4499.86) 1412.0.3 (4596.03) 116.80 (84.03) 
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6.7.2 Incremental cost effectiveness 
The primary incremental cost effectiveness ratios (ICERs) for each between-group 
comparison were calculated and presented graphically (Figure 6-1) with 95% confidence 
ellipses. There was a 99% and 97% probability that Mepilex Ag™ dominated (was cheaper 
and more effective) Acticoat™ (Figure 6-1b) and Acticoat™ with Mepitel™ (Figure 6-1c), 
respectively. After a-priori adjustments, the mean (95% confidence intervals) cost-saving 
per participant from use of Mepilex Ag™ was $95.19 ($46.67, $142.99) in comparison to 
Acticoat™ and $74.80 ($30.19, $122.60) in comparison to Acticoat™ with Mepitel™. 
Similarly, after a-priori adjustments, the mean (95% confidence intervals) fewer days to re-
epithelialization per participant from use of Mepilex Ag™ was 2.1 (0.1, 4.1) days in 
comparison to Acticoat™ and 1.3 (0.22, 2.47) days in comparison to Acticoat™ with 
Mepitel™. There was an 82% probability that Acticoat™ with Mepitel™ dominated 
Acticoat™ in the primary analysis. After a-prior adjustments, Acticoat™ with Mepitel™ 
demonstrated a mean (95% confidence intervals) cost-saving per participant of $107.55 ($-
1.57, $239.51) and fewer days to re-epithelialization of 1.1 (-1.25, 3.68) days in comparison 
to Acticoat™.   
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Figure 6-1 Incremental cost-effectiveness (and 95% confidence ellipses) from the primary trial analysis for a) 
Acticoat™ with Mepitel™ versus Acticoat™ b) Mepilex Ag™ versus Acticoat™ and c) Mepilex Ag™ versus 
Acticoat™ with Mepitel™
-4
00
-2
00
0
20
0
D
iff
er
en
ce
 in
 c
os
t (
A
U
D
)
-6-4-2024
Difference in days to re-epithelialization
a)
-4
00
-2
00
0
20
0
D
iff
er
en
ce
 in
 c
os
t (
A
U
D
)
-6-4-2024
Difference in days to re-epithelialization
-4
00
-2
00
0
20
0
D
iff
er
en
ce
 in
 c
os
t (
A
U
D
)
-6-4-2024
Difference in days to re-epithelialization
b)
c)
109 
 
6.7.3 Sensitivity analyses 
Both approaches to inclusion of the four participants who required a skin graft (Figure 6-2) 
yielded similar findings to the primary analysis for the Mepilex Ag comparisons (Figure 6-2c-
f), albeit that the scale of cost savings and variance in the data were potentially larger in the 
direction of effect observed in the primary analysis which was attributable to the substantial 
costs associated with skin grafts.  When the less conservative approach to assigning the 
‘days to epithelialization’ as the day of the surgical split graft was used, there was a 95% 
and 91% probability that Mepilex Ag™ dominated Acticoat™ and Acticoat™ with Mepitel™, 
respectively. When an artificial ‘time to re-epithelialization’ value of one day longer than the 
longest time to re-epithelialization from conservative management observed in the trial was 
used, there was a 97% and 94% probability that Mepilex Ag™ dominated Acticoat™ and 
Acticoat™ with Mepitel™, respectively.  
The inclusion of patients who received a graft substantially increased the uncertainty of 
ICER estimates for the comparison of Acticoat™ to Acticoat™ with Mepitel™, which is 
demonstrated in the wider confidence ellipse (Figure 6-2a and b in comparison to Figure 
6-1). This greater variance in bootstrapped estimates (particularly the cost side of the 
equation) was directly attributable to the inclusion of a small number of cases with skin 
grafting that were associated with substantial costs. When the day of surgery was used in 
the effect estimate, there was a 33% probability that Acticoat™ with Mepitel™ dominated 
Acticoat™. When the artificial ‘time to re-epithelialization’ value of one day longer than the 
longest time to re-epithelialization was used, there was a 52% probability that Acticoat™ 
with Mepitel™ dominated Acticoat™. 
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Figure 6-2 Incremental cost-effectiveness (and 95% confidence ellipses) from the sensitivity analyses using 
date of skin graft (a, c, e) or a dummy value (b, d, f) as a proxy for time to re-epithelization for Acticoat™ with 
Mepitel™ versus Acticoat™ (a, b) Mepilex™ versus Acticoat™ (c, d) and Mepilex Ag™ versus Acticoat™ 
with Mepitel™ (e, f). 
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6.8 Discussion 
This study was the first economic evaluation to compare the use of three silver dressings 
for partial thickness burns ≤10% TBSA in children up to the age of 15 years who were treated 
in an outpatient setting. Patients who received Mepilex Ag™ required fewer healthcare 
resources and had significantly shorter re-epithelialization times than those who received 
Acticoat™ with Mepitel™ or Acticoat™. The Mepilex Ag™ was the dominant intervention 
(cheaper and more effective) in the primary analysis and both sensitivity analyses. This has 
lead the authors to conclude that Mepilex Ag™ was more cost-effective than the two other 
dressings investigated under the conditions of this trial, with this patient sample and with the 
application of market pricing at the time of the study (2014). The recommendation from this 
evaluation is that Mepilex Ag™ be the dressing of choice for this population of children who 
sustain partial thickness burn injuries ≤10% TBSA. While this was a definitive outcome from 
the present evaluation, and there is a paucity of economic evaluations to support or refute 
the present finding, there are several caveats that the authors would like to highlight for 
consideration. 
First, the trial on which this economic evaluation was based received some financial support 
from Molnlycke Healthcare (the company which supplies Mepilex Ag™ and Mepitel™). This 
company had no input into study design, data collection, analysis or manuscript preparation 
and no right or opportunity to stop the authors from publishing the findings regardless of how 
their products performed during the trial. Nonetheless, the authors would encourage further 
clinical trials and economic evaluations of these dressings (particularly those funded through 
independent not-for-profit sources) within the same clinical population to confirm or refute 
the findings observed in this evaluation. It is also noteworthy that this was a single site trial 
and that variation in clinical practice across facilities within Australia and internationally may 
influence patient outcomes. Similarly, valuations of labor and non-labor resource use may 
differ between jurisdictions.   
Second, this evaluation was conducted using a healthcare provider perspective and was 
limited to a time horizon of one year. The authors considered this the most appropriate 
perspective and time-horizon for this evaluation to inform decision makers choosing which 
dressing to use for this clinical group. This meant that broader societal impacts (for example, 
between group differences in productivity losses associated with parents or caregivers 
accompanying children to burn-related healthcare appointments) were considered beyond 
the scope of this investigation. Similarly, only resources consumed within one year post re-
epithelialization were within the time-horizon for this study. However, given that cost savings 
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for the Mepilex Ag™ group were (at least in part) attributable to fewer appointments and 
faster healing, it is likely that a similar patterns of incremental cost-effectiveness estimate 
ratios would have been observed regardless of the any alternative perspective or time 
horizon that could have been selected.  
A design feature of the present study that may limit comparisons to be made outside the 
field of wound healing was that no measures of health-related quality of life (HRQoL) were 
completed for this evaluation. Subsequently, analyses were limited to randomized controlled 
trial data using the primary outcome of days to re-epithelialization as the health outcome. 
While this is consistent with prior evaluations in the field [18], the inclusion of a preference 
based HRQoL measure would have led to a greater understanding of the respective impacts 
(if any) of earlier healing (and potentially a reduction in the need for scar management or 
skin grafting). Burn injuries can be a life-changing event for children, young people and their 
families both physically and psychosocially and the measurement of HRQoL would have 
been beneficial when determining the cost effectiveness of treatments. Specifically, use of 
a preference-based measure in future studies would enable the determination of quality 
adjusted life years gained (or lost). The Child Health Utility 9D Index [132] would seem a 
worthwhile measure for consideration in future economic evaluations to both understand life 
impacts from the patients’ perspective from a clinical perspective, but also calculate quality 
adjusted life years for inclusion in cost-utility analyses. 
One final point for consideration was the impact of the few cases with the worst outcomes 
and highest costs. The skewed distribution of resource utilization (and therefore costs) 
meant that the mean costs were considerably higher than median costs with the mean 
influenced by a relatively small number of cases with particularly high costs. This was able 
to be accounted for in the analysis in two ways. First, the bootstrap resampling approach 
enabled the calculation of non-parametric confidence intervals (for costs and effects) as well 
as confidence ellipses (for incremental cost effectiveness estimates), to quantify the level of 
uncertainty and probability of dominance based on the actual distribution of outcomes 
observed in the trial. Second, the sensitivity analyses examining the potential impact of 
inclusion of the outlying costs associated with the small number of cases requiring skin grafts 
further supported the principal finding of the study (dominance of the Mepilex Ag™ 
intervention). However, the sensitivity analyses demonstrated the potential volatility in cost 
estimates attributable to the small number cases that may require skin grafts. As skin 
grafting is primarily used for deep dermal partial thickness and full thickness wounds that 
will not re-epithelialize in a reasonable amount of time, it is recommended that skin grafting 
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be considered as an entirely separate, but economically important, type of treatment for burn 
wounds with its own set of costs and health outcomes.  
6.9 Conclusion 
This trial-based economic evaluation has demonstrated that Mepilex Ag™ is a dominant 
(cheaper and more effective) dressing choice over both Acticoat™ and Acticoat™ with 
Mepitel™ and is recommended for treatment of pediatric partial thickness burns ≤10% 
TBSA. Acticoat™ with Mepitel™ may also dominate Acticoat™ for the same population 
based on the primary analysis of this trial; however, there was greater uncertainty in between 
group differences in cost and effects for these two interventions than for the dominance of 
Mepilex Ag™ over both of these alternatives. 
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6.11 Chapter conclusion 
This chapter has demonstrated that Mepilex Ag™ is a cost-effective option over both 
Acticoat™ and Acticoat™ with Mepite™l. There was a 99% and 97% probability that Mepilex 
Ag™ was cheaper and more effective Acticoat™ and Acticoat™ with Mepitel™, 
respectively. The mean cost-savings per participant from use of Mepilex Ag™ was $95.19 
in comparison to Acticoat™ and $74.80 in comparison to Acticoat™ with Mepitel™. The use 
of an effective dressing which is significantly more cost-effective than the usual standard of 
care will likely reduce the financial burden of such burn injuries to the healthcare system.  
The results from this study have indicated that not only is Mepilex Ag™ more effective than 
Acticoat™ and Acticoat™ with Mepitel™ with respect to wound re-epithelialization time and 
pain during dressing changes, it is also a less expensive option. As clinical practice for the 
treatment of pediatric partial thickness burns ≤10% TBSA has already changed within 
Queensland, these findings will further strengthen the RCT results and further solidify the 
decision for the change. It is anticipated that the findings of the cost analysis will also 
strengthen the case for the use of Mepilex Ag™, interstate and in New Zealand, in the 
treatment of pediatric partial thickness burns in the outpatient setting.  
Chapter 7 is a continuation of the RCT presented in Chapter 4. This chapter will discuss and 
present results from of scar assessments of trial participants, conducted at 3 and 6 months 
post wound re-epithelialization.  
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Chapter 7. Long-term scar outcome of 
pediatric partial thickness burns 
 
This chapter is based on a published paper in Burns journal 
Citation: Gee Kee, E. L., Kimble, R. M., Cuttle, L., & Stockton, K. A. (2015). Scar outcome 
of children with partial thickness burns: A 3 and 6 month follow up. Burns. doi: 
10.1016/j.burns.2015.06.019 
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7.1 Chapter foreword 
Hypertrophic scarring from burn injuries with prolonged re-epithelialization times or which 
require skin grafting can have a potentially devastating effect on a child’s physical and 
psychosocial functioning [94]. They also often necessitate surgical reconstruction to keep 
up with a child’s growing body [42]. In comparison, the longer term outcome for pediatric 
partial thickness burns is less complex with the majority of children discharged and not 
requiring scar management therapy post-wound re-epithelialization.  Partial thickness burn 
sites are clinically reported to return to a normal skin appearance and pigmentation within 
six months post-wound re-epithelialization, but there is very limited research evidence to 
support this. Education provided to children and their families on longer term outcome from 
these burn injuries is therefore restricted to clinical knowledge and experience of the treating 
consultant. 
Changes in skin pigmentation and appearance as a result of partial thickness burns are at 
the lower end of the spectrum in terms of clinical significance, as many of these changes 
are assumed to be temporary. However there is the capacity for such appearance changes 
to negatively impact on the psychosocial functioning of children and their families, as has 
been shown in children and adolescents with ‘visible’ burn scars or skin conditions such as 
vitiligo [95-97]. It is therefore vital that information on scar outcome for children with partial 
thickness burns is thoroughly investigated to ensure appropriate education and advice is 
provided to children and their parents and to facilitate early identification and management 
of potential psychosocial concerns prior to discharge from treatment.  
This chapter is based on the publication titled ‘Scar outcome of children with partial thickness 
burns: A 3 and 6 month follow-up’. The chapter will present results from the scar follow-up 
phase of children recruited into the randomized controlled trial presented in Chapter 3. 
Detailed methods and results will be presented, along with a discussion of clinical outcomes 
from this study. 
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7.2 Abstract 
7.2.1 Introduction 
There is a paucity of research investigating the scar outcome of children with partial 
thickness burn injuries. The aim of this study was to assess the scar outcome of children 
with partial thickness burns who received a silver dressing acutely.  
7.2.2 Method 
Children aged 0 to 15 years with an acute partial thickness burn, ≤10% TBSA were included.  
Children were originally recruited for an RCT investigating three dressings for partial 
thickness burns. Children were assessed at 3 and 6 months post re-epithelialization. 3D 
photographs were taken of the burn site, POSAS was completed and skin thickness was 
measured using ultrasound imaging.  
7.2.3 Results 
Forty-three children returned for 3 and 6 month follow-ups or returned a photo. Days to re-
epithelialization was a significant predictor of skin/scar quality at 3 and 6 months (p<0.01). 
Patient-rated color and observer-rated vascularity and pigmentation POSAS scores were 
comparable at 3 months (color vs. vascularity 0.88, p<0.001; color vs. pigmentation 0.64, 
p<0.001), but patients scored higher than the observer at 6 months (color vs. vascularity 
0.57, p<0.05; color vs. pigmentation 0.15, p = 0.60).  Burn depth was significantly correlated 
with skin thickness (r=0.51, p<0.01). Hypopigmentation of the burn site was present in 
25.8% of children who re-epithelialized in ≤2 weeks.  
7.2.4 Conclusion  
This study has provided information on outcomes for children with partial thickness burns 
and highlighted a need for further education of this population. 
7.3 Keywords 
Child, partial thickness burn injury, scar outcome, skin thickness 
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7.4 Introduction 
Small, but significant partial thickness burns in children are common injuries in high-income 
countries [42]. It is well known that partial thickness burns in children which take longer than 
two weeks to re-epithelialize are at a greater risk of hypertrophic scarring [7, 79, 133] and 
that clinically, a normal skin appearance is expected within six months for partial thickness 
burn injuries which re-epithelialize in two weeks or less., A comprehensive observational 
study by van der Wal and colleagues [20] compared the long-term scar outcomes in a 
representative group of children and adults with partial and full thickness burns. Partial 
thickness wounds were shown to result in a better scar quality than full thickness wound and 
that in children with scald burns, the scar maturation patterns between partial and full 
thickness wounds were different. However despite these demonstrated differences in scar 
maturation and clinical knowledge of partial thickness burn outcome, high-level research 
solely focusing on the outcomes of children with partial thickness burns is severely lacking.  
Partial thickness burns in children are often treated acutely with conservative treatments 
such as recently developed silver-containing dressings. As acute treatment can have an 
effect on long-term scar quality, it is essential for comprehensive long-term studies of scar 
outcome following clinical trials of burn dressings to be completed in order to determine the 
impact of dressings on scar outcome. A recent systematic review by Vloemans et al. [80] 
investigating acute dressings and topical treatments for children with partial thickness burns, 
noted that only one randomized controlled trial (RCT) included a scar follow-up of its 
participants. The follow-up phase of this RCT however only consisted of the review of a very 
small number of children (exact number not stated) at 3 months post re-epithelialization [81]. 
Furthermore, external to the systematic review, Mabrouk et al. [82] compared Aquacel® Ag 
to the moist, open dressing MEBO and conducted 3 and 6 month follow-ups, however age 
range was broad (children and adults) only partial thickness facial burns were included and 
follow-up numbers were again not stated.  
Therefore the aim of this study was to assess the scar outcome of children aged 0-15 years 
with partial thickness burn injuries <10% TBSA who were originally recruited into an RCT 
comparing silver dressings in the acute phase of treatment [127]. 
7.5 Method 
This study was an extension of the prospective, randomized controlled trial ‘Randomized 
controlled trial of three different dressings for partial thickness burns in children’ [127]. The 
study is registered with the Australian New Zealand Clinical Trials Registry 
(ACTRN12613000105741) and was approved by the Queensland Children’s Health 
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Services (Royal Children’s Hospital) Human Research Ethics Committee and The University 
of Queensland Ethics Committee. 
7.5.1 Participants 
Children aged 0 to 15 years with an acute partial thickness (superficial partial to deep partial 
thickness inclusive) burn injury and a burn total body surface area (TBSA) of ≤10%.  
7.5.2 Recruitment 
Eligible patients were originally recruited from the Stuart Pegg Pediatric Burns Centre 
(SPPBC) at the Royal Children’s Hospital, Brisbane, Australia between March 2013 and 
January 2014 as part of the RCT. For the RCT, children were randomized to one of three 
burns dressings (Acticoat™, Acticoat™ with Mepitel™ or Mepilex Ag™) and received this 
dressing until re-epithelialization or grafting occurred. Children and their families were 
informed prior to consent that participation in the RCT would require long-term follow-up 
appointments at 3 and 6 months post wound re-epithelialization.  
7.5.3 Procedure 
Children who completed the randomized dressing treatment until re-epithelialization of the 
burn wound or received skin grafting were brought in for follow-up appointments in the burns 
clinic at 3 and 6 months post burn wound re-epithelialization. Parents were phoned to 
organize a meeting time and if unable to attend follow-up appointments (e.g. due to living in 
a regional or rural centre), were given the option of sending in a photo of the child’s original 
burn wound site via email.  
At the 3 month appointment, children had a 3D photograph (3D LifeViz™ Camera, 
Quantificare, Cedex, France) taken of the burn wound site, the Patient and Observer Scar 
Assessment Scale (POSAS) was completed and an ultrasound scan was taken of the burn 
site and an unaffected contralateral site. Where a child had multiple sites, this process was 
completed for each site. This process was then replicated at the 6 month follow-up 
appointment.  
7.5.4 Outcome measures 
7.5.4.1 The Patient and Observer Scar Assessment Scale 
The Patient and Observer Scar Assessment Scale (POSAS) was completed on participants 
at both 3 and 6 month follow-ups. The observer section was completed by the study 
investigator and the patient section was completed by the child (if over the age of 8) or the 
caregiver. A total score and overall opinion score were generated from both the patient and 
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observer assessments. For total scores, a score of 6 is equal to normal skin. For overall 
opinion scores, a score of 1 is equal to normal skin.  
7.5.4.2 3D photography 
All children had a 3D photograph taken of their original burn wound site using the 3D 
LifeViz™ Camera (Quantificare, Cedex, France). The 3D photographs were analyzed by the 
primary investigator on the DermapixTM software program (Quantificare, Cedex, France) to 
calculate scar height (if present). A ruler was included in all 3D photographs for 
measurement calibration in the associated software package DermapixTM.  
7.5.4.3 Ultrasound 
An ultrasound scan using the BT12 Venue 40 MSK with an 8-18 MHz hockey stick probe 
(GE Healthcare) was taken of the original burn wound site to measure skin thickness. The 
probe was placed in the center of the original burn site when there was no evidence of scar. 
If scar tissue was present, the probe was placed on the area originally classified as having 
the deepest wound depth. An additional measurement was taken of an unaffected 
contralateral site to the burn. Where a contralateral site was not available (e.g. bilateral burn 
sites), the closest, unaffected adjacent site was used. Measurements were taken from the 
top border of the epidermis to the lower border of the dermis (see Figure 7-1). The direction 
of the ultrasound probe was recorded at 3 months to ensure consistency for the subsequent 
6 month appointment. Five measurements were taken at each site for reliability analysis. To 
account for differences in scar or burn site location, the mean measurement at each burn 
site was used to calculate a percentage difference of burn site skin thickness (compared to 
the normal site) at 3 and 6 months. 
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Figure 7-1 Example ultrasound image output indicating epidermal and dermal borders 
 
7.5.5 Statistical Analysis 
All statistical analyzes were conducted using SPSS 21 (IBM Corporation, Armonk, NY, 
USA). Demographic data (age, gender, burn TBSA and burn depth) are presented as 
median and interquartile range (IQR) or percentage where appropriate. Non-parametric 
demographic data was calculated using a Kruskal-Wallis test. Correlation of variables was 
calculated using Pearson correlations or Spearman’s rho where necessary. Multiple 
regression models were used to identify predictors of POSAS scores and Wilcoxon Signed 
Rank Tests were used to analyze POSAS scores and ultrasound measurements over time. 
All tests with a p value <0.05 were considered statistically significant. 
7.5.6 Data storage 
Data is securely stored in a locked filing cabinet in a secure area of the Queensland 
Children’s Medical Research Institute, The University of Queensland. Data were entered 
into an SPSS spreadsheet and any incomplete data were coded as missing, unknown or 
not applicable. The full dataset was cleaned and checked before being locked for analysis. 
Data from this study will be kept for a period of 15 years in accordance with NHMRC 
guidelines. 
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7.6 Results 
7.6.1 Demographics 
7.6.1.1 Follow-up cohort 
Ninety-two children from the original RCT who completed the entire course of treatment 
were contacted for follow-up appointments. From this cohort of 92 children, 43 children (26 
male/17 female) with a median age of 1.0 year (IQR 1.0-6.0 years) (See Table 1-1) returned 
to the hospital for either: 3 and 6 month follow-ups, 3 month follow-up only, 6 month follow-
up only, or returned a photo to the primary investigator via email as shown in the participant 
return flowchart (Figure 7-2). Of the children who returned, 69.8% were classified acutely as 
having a superficial partial thickness burn. Two out of four children from the original cohort 
who received a split-skin graft returned for a follow-up at the hospital and one returned a 
photo (See Table 7-1). From the 3 to 6 month follow-ups, there was a 48% dropout in 
participants returning to hospital for review and 70% dropout in photo returns.  
7.6.1.2 Did not return cohort 
Forty-nine children (27 male/ 22 female) with a median age of 1.0 year (IQR 1.0-3.5 years) 
did not return for any follow-ups (hospital or photos) (See Table 7-1). This group of children 
were significantly different to the returned cohort in regards to burn depth (p = 0.03), as a 
larger number of children with deeper burns returned for follow-ups. There was no significant 
difference between the remaining baseline characteristics of the two groups. 
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Figure 7-2 Flow chart of participant follow-up numbers 
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 Table 7-1  Demographic characteristics 
  Did not return 
n=49 
Median (IQR) 
Clinic return  
n=43 
Median (IQR) 
p-
value 
Age (years) 
 
 1.0 (1.0-3.5) 1.0 (1.0-6.0) 0.13 
 
TBSA (%) 
 
 0.5% (0.50-2.50) 1.0% (0.5-2.0%) 0.52 
 
Gender 
 
 
Male 
n (%) 
27 (55.1) 
n (%) 
26 (60.5) 
 
0.60 
     
Burn depth Superficial 
partial only 
Mixed partial 
thickness 
 
43 (87.8) 
 
6 (12.2) 
 
 
30 (69.8) 
 
13 (30.2) 
0.03* 
MOI Scald 
Contact 
Flame 
Electrical 
 
27 (55.1) 
20 (40.8) 
1 (2.0) 
1 (2.0) 
27 (62.8) 
14 (32.6) 
1 (2.3) 
1 (2.3) 
0.50 
Residential Postcode Metropolitan 
Regional 
Different State 
38 (77.6) 
10 (20.4) 
1 (2.0) 
38 (88.4) 
4 (9.3) 
1 (2.3) 
0.19 
 
Wound  
re-epithelialization time 
 
<2 weeks 
2-3 weeks 
>3 weeks/graft 
 
37 (75.5) 
10 (20.4) 
2 (4.1) 
 
31 (72.1) 
7 (16.3) 
5 (11.6) 
 
0.15 
Skin grafts  1 3  
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7.6.2 POSAS scores  
To account for photo returns where a hospital follow-up was not possible, the POSAS 
observer section was completed on these photos. To ensure validity of these scores, original 
burn site photos taken of children who did return for follow-ups were scored on the POSAS 
observer section again retrospectively. The retrospective observer POSAS scores and 
original follow-up observer scores were correlated and found to have a high correlation (total 
scores ICC 0.83, 95% CI: 0.67-0.92; overall opinion scores: ICC 0.87, 95% CI: 0.75-0.94). 
As a result, observer POSAS scores from the photo returns were included in the overall 
dataset. Additionally, data from the children who received split skin grafts were identified as 
outliers and excluded from the analysis. 
Median total scores at 3 months were patient: 7.00 (IQR 6.00-11.00) vs. observer: 6.00 (IQR 
6.00-8.00). At 6 months the median total scores were patient: 8.00 (IQR 6.00-17.75) vs. 
observer: 6.50 (IQR 6.00-9.00) Total POSAS scores for patient and observer over 3 and 6 
months were analyzed using a Wilcoxon Signed Rank Test. There was no significant 
difference in any score sets between 3 and 6 months.  
7.6.2.1 Predictors of POSAS scores 
Total scores (patient and observer) and overall opinion scores (patient and observer) at 3 
and 6 months were analyzed using separate multiple linear regression models, where each 
set of scores (e.g. patient total scores at 3 months) were used as the dependent variable for 
each model. Days to re-epithelialization, burn depth, total burn surface area (TBSA) and 
dressing type were identified as having a significant contribution to all POSAS score sets 
and were included in the models. Due to evidence of multicollinearity between days to re-
epithelialization, burn depth and dressing type, only days to re-epithelialization was included 
in the final models. TBSA was included in the models for scores at 3months, but was not 
included in 6 month models due to low participant numbers. 
As shown in Table 7-2, at 3 months, days to re-epithelialization was a significant predictor 
of all POSAS total scores (total and overall opinion for both patient and observer) – indicating 
burns which took longer to re-epithelialize were associated with higher POSAS scores 
(worse scar outcome). Total body surface area was not a significant predictor in any of the 
models. At 6 months, days to re-epithelialization was again a significant predictor of all 
POSAS scores except patient total scores (Table 7-2).  
127 
 
Table 7-2. Predictors of total and overall opinion POSAS scores 
 
7.6.2.2 Agreement of patient and observer POSAS scores 
Patient and observer total and opinion scores were correlated using a Pearson Correlation. 
At 3 months there was a high correlation of total scores between patient and observer (0.84, 
p <0.001) and overall opinion scores (0.91, p <0.001). However at 6 months, there was a 
lower correlation for both total (0.62, p=0.01) and overall opinion scores (0.72, p<0.01). 
POSAS parameters were separated out (e.g. color, thickness etc) and compared between 
patient and observer. Scores of patient-rated scar or skin color and observer rated 
vascularity and pigmentation had a high correlation at 3 months (color vs. vascularity 0.88, 
p<0.001; color vs. pigmentation 0.64, p<0.001), but had a lower correlation at 6 months 
(color vs. vascularity 0.57, p<0.05; color vs. pigmentation 0.15, p = 0.60).  
7.6.3 Ultrasound 
As per the analysis for POSAS scores, data from the children who received split skin grafts 
were identified as outliers and excluded from the analysis. Median skin thickness of burn 
sites at 3 months was 1.3mm (IQR 1.2-1.6mm) compared to 1.2mm (IQR 1.1-1.5mm) at 6 
  B 95% CI p-value 
3 month follow-up     
Patient total score Days to re-epithelialization 
TBSA 
0.97 
1.92 
0.51-1.43 
0.04-3.80 
<0.01 
<0.05 
Patient overall opinion score Days to re-epithelialization 
TBSA 
0.23 
0.38 
0.13-0.34 
-0.05-0.80 
<0.01 
0.08 
Observer total score Days to re-epithelialization 
TBSA 
0.73 
0.50 
0.50-0.95 
-0.45-1.45 
<0.01 
0.29 
Observer overall opinion 
score 
Days to re-epithelialization 
TBSA 
0.13 
0.19 
0.08-0.18 
-0.01-0.38 
<0.01 
0.05 
     
6 month follow-up     
Patient total score Days to re-epithelialization 0.68 -0.15-1.5 0.10 
Patient overall opinion score Days to re-epithelialization 0.20 0.06-0.34 <0.01 
Observer total score Days to re-epithelialization 0.63 0.34-0.92 <0.01 
Observer overall opinion 
score 
Days to re-epithelialization 0.15 0.08-0.21 <0.01 
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months. Comparatively, median skin thickness of unaffected sites at 3 months was 1.1mm 
(IQR 1.0-1.3mm) and 1.1mm (IQR 0.9-1.1mm) at 6 months. Skin thickness of burn sites was 
found to be significantly lower at 6 months than at 3 months (p<0.02). The percentage 
difference in skin thickness between burn site and an unaffected site for each participant 
was calculated at 3 and 6 months. The median percentage difference in skin thickness at 3 
months was 15.38% (IQR 0.00-31.82%) compared to 10.03% (IQR 2.18-35.00%) at 6 
months. The percentage difference in skin thickness between burn site and unaffected site 
was significantly lower at 6 months than at 3 months (p<0.02).  
Days to re-epithelialization, burn depth and total body surface area of burn were correlated 
with percentage difference in skin thickness. Burn depth was found to have a moderate and 
significant correlation with percentage difference in skin thickness at 3 months (0.41, 
p<0.05), the correlation at 6 months was not significant. The remaining variables did not 
have significant correlations with percentage difference in skin thickness. Additionally, there 
was no significant difference between acute dressing type groups (Acticoat™, Acticoat™ 
with Mepitel™ and Mepilex Ag™) and percentage difference in skin thickness at 3 or 6 
months. 
Burn site skin thickness measurements and the POSAS observer-rated thickness parameter 
were also found to have a high correlation at both 3 (0.59, p<0.01) and 6 months (0.62, 
p<0.05). 
7.6.4 Scar height and skin pigmentation 
Due to very low numbers of scar areas to map (as the majority of children had no residual 
scarring at the original burn site) and software limitations mapping scar areas (e.g. 
circumferential scar areas), scar height was not calculated.  
Photos taken of all participants who returned for follow-up were used to visually assess 
pigmentation changes over time. Photos indicated  that a small proportion (n=8, 25.8%) of 
children with burns that re-epithelialized in two weeks or less had visible hypo-pigmentation 
at the burn site compared to normal surrounding skin at 3 months. In some instances, hypo-
pigmentation was still visible at 6 months post re-epithelialization. Of these 8 participants, 
six participants originally had a scald burn and two had a contact burn. The most obvious 
case of hypopigmentation was observed in a child with very dark skin pigmentation at 3 
months (Figure 7-3). Ethnic background and skin color were not assessed at recruitment or 
follow-up and therefore not considered for their contribution to these results; however this 
should be included in future studies. In terms of acute dressing, four received the Acticoat™ 
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dressing, one received Acticoat™ with Mepitel™ and one received Mepilex Ag™. There 
were no incidences of hyper-pigmentation in any participants.  
 
 
 
 
 
 
 
 
 
 
 
Figure 7-3 Example of burn site hypopigmentation at 3 months in a child with dark skin 
pigmentation: Scald burn to chest and abdomen which re-epithelialized in 7 days 
 
7.7 Discussion 
Small but significant partial thickness burns which re-epithelialize are a common injury for 
children in high-income countries [42]. While anecdotally there is much known about the 
scar outcomes of children with partial thickness burns, there is little research available to 
support such knowledge. The results of this study have demonstrated that time to wound 
re-epithelialization is predictive of skin or scar quality, while burn depth can impact on skin 
thickness post-burn injury. Hypo-pigmentation of the burn site can still be present in burn 
sites up to 6 months, post-injury and patients were found to rate skin appearance as worse 
than therapists. 
While a moderate number of children were able to be followed-up for this study, getting 
families to return for long-term research post-discharge remains problematic and has been 
previously highlighted in the literature [20]. For many families in this study, motivation levels 
to return may have been low as the child was discharged and the burn injury may have been 
fully resolved (no visible difference). Additionally, arranging time off work was difficult and 
some families lived regionally or inter-state. These difficulties and large drop-out rates need 
to be taken into account for future studies. Incidentally, following-up with patients who were 
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still returning for scar management treatment was more successful and this accounted for 
the greater number of children with deeper burns returning for a follow-up in this study.   
Days to re-epithelialization has been established as a predictor of scar outcome in partial 
thickness burns at 3 and 6 months post wound re-epithelialization. The relationship between 
re-epithelialization time and burn scar outcome has previously been reported in the literature 
[7, 79, 133] and this study has provided current evidence supporting this relationship in 
children with a range of partial thickness burn injuries. As the majority of children reviewed 
in this study re-epithelialized in two weeks or less, more in-depth research regarding patients 
who fall into the grey area of burns which re-epithelialize spontaneously in 2-3 weeks is 
recommended. Many of these patients go on to receive scar management and are left with 
residual scarring, while others do not require such therapy. Research into predictors of scar 
outcome for this cohort would be beneficial and serve to allocate resources and predict 
treatment needs more effectively.  
The BT12 Venue 40 MSK ultrasound (GE Healthcare) has been demonstrated to be simple 
to use and could be utilized easily and accurately in a busy, hospital environment with small 
children. Previous research has indicated that ultrasound measured skin thickness 
(epidermis to dermis) can range from 1.53-1.97mm over a range of body areas in children 
aged 2-6 years with diabetes and increases with age [134]. The median unaffected skin site 
thickness in our current study was slightly below this range, however as the majority of 
children seen were under the age of two years, this fits within the projectory of increasing 
skin thickness with age. Furthermore, measurements of skin thickness on burn sites had a 
strong correlation with the POSAS thickness parameter, indicating its potential utility as 
objective measure of skin thickness in children with burn injuries; however more research is 
required to validate this. The finding that burn depth is associated with an increase in skin 
thickness post wound re-epithelialization is consistent with research that there is a greater 
risk of hypertrophic scar with increasing burn depth [7]. As more robust statistical analyzes 
could not completed for this current study due to low numbers, further research into the 
relationship between burn depth and skin thickness with a larger group of children with 
partial thickness burns would be beneficial to strengthen these results.  
It has been demonstrated in this study that hypopigmentation of the burn site can still persist 
up to or longer than 6 months post re-epithelialization in some children. This finding is 
despite the general consensus that partial thickness burns in children which re-epithelialize 
in 2 weeks or less are expected to be resolved by 6 months. Recent research has shown 
that erythema in donor sites does not fully return to normal until 12 months, indicating that 
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color changes as a result of partial thickness burns may take longer to resolve in some 
children than initially thought [135].  Ethnic background and objective skin color 
measurements was not recorded for this study and such data from future research would 
further assist in enriching the knowledge of skin pigmentation changes following partial 
thickness burn injuries in children, particularly those with darker skin pigmentation. This 
study also noted that parents and patients were scoring higher than therapists on the skin 
color parameter of the POSAS at 6 months, a finding which is corroborated in previous 
research [20]. Such findings indicate that clinicians need to be continually aware of patient 
opinions of skin appearance and that education regarding skin color changes post-burn is 
imperative, particularly for those who re-epithelialize in 2 weeks or less and do not receive 
ongoing scar management therapy. 
7.8 Conclusion 
This study has provided data regarding the long-term scar outcome for children with partial 
thickness burn injuries and expands the clinical knowledge base for this population. Days to 
re-epithelialization was identified as a predictor of scar outcome severity. A small proportion 
(n=8, 25.8%) of children with burns that re-epithelialized in two weeks or less had visible 
hypo-pigmentation at  3 months and hypopigmentation was still present in some children at 
6 months. This study has again demonstrated the discrepancy in opinions of patients and 
parents and therapists regarding long-term skin appearance and highlighted a further need 
for education regarding long-term outcomes for patients. 
7.9 Acknowledgements 
The authors would look to thank all the children and their families who participated in this 
study. The would also like to acknowledge all the staff at the Stuart Pegg Pediatric Burns 
Centre at the Royal Children’s Hospital Brisbane, Australia for their support and assistance 
throughout data collection.  
7.10 Conflict of Interest Statement 
Funding for this study was supplied by a grant given to the Royal Children’s Hospital, 
Brisbane by Mölnlycke Healthcare. Despite this financial support, Mölnlycke Healthcare had 
no part in the study design and data collection of this project, nor did they have any 
involvement in the analysis or publication of the results. The chief investigator is a student 
of The University of Queensland and receives a stipend from this grant.  
132 
 
7.11 Chapter conclusion 
The study presented in this chapter has provided an overview of the outcomes of partial 
thickness burn injuries in children who received a silver dressing acutely.  
While the burn injury and changes to skin pigmentation may have resolved completely for 
some children by six months post wound re-epithelialization, children with darker skin types 
and burns re-epithelializing in 2-3 weeks may have differing experiences. These children 
represent a significant proportion of those treated in the outpatient setting. Hence, it is 
imperative for more research evidence to be obtained for these particular populations of 
children in order to provide families with accurate education on longer term resolution of 
such burn injuries.  
This study also utilized ultrasound as an objective measure of skin thickness. Traditionally, 
burn scar thickness is visually and physically assessed using the Patient and Observer Scar 
Assessment Scale (POSAS). Assessments such as these are widely used but are largely 
subjective, and ultrasound has the potential to provide an objective quantification of scar 
thickness. External to this thesis, the clinical utility of the GE Healthcare ultrasound device 
is currently being assessed in a research study alongside the 3D LifeViz™ system for the 
objective measurement of burn scars, as stated in the Chapter 5 chapter conclusion. The 
device is beginning to be utilized clinically in the assessment of burn scars and it is 
anticipated that the new research study will show ultrasound to be a reliable tool for use in 
this setting.  
While the information obtained from this research has given clinicians some evidence to 
educate children and their families on longer term outcome post-burn, further research is 
still required to present a complete picture of pediatric partial thickness burn outcome.  
This chapter completes Part 1 of the thesis. Part 2 is an exploratory study of the experiences 
of parents or caregivers supporting a child through burn care in the outpatient setting. This 
study will be presented as Chapter 8 of this thesis.    
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Part 2
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Chapter 8. Parent experiences of 
pediatric outpatient burn care 
 
The following chapter is a qualitative exploration of parent experiences of accompanying 
their child through outpatient burn care. This chapter was not submitted for publication and 
is presented in this thesis as a stand-alone chapter. 
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8.1 Introduction 
Burn injuries in children are often traumatic involving multiple trips to unfamiliar hospital 
environments, painful and potentially distressing dressing changes and interactions with 
numerous staff members as the burn re-epithelializes. Young children and infants who 
sustain burn injuries are dependent on their parents or caregiver throughout treatment. 
Parents have the role of supporting the child through wound care procedures and 
management of the burn at home, but often times also witness the burn accident [21]. 
Understanding the effect and burden of a child’s burn treatment on parent or caregivers is 
of major importance, given the impact that a parent’s experience may have on the child’s 
outcome post-burn injury. For a child who sustains a traumatic, unintentional injury such as 
a burn, recovery can be affected by both the experience of the parent and child during 
treatment, as parental stress reactions are known to impact on the child’s own reactions to 
stressful situations [23, 98, 99]. Parents of children who sustain burn injuries have been 
found to display acute stress reactions related to concerns for their child during the acute 
treatment phase and longer-term potential psychosocial impacts for the child [136]. 
Qualitative studies into the experiences of parents of children who sustaining severe burns 
requiring length hospital stays have shown that many parents experience negative coping 
reactions such as guilt and blame [22, 102]. Watching their child in pain was particularly 
distressing and there were reported feelings of hopelessness during hospital stays.  
The knowledge of parent experiences of children who sustain severe burns requiring 
inpatient hospital admission and lengthy rehabilitation has been reported in the literature 
[22, 102, 137]. However, relatively little is known regarding parents of children who sustain 
less severe burn injuries which only require outpatient treatment and little to no rehabilitation 
or scar management therapy. This is despite research evidence demonstrating that post-
traumatic stress disorder (PTSD) symptoms in parents may occur as a result of burn injuries 
of any size and severity [24].  Additionally, research also shows that while many mothers 
and fathers experience acute stress reactions which can last up to 12 months post-burn but 
gradually diminish with time, for some parents symptoms can become chronic [138, 139]. 
As the majority of children in high-income countries sustain burn injuries <10% total body 
surface area (TBSA) which can be treated in the outpatient setting [6], understanding the 
burden of minor burn injuries on parents and caregivers can assist in improving the 
outpatient burn care process. 
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This study aimed to answer the question: ‘What are the experiences of parents 
accompanying their child through outpatient burn care’? Through answering this question, 
the study sought to provide healthcare workers with a greater understanding of how to 
prepare parents for the burn care process and provide appropriate support throughout 
treatment. 
8.2 Methodology 
The study was approved by the Queensland Children’s Health Services (Royal Children’s 
Hospital) Human Research Ethics Committee and The University of Queensland Ethics 
Committee (Approval number: HREC/14/QRCH/8).  
8.2.1 Study Design 
This was a qualitative study using a phenomological approach which is appropriate for use 
when a phenomenon is poorly defined [140].  Phenomenology is a person’s experience of 
a phenomenon (i.e. particular situation) and how they make sense of these experiences 
[134]. A phenomological study therefore aims to examine and analyze people’s lived or 
subjective experiences of the phenomenon [140]. This approach is best suited to small 
sample sizes (≤10 participants) where larger sample sizes can be difficult to manage. 
8.2.2 Participants 
Parents and/or caregivers of children aged 0 to 5 years with an acute partial thickness burn 
injury (re-epithelializing within 2 weeks) and a burn total body surface area (TBSA) of ≤10% 
were considered for inclusion. Children were required to have been referred to the former 
Royal Children’s Hospital (RCH) or Lady Cilento Children’s Hospital (LCCH) burns 
outpatient unit from the Department of Emergency. The parent must have also been present 
for all dressing change appointments. Eligible participants were recruited via informed 
consent between September 2014 and September 2015. Parents and caregivers were 
excluded if their child had received silver dressings prior to presentation at RCH/LCCH; had 
sustained a superficial (erythema only), full thickness, chemical or friction burn; had a 
cognitive impairment; or were currently involved with the Department of Communities, Child 
Safety and Disability Services. Non-English speaking parents and caregivers were also 
excluded from the study. 
8.2.3 Data collection 
Participants were recruited to this study via purposive sampling. The aim of purposive or 
purposeful sampling as defined in Patton [141] is to “select information-rich cases whose 
study will illuminate the questions under study”. Interviews were conducted with parents on 
the day of their child’s discharge from the service, usually the day that the burn wound was 
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fully re-epithelialized. Semi-structured interviews were conducted using a pre-defined list of 
prompt questions to ensure a degree of standardization between participants [142] (Table 
8-1). Prompting questions were designed to promote open-ended responses to explore 
participants’ experiences and stories and to allow the participant to guide the direction of the 
interview [142]. Further probing questions were added to the schedule after several 
interviews were conducted, as data emerged which required further clarification from future 
participants to determine if a pattern was present. 
Interviews were conducted on the outpatient ward either in a private treatment room or 
available interview room, with a maximum of thirty minutes available for the interview. The 
timeframe for interviews was set to a maximum of thirty minutes due to: age of children and 
their patience level after treatment (most parents attended the appointment alone and were 
without assistance to keep the child occupied during the course of the interview), parent 
transport restrictions (i.e. hospital parking and cost) and researcher time.  All interviews were 
audio recorded and transcribed verbatim by the principal investigator. 
Demographic information was also collected from patients’ medical records, including; age 
of child, burn depth, mechanism of the burn injury, the site of the injury and burn total body 
surface area. 
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Table 8-1 Study interview schedule 
Interview questions 
1. Can you please describe your experience when you first came into emergency? 
2. Can you please tell me about your time at the burns outpatients’ clinic? 
3. Can you please describe your experience of taking part in the first dressing 
change procedure with your child? 
4. What were your thoughts about the dressing and managing it at home? 
5. How did you feel about the information you were given while at the clinic? 
6. Can you tell me about your experiences in dealing with doctors, nurses and the 
allied health staff in the burns outpatients’ clinic? 
7. Parents have mentioned that hearing other children crying or see other children 
in the waiting room with burn injuries was confronting. How did you feel about 
this? 
 
8.2.4 Data Analysis 
Transcribed interviews were analyzed using an inductive thematic analysis method.  The 
inductive thematic analysis was undertaken according to Braun and Clarke’s [143] thematic 
analysis method: familiarizing self with data, generating initial codes, searching for themes, 
reviewing themes, defining and naming themes. Coding of interviews was completed by the 
principal investigator and second rater experienced in qualitative research. Initial line-by-line 
coding of interviews was completed independently by both raters. Coded data abstracts 
were compiled under each identified code for each rater and a code definition table was 
developed which provided a definition for each code. The two raters then came to together 
and using the definition list, discussed any discrepancies in coding until agreement was 
reached.  Data abstracts were re-compiled (as required where corrections to coding were 
made) under their relevant codes in a table which was then used to identify themes within 
the data. All names in data extracts have been replaced with pseudonyms to ensure patient 
confidentiality. Participant I.D. numbers (e.g. 001) have been used to differentiate between 
data extracts. 
8.3 Results 
Data collection and recruitment was ceased when 10 participants were recruited. The aim 
was to continue recruitment until data saturation of the participant group was reached, 
however due to time constraints from the principal investigator, recruitment was concluded 
before it was determined that data saturation was reached. The final sample size is however 
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acceptable within a phenomological approach to research where small sample sizes of up 
10 are most suitable [140]. 
8.3.1 Demographic characteristics 
Ten parents (1 father, 9 mothers) of children with a median age of 1 year (range 1-5 years) 
participated.  Children had superficial partial thickness burns (contact and scald burns) with 
a median total body surface area (TBSA) of 0.5% (IQR 0.5-2.5%). All burns re-epithelialized 
within a two week timeframe with a median days to re-epithelialization of 10.5 (IQR 9.75-
12.5). Children and parents attended at least two dressing change appointments before 
discharge. 
8.3.2 Themes from the dataset 
Analysis of identified codes and data extracts from completed interviews identified three 
themes and eight subthemes which described the experiences of parents accompanying 
their child through outpatient burn care treatment (Table 8-2). 
Table 8-2 Themes and sub-themes 
Theme Sub-themes 
Going into the unknown Unfamiliarity with hospital environment 
 Feeling overwhelmed 
 Anticipation of outcome 
Facilitation Familiarity with hospital environment 
Staff support 
Distraction and minimization of pain 
Resilience Guilt and blame 
 Short term pain, long term gain 
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8.3.3 Theme 1: Going into the unknown 
The theme ‘going into the unknown’ explained that a major factor in the experiences of 
parents attending outpatient burn care with their child was not knowing what to expect when 
it came to burn care or wound healing. Accompanying their child for burn injury treatment 
was like navigating without a map and triggered feelings of anxiety and fear. This theme 
comprises of the subthemes: unfamiliarity with the hospital environment, anticipation of 
outcome and feeling overwhelmed. 
8.3.3.1 Unfamiliarity with hospital environment 
For many, being unfamiliar with the hospital environment and the process of care in the 
outpatient burns setting was anxiety-provoking and stressful. One parent described hearing 
other children crying and she became worried about what her child would experience during 
the dressing change: 
Oh I was really scared. Like, yeah how it was going to be ‘cause I could hear all the 
little ones crying. Like you know, how it was going to come off, I just thought what 
was it going to look like underneath? Um, yeah just yeah was I wasn’t sure how they 
were going to get it off and things like that. (004) 
Others parents expressed uncertainty about the length of time a dressing change would take 
and whether/how they could keep their child occupied for an extended period of time.  
Um, though I guess coming in as a first time, you don’t know what’s going to happen, 
you don’t know if there’s toys already in the room or how long you’re going to be 
waiting or anything like that. (009) 
Parents were also unaware of the processes surrounding pain medication protocols in the 
outpatient setting and waiting times required for medication to have an effect. This provoked 
feelings of impatience and the notion that the experience was being unnecessarily prolonged 
for the child:  
Erm, last, last time we came they gave him um, painkiller, strong painkiller, and um 
we were waiting around half an hour, 40 mins. I think it was too much, but no, no I 
know it’s hospital and they all busy, but nah it just…I thought perhaps too long a wait 
because he is small and he gets bored or he wants to get out of here. (001) 
8.3.3.2 Anticipation of outcome 
The wound healing process and final outcome from a burn injury was particularly concerning 
for parents. The healing process and what this looks like at each stage was not prior 
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knowledge for parents and this often meant parents jumped to the worst possible outcome 
e.g. skin grafting, despite burns being relatively minor.  
I was more concerned of the fact that, the second time we came in, they were really 
not happy with his healing process on the shoulder. And they said if this doesn’t heal 
in another week or so, we’re going to have to do a skin graft. That actually scared my 
husband and I. A lot. Because it’s like well you have to cut another part of his body, 
scar that, to fix another part. (007) 
I was anxious, I didn’t want him to have a skin graft and uh he healed so quickly, so 
it was great. (003) 
Not knowing what a burn wound looked like as it healed also made it difficult for parents to 
distinguish progress themselves and this provoked some uncertainty going into dressing 
changes about whether the burn would be healed or not. 
It was probably actually harder today, where they were saying they’re hoping it’s 
healed, and they took it off and I didn’t know if it looked healed or not. (009) 
8.3.3.3 Feeling overwhelmed 
Coping with the hospital visits in an unfamiliar environment and sometimes watching their 
child in pain was particularly difficult for parents. One father described that while he was able 
to deal with the situation and handle his emotions, his wife had a significantly harder time 
and was unable to provide support and comfort to her child during treatment as a result: 
Sarah sort of like can’t really, she doesn’t really want to go into that side of things, 
you know? Because you know I know it has to be done, and I can hold it in a little bit 
and sort of deal with that kind of stuff. But yeah, Sarah just, yeah, as soon she would 
have to hold her down and watch her bawl her eyes out, she’d be right beside her 
bawling her eyes out, you know what I mean.  (005) 
Another parent described the feeling of having to constantly explain the burn incident and 
how this negatively affected her ability to stay calm at the time for her child and provide 
support. 
The one thing probably, that I did take a little bit to heart, was um when the accident 
first happened, I think I got asked maybe 10 times what happened. And like, at the 
time, I was just really upset because I was like, God, I just want to focus on him, I 
don’t want to be, why do I have to keep repeating myself? But afterwards, I 
understand why they want make sure there’s no abuse or whatever there. And I 
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understand that. But at the time, I was like, can you just leave me alone? I want to 
like, just focus on my baby! (007) 
8.3.4 Theme 2: Facilitation 
The theme ‘facilitation’ explores aspects of the burn treatment that parents perceived 
enabled them to cope with the experience and improved their ability to appropriately support 
their child through the treatment. This theme encapsulates subthemes of: familiarity with the 
hospital environment, staff support and distraction and minimization of pain. 
8.3.4.1 Familiarity with the hospital environment 
In contrast to theme 1, parents found that having prior knowledge of the hospital and hospital 
processes made them feel much more at ease and as a result were less stressed coming in 
for a dressing change in the burns unit the first time around. Familiarity with the process was 
represented in various ways. For some, having prior knowledge of hospital processes due 
to their work background or having other children sustain injuries requiring hospital treatment 
made the experience easier knowing what was involved. One parent commented: 
I guess I’ve got a pseudo-health background, I’ve worked around hospitals, so, and 
I’ve had kids who’ve had to come into Emergency before, so I don’t think I’m 
particularly easily ruffled by that kind of thing, so no I didn’t find it particularly stressful. 
(009)  
Having friends who had gone through similar experiences also provided background 
knowledge regarding the outpatient burn care process: 
And we did have a friend who is in her music group who did a similar thing two weeks 
before her, so we had a bit of heads up on what the actual process was. (010) 
Knowledge of basic skin physiology also made understanding the burn wound healing 
process easier for a parent dealing with a chronic skin condition in another child: 
I’ve got one who’s got atopic eczema, so, the whole system of the skin, we were right 
on, aware of that. Like I said, we’ve spent a lot of time with skin conditions and 
hospitals and in and out. So yeah. So we’ve been through it. We go through two 
different clinics. That for us, hasn’t been an issue. (008)  
8.3.4.2 Staff support 
Support from clinical staff and volunteers was recognized as playing a large part in positively 
assisting parent coping throughout the treatment phase. Many parents expressed gratitude 
for the hospital volunteer service which provides staff to help parents navigate the hospital 
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and to engage with children and their families in the clinic waiting room. Keeping the child 
occupied and calm with fun activities and engaging with parents helped to alleviate parent 
anxiety waiting for the appointment: 
But overall, um, like today there’s volunteers out there and they came and played 
with Zac. And I think that’s really nice. It’s really nice for um, break up, not break the 
ice, but something a little bit different for the parents to change their focus, you know. 
They were quite friendly. (007) 
Parents also described the benefit of the volunteer service for siblings of the child who also 
had to attend the appointment and could witness treatment and dressing changes. The 
volunteer service allowed parents to concentrate and focus on the child with the injury 
without the stress of also supervising siblings: 
Especially, the um, one thing I really like is the volunteer service here. There was 
another volunteer here and she helped keep the eldest occupied, with coloring. Part 
of it is. Um, not just about keeping the um the patient happy, it’s about keeping the 
siblings happy as well. Because they can feel the parents and their siblings pain and 
worry. So to keep them occupied with toys and volunteers to help them, to play with 
them, it’s just a great service. That took part of the stress away, because the parents 
could concentrate on Max and that helped a lot. (006) 
Putting trust in the treating clinicians ameliorated feelings of anxiety that parents may have 
had about what the treatment would entail. Parents acknowledged that witnessing the care 
provided to their child, and observing improvements that indicated that their child was getting 
better, reduced stress levels coming into appointments. One parent reported: 
There was a lot of attention on him, which I think is good. Um, uh and you feel that 
the doctors and nurses know what they’re doing and you can feel their confidence in 
treating Max. And that made us feel good. (006) 
Another parent commented on staff demeanor towards her child and herself and the positive 
affect it had on the treatment experience: 
And the nurse that helped Zac both times, there was two different ones, but we saw 
them both often. Both of those ladies were really lovely with Zac and really gentle 
with him and patient. Um, everyone’s polite, everyone’s not rushing to be rid of you, 
but at the same time not making you wait too long. I’ve had a very good experience 
and I think has Zac has too, because he hasn’t cried. (007) 
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8.3.4.3 Distraction and minimization of pain 
Having a child that was distracted from the burn injury and not in pain was particularly 
positive for parents as they did not want to see their child in distress during treatment: 
Um it was ok, because he wasn’t bothered by it. You know, it didn’t phase him. I think 
if he was crying or showing agitation or something, I think I would have had to have 
left the room.  (007) 
Many parents described the perceived instantaneous ability of the burns dressings to 
decrease distress levels and allow the child to return to a pre-burn functioning level. This 
was seen as an encouraging sign of recovery for the child: 
So, and no but it was as if nothing had happened to him, so the dressings are great. 
They cover it up and it’s like magic. He didn’t even realize it because after they put 
the dressing on it was as if nothing had had happened to him. He was running around 
and playing. (001) 
Um, he was very distressed a bit, about having to have the dressings changed, that’s 
the bit that distressed him. But once they done it and put it on, he was fine again. 
(008) 
Parents also reported the benefit of having items such as toys for children to play with during 
treatment, as this gave the child a sense of normalcy within the process, and a different line 
of focus away from the burn injury. 
What great is though, you have toys. Thomas, this case is distracted and has new 
things to do and is fun for him, and that’s great for us. Because it was sometime, we 
could, we could distract him about his burn no? (001) 
8.3.5 Theme 3: Resilience 
The theme ‘resilience’ explains the impact the burn injury had on reflection of parenting 
styles and supervision parents provided to their child. It also encompasses parent 
acceptance of the injury and persevering through feelings of shame for the sake of their 
child’s wellbeing. This theme is comprised of the subthemes: ‘guilt and blame’ and ‘short 
term pain, long term gain’.  
8.3.5.1 Guilt and blame 
Parents described disbelief that the accident had occurred and feelings of guilt for not being 
able to prevent it happening or protect their child. Some parents commented that guilt over 
the accident (despite the child having a good outcome) would persist indefinitely: 
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Yeah, you don’t think, it, it something like this would happen to you. So, you take all 
the precautions, still accidents happen. Yes, and part of, I think part of it is feeling 
really bad that you couldn’t protect him from such an accident. Yeah, that guilt will 
always be there. (006) 
To tell you the truth, I just, I feel like crying now even. I just feel so awful because the 
cup was right beside me, you know? And I didn’t see it *crying*. It was fast. Yeah, 
you don’t want your kids hurt though. You spend so much time trying to protect them 
all the time and take care of them and I don’t know. A few tears, because you know, 
why does it have to be this way, why does he have to go through that? (007)  
Having to then watch their child in distress while going through treatment further amplified 
these emotions. One parent described an experience with the burns bath as particularly 
distressing: 
And then the hardest thing for me was having to hold her down in the bath.  You know 
like, you feel like you’re letting the kid down, you know when you’re sitting there and 
she’s absolutely bawling her eyes out, screaming at you and you can’t do anything 
about it because you know it’s the best thing for her cause they’re rubbing all the 
dead skin and all that off. So you have sit there and hold her down in the bath. Not 
anything I’d wish upon anyone, you know what I mean, having them look at you like 
that. (005) 
8.3.5.2 Short term pain, long term gain 
Despite experiencing reactions of guilt over the burn accident, parents spoke of putting on 
a strong front and pushing their personal feelings aside for the benefit of their child and their 
recovery: 
So yeah like, for me it’s, it’s not, when I know it’s going to benefit her in the long run, 
I’ll do whatever is necessary or whatever they want me to do you know (005) 
Parents also commented on acceptance of the injury and not being held back by what may 
happen and just taking things on as they occurred: 
I thought right, we’ll just deal with it. If it’s worse than what we think it is, we’ll just deal 
with it one step at a time. (008) 
Looking back on their experiences of accompanying their child through outpatient burn care 
gave parents perspective and the realization that things will work out for the best in the long 
run and that patience and optimism are key: 
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So, yeah, just that you don’t have to stress about it and you can just trust that it will 
happen even if you have to wait for things to happen. You just don’t need to stress 
about it. (009) 
Oh, just be positive and be patient. As well as be confident in what the nurse and that 
are doing, because in the long run it’s always going to be beneficial for your child. 
You’ve just got to keep a positive attitude. (005) 
8.4 Discussion 
This was a pilot study exploring the experiences of parents accompanying their child through 
burn care treatment in the outpatient setting. The majority of parents identified major 
stressors related to their experience as being unprepared for the challenges and processes 
of pediatric outpatient burn care, watching their child in pain or distress and persisting 
feelings of guilt over the burn accident. Despite this, many also commented on aspects of 
care, such as support from staff members and prior hospital experiences and knowledge 
that assisted them to cope and persevere through the treatment phase towards recovery. 
Many parents in this study commented on feeling unprepared bringing their child in for 
outpatient treatment and uncertain of what the process would entail. Associated anxiety 
regarding the long-term outcome for their child, stemming from a lack of prior knowledge of 
burn injury severity, was also present for parents. Such concerns were also identified in 
previous research on the burden of parents from a child’s severe burn injury [22, 102] as for 
many parents with a young child, the burn injury was often the first hospital visit and parents 
were largely ill-equipped for the stressful hospital environment. The research by Rimmer 
et.al [102] also identified that educational tools for parents on aspects of acute pediatric burn 
care may be of benefit to alleviate parent stress and anxiety. In Australia, the Ditto 
multimodal device provides a procedural preparation story ‘Bobby got a burn’ for children 
with burn injuries [47]. Parent experiences from this study would also indicate that the 
formulation of a parent education tool which can be used in the waiting room prior to the 
appointment, or an education package given on referral to the burns outpatient clinic would 
be beneficial in assisting to decrease parent anxiety and increase knowledge of burn care. 
Watching their child in pain or distress was identified as a stressor for parents and amplified 
feelings of guilt over the burn accident. Parents reported feeling overwhelmed during 
dressing changes, particularly when children had to be physically constrained, which for 
some affected their ability to appropriately support their child during this time. Similar 
parental experiences have also been identified in children with severe burns requiring 
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inpatient hospitalization [22, 102]. Research suggests that effective pain relief for children 
undergoing dressing changes can consequently help to improve parent distress [144]. A 
study investigating pediatric pain management for invasive procedures has also found that 
including parents within the procedure and in distraction of the child may not only improve 
patient pain levels, but allow parents to feel included and helpful in the process [145]. Such 
strategies may be of use in the outpatient setting to support the parent and child through 
dressing changes. 
Parent resilience throughout their child’s treatment was a prominent theme. Despite 
persisting guilt over the burn accident, parents reported accepting the accident and staying 
strong for the benefit of their child’s recovery, which is again consistent with parental reports 
of severe burn injuries [22, 102]. Preliminary research into the resilience of pediatric burn 
survivors and resilience in their caregivers concluded that they were correlated, with a child’s 
positive adjustment and well-being post-burn being affected by the psychological responses 
of the caregiver [146]. This again ties in with the knowledge that parent stress reactions can 
affect the child’s own reactions to a burn or traumatic injury [23, 98, 99].  
While the experiences of parents with children who sustain severe burns may be prolonged 
and involve different hospital procedures compared to children sustaining minor burns, this 
study has demonstrated that all burn injuries in children are distressing regardless of 
severity. These study findings highlight the continued need for appropriate support for all 
parents of children with a burn injury, regardless of burn severity. In this setting, social work 
and occupational therapy psychosocial support is provided to all families if required.  It is 
possible however, that some families may fall through the cracks or are missed during 
outpatient appointments. Therefore informing all parents prior to appointments where and 
how they can request support and counseling may ensure that all families get the assistance 
they need. 
8.4.1 Limitations 
While this qualitative exploration has provided a wealth of information regarding the 
experiences of parents in this setting of burn care, it is considered that data saturation may 
yet to be reached. The continued collection of interview data until saturation would allow for 
further exploration of the identified themes or identification of new themes which may be a 
better fit for the data. In addition to this, re-interviewing participants or discussing study 
results with a new set of participants would allow investigators to check the accuracy of the 
data interpretation and determine if the results are representative of the views of the whole 
parent population within this acute, burn care setting. 
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The sample of this study was limited due to the inclusion of one father to nine mothers. This 
may have skewed the sample as in the interview data, a father’s view may be different to 
that of the mother. The father in this study also reflected on gender differences in how he 
and his wife viewed and reacted to the situation. While the views of fathers are important in 
this setting, future research would benefit from differentiating between parent gender and 
how they cope with the hospitalisation of their child post-burn injury. 
Interview timing may have been a limiting factor as parents were interviewed on the day of 
discharge in the hospital environment. As previous research has noted [136], interviewees 
are likely able to process and understand their experiences more effectively when interviews 
are timed to occur up to a month post-discharge or completion of treatment. However, given 
the difficulties experienced with getting discharged participants to return for follow-up in the 
scar assessment phase of this thesis (Chapter 7), the decision was made to interview 
parents on day of discharge to ensure a more successful capture rate due to study time 
constraints. 
8.5 Conclusion 
This study has provided an understanding and insight into the experiences of parents 
accompanying their child through acute, outpatient burn care for minor burn injuries. Further 
data collection and analysis is required to confirm study results, however parent reported 
experiences of feeling unprepared for treatment, distress and guilt watching a child go 
through treatment and resilience were consistent with experiences of parents of children 
who sustain burn injuries of a greater severity. Educational tools and parent psychosocial 
support may assist in alleviating parent anxiety and stress attending dressing change 
appointments for the first time. 
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Chapter 9. Discussion  
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9.1 Thesis rationale 
The aim of this thesis was to provide a holistic and comprehensive overview of pediatric 
partial thickness burn care in the outpatient setting. There are significant gaps in the 
research literature pertaining to pediatric partial thickness burns, despite these being the 
most prevalent types of burns in children. Therefore, this thesis was split into two parts to 
address the treatment and expected outcomes of partial thickness burn care and to explore 
the psychosocial impact of burn injury and care on parents. 
The research outcomes from this body of work have formed a more complete picture of 
pediatric partial thickness burn care, informed and changed clinical practice within 
Queensland and identified area for future research in this field. 
9.2 Main findings of thesis 
9.2.1 Pediatric partial thickness burn treatment 
This thesis included one of the first randomized controlled trial studies comparing silver-
impregnated fabric dressings for partial thickness burns ≤10% TBSA in children (age range: 
4 months - 15 years). Silver dressings are commonly used to treat pediatric partial thickness 
burns in Australia and New Zealand. However, previous research in this area has made it 
difficult to distinguish the most appropriate dressing for use in these children as the majority 
of studies investigating silver dressings: compared silver-impregnated fabric dressings to 
silver sulfadiazine cream (SSD); combined adult and pediatric populations; and had flaws in 
methodology [17, 73].  
Due to the paucity of evidence for pediatric dressing treatment protocols, no two pediatric 
burn centers in Australia and New Zealand utilize the same protocol.  
9.2.1.1 Silver dressings 
The randomized controlled trial found that children treated with the Acticoat™ dressing, had 
wound re-epithelialization time extended by 40% (p <0.01) compared to those treated with 
Mepilex Ag™. Similarly, for those treated with Acticoat™ with Mepitel™, wound re-
epithelialization time was extended by 33% (p<0.01) compared to Mepilex Ag™.  
Pain and distress levels in the study were measured using patient (Faces Pain Scale-
Revised and Visual Analogue Scale-Pain), parent (Visual Analogue Scale-Pain) and nurse-
report (FLACC) pain scales. The study found that in comparison to those treated with 
Acticoat, FLACC scores were significantly lower at dressing removal and dressing 
application for children treated with both Mepilex Ag™ and Acticoat™ with Mepitel™. The 
VAS-P data showed similar results, with children in the Mepilex Ag™ and Acticoat™ with 
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Mepitel™ groups recording significantly lower scores at dressing removal and application 
than those treated with Acticoat™. Data from the Faces Pain Scale were not analyzed in 
the study due to the limited number of participants who could use this scale (as the majority 
were under the age of three years). 
Acticoat™ alone was shown to be difficult to remove due to adherence to the wound bed, 
which in some cases caused bleeding on removal. These study results have indicated the 
importance of using dressings with non-stick interfaces such as silicone for pediatric 
patients, as they have been demonstrated to reduce pain on dressing removal and 
application and promote ease of dressing removal. 
Overall, this trial found that Mepilex Ag™ is a more effective dressing compared to 
Acticoat™ and Acticoat™ with Mepitel™ with regards to days to re-epithelialization and pain 
for partial thickness burns ≤10% TBSA in children aged 0-15 years when dressings are 
changed twice-weekly. It has however, also highlighted that this dressing in its current form 
is difficult to apply to the small hands and feet of children under the age of three years. The 
thickness of the foam renders it a challenge to conform to fingers and toes and results in 
unnecessary dressing bulk and a potentially lengthy dressing application for a distressed 
infant. To account for this limitation, the newly developed dressing protocol (see 9.4.1) has 
included the option of either Mepilex Ag™ or Acticoat™ with Mepitel™ for hands and feet of 
children less than three years, depending on which is clinically determined by nursing staff 
to be easier to apply for each individual child. This has clinical implications for these children 
who may receive Acticoat™ with Mepitel™ as highlighted in Chapter 4 (in terms of re-
epithelialization time), but will however limit the possibility of children requiring extra visits to 
hospital to fix dressings which become loose. 
9.2.1.2 Cost-analysis 
Identifying effective treatments is necessary in determining which to use, however, cost to 
the healthcare system is also of prime importance. Cost-analyses of silver dressings in the 
pediatric population are required to allow healthcare providers to make a well-informed 
decision. Despite this, true cost-effective analyses in burn care are lacking, with the majority 
of studies only conducting basic cost comparisons [18] and there is presently with no 
published study comparing silver dressings in the pediatric outpatient setting. Therefore a 
cost-effectiveness analysis of the silver dressings: Mepilex Ag™, Acticoat™ and Acticoat™ 
with Mepitel™ was conducted in conjunction with the RCT.  
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The economic evaluation completed for this thesis found the cost-saving per participant from 
use of Mepilex Ag™ was $95.19 (95% CI: $46.67, $142.99) in comparison to Acticoat™ and 
$74.80 (95% CI: $30.19, $122.60) in comparison to Acticoat™ with Mepitel™. There was a 
99% and 97% probability that Mepilex Ag™ dominated (was cheaper and more effective) 
than Acticoat™ and Acticoat™ with Mepitel™. 
The results from this cost-analysis further solidified the findings from the RCT, showing 
Mepilex Ag™ to be not only a more effective, but also less expensive dressing choice than 
Acticoat™ and Acticoat™ with Mepitel™. The use of Mepilex Ag™ clinically for pediatric 
partial thickness burns ≤10% TBSA will improve re-epithelialization times for patients (and 
decrease the risk of hypertrophic scarring), decrease pain during dressing changes and be 
a less expensive option than the current standard treatment.  
9.2.2 Objective measurement of burn wound characteristics 
Objective measurement of burn wound re-epithelialization is imperative for research studies 
to document progress. Mapping of burn wounds has previously been completed using digital 
planimetry (Visitrak™ device) which involved placing a plastic grid in contact with an 
exposed wound and tracing the wound border. While this has been found to be a reliable 
method of measurement, it can be difficult to utilize in the pediatric burns population, where 
the majority of children are under the age of three years and compliance is not always 
guaranteed. A wound measurement device which involves no contact with the wound bed 
such as stereophotogrammetry (3D photography), would be preferable in the pediatric burns 
population. 
Chapter 4 of this thesis assessed the reliability of 3D photography compared to Visitrak™ 
for the mapping of burn wounds at the first dressing change for children recruited into the 
RCT. Wound surface area measurements were able to be completed using both devices for 
76 out of 96 participants. The level of agreement between wound surface area 
measurements calculated using an intra-class correlation coefficient (ICC) was excellent 
(ICC 0.96, 95% CI 0.93, 0.97), indicating that although the 3D camera was not touching the 
skin surface, it was still able to give an accurate measure of wound area. 
An interesting finding from this study was that Visitrak™ tracings could not be completed in 
19 participants, with 16 of those aged less than two years. Barriers to completing Visitrak 
tracings were identified as: excessive movement from the child, pain, young age and wound 
location. 3D photography could not be completed for one participant only due to the location 
of the wound (perineum). These results, along with the lack of laser Doppler scans 
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completed successfully in the RCT (due to similar patient compliance issues) have 
emphasized the importance of the use of fast, non-invasive tools in the pediatric burns 
population. Objective measurements of burn characteristics are vitally important to ensure 
the collection of accurate and unbiased research data. Research from this thesis has 
demonstrated that for these to be successful however, care needs to be taken to select 
appropriate tools and devices which will minimize unnecessary distress to the child. 
9.2.3 Partial thickness burn scar outcome 
The long-term scar outcome from pediatric partial thickness burns is largely under-
researched, with literature on long-term burn scar outcome focused on more severe burns. 
Clinically, children with partial thickness burns which re-epithelialize in two weeks or less 
are discharged without scar management, with complete resolution of the burn expected 
within six months. Research has shown the scar maturation pattern of partial thickness 
burns to be different to full thickness burns [20], however there is no comprehensive and 
objective assessment of long term outcome of partial thickness burns in children.  
Chapter 6 of this thesis provided insight into the scar outcome for children who sustain partial 
thickness burns ≤10% TBSA. Results demonstrated that days to re-epithelialization was a 
significant predictor of scar quality at 3 and 6 months post full re-epithelialization, with burns 
taking longer to re-epithelialize having a worse outcome. This was finding was as expected, 
with previous literature stating that prolonged re-epithelialization time increases the risk of 
hypertrophic scarring [7, 79].  Hypopigmentation of the burn site was present in 25.8% of 
children with a burn re-epithelializing in 2 weeks or less at 3 months post-burn re-
epithelialization. This color difference was most evident in children with darker skin types. It 
was beyond the realm of this study to determine the exact time for skin color to return post-
burn for children with darker skin types, but results suggest it is longer than the 6 month 
statement commonly used clinically and warrants further investigation. Given this 
preliminary finding, education provided to patients and parents on discharge regarding the 
timeframe for skin color changes should be also be reviewed. 
Lastly, patients and parents were shown to be rating scars comparably to therapists at 3 
months, but at 6 months were rating scars as worse compared to therapists. This was 
despite many burns assessed by therapists to have returned to a normal skin appearance 
by this timepoint. Such results indicated that partial thickness burns, although temporary in 
their appearance, may still have a psychosocial impact even after resolution and that 
clinicians should be aware of this and provide appropriate education to patients and parents. 
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9.2.4 Parent experiences of outpatient burn care 
The experiences of parents overarch the entire process of pediatric burn care treatment and 
outcome with many children of a young age and therefore reliant on parent support 
throughout care. Similarly to the other facets of burn care presented in this thesis, the parent 
experience of pediatric outpatient burn care (at the lower end of severity) is under-
represented in the literature. In the literature, studies relating to parent experiences are 
restricted to children sustaining severe burns or other traumatic injuries requiring lengthy 
inpatient hospitalization. 
The pilot study presented in this thesis used a phenomological approach to explore the 
experiences of parents accompanying their child through outpatient burn care. Themes 
identified in this study appear to be consistent with the experiences of parents with children 
who sustain severe burn injuries. Parents reported feeling unprepared for the burn care 
process due to being unfamiliar with the hospital and a lack of prior knowledge of burn 
injuries. Persistent guilt over the accident and an inability to protect their child was described 
by parents. However, factors such as staff support and being prepared for the burn care 
process, facilitated parent’s ability to cope and provide support for their child as they 
recovered. 
This study highlighted that burns, regardless of the size or severity are distressing for 
parents and the burn care process can be a daunting one. These results have also 
emphasized that psychosocial support for parents of children with partial thickness burns is 
just as important for those with more severe injuries. As is well documented in the literature, 
post-traumatic stress disorder (PTSD) in parents does not discriminate across burn size and 
can occur in parents of children with relatively minor injuries. 
Education for parents on the outpatient burn care process and information on basic burn 
wound healing processes and long-term scar outcome progression is therefore required. 
Such educational strategies could seek to alleviate stress and prevent the development of 
PTSD symptoms which may result in longer term mental health issues for parents and 
children post burn-recovery. 
9.3 Research limitations 
9.3.1 Objective measurement of burn characteristics 
This body of work was not without limitations. A major challenge within this pediatric 
population is compliance during wound care procedures in children under the age of three 
years. In this thesis, a number of laser Doppler scans and Visitrak™ measurements were 
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unable to be completed in many children aged three years or less due to the need for the 
child to remain still while the wound was exposed. While wound surface area measurement 
using 3D photography has been shown to be a reliable and non-invasive alternative to 
Visitrak™, laser Doppler remains the only device for objectively assessing the healing 
potential of burns. The laser Doppler line scanner is a recent development which has a four 
second scan time in comparison to the 30 second scan of the laser Doppler used in this 
study. Using this new device in future studies may improve the total capture rate of objective 
burn wound healing potential data, reduce the time for the wound to be exposed and 
subsequent child distress may also be alleviated. 
9.3.2 Patient follow-up  
This thesis has also highlighted the difficulty following up patients and their families post-
discharge, many months after the original injury. Attrition rates in Chapter 6 (scar 
assessment) of the thesis were close to 50% and this increased at the six month follow-up 
time point. Due to low numbers of patients returning for follow-ups, rigorous statistical 
analyses could not be completed. Families participating in this research were often unable 
to attend follow-up visits due to having to arrange time off school and work, limited transport 
options or living regionally, rurally or interstate. Appropriate study designs should also be 
formulated to account for potentially large losses to follow-up, such as increasing sample 
sizes to account for attrition.  
9.3.3 Cost-analysis 
The cost-analysis study presented in chapter 5, while presenting favorable results towards 
Mepilex Ag™, was limited due to no patients in the Mepilex Ag™ group in the RCT having 
received a skin graft which may have skewed the data. However, sensitivity analyses were 
included in the analysis, removing skin graft data from the total dataset, with Mepilex Ag™ 
still shown to be a dominant choice.  
9.3.4 Qualitative study design 
Lastly, the qualitative chapter 7 presented the experiences of parents accompanying their 
child through outpatient burn care treatment. Due to time constraints, recruitment for this 
study was concluded at 10 participants. However after data analysis, it appeared that data 
saturation may not have been reached. Therefore further interviews with parents may be 
required to confirm identified themes in the data or the identification of new themes. 
Furthermore, results from this study were not taken back to the study population to gauge if 
the conclusions drawn were accurate and representative of the general views of all parents. 
Completing this step in future research will serve to strengthen and validate the final results.  
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9.4 Clinical implications and recommendations  
9.4.1 Randomized controlled trial and cost-effective analysis 
The favorable outcome for Mepilex Ag™ presented from the randomized controlled trial in 
Chapter 3 and associated cost-analysis in Chapter 5 has resulted in the development of a 
new treatment protocol for pediatric partial thickness burns (See Appendix 7). The protocol 
recommends a change from Acticoat™ and Mepitel™ as the standard dressing choice for 
partial thickness burns ≤10% TBSA to Mepilex Ag™. This new protocol has subsequently 
altered clinical practice within Lady Cilento Children’s Hospital (LCCH), since December 
2014. As LCCH is the main tertiary pediatric burns center in Queensland, this change to 
clinical practice has been state-wide, with the new protocol available online via the 
Queensland Health QHEPS staff portal and accessible to all clinicians. It has also been 
made available online to nurses via the International College of Emergency Nurses website. 
In addition to these changes in Queensland, this research has been presented to clinicians 
at a national and international burns and emergency nursing conferences and has been 
taken up in some Australian and New Zealand pediatric centers (Melbourne and 
Middlemore, NZ).  
The randomized controlled trial results have also instigated the development of upcoming 
statewide (QLD) education sessions on the new protocol to educate staff who may manage 
patients regionally or treat and refer patients to LCCH. Education sessions will be presented 
by Pegg Leditschke Children’s Burns Centre staff and will be held in major regional hospitals 
of Queensland (southern, central and far north Queensland) and surrounding regional and 
rural hospitals will be able to attend via teleconferencing. It is anticipated that these sessions 
may extend interstate to inform as many clinicians as possible in the near future. 
9.4.2 Objective measures 
Results from this thesis have also prompted the use of 3D photography instead of Visitrak™ 
in all clinical trials conducted in the center measuring wound surface area. This change of 
practice will allow for an increased compliance in assessing of wound area and it has the 
added benefit of the associated Dermapix™ program allowing the storage of progressive 
wound photographs to track wound healing over time. The 3D camera is now also used 
clinically for burn wound mapping and chronic wounds (e.g. pressure areas and ulcerating 
hemangiomas). As an adjunct to the research completed for this thesis, I have also been 
extensively involved in establishing the clinical utility of the 3D camera to measure burn scar 
and infantile hemangioma height and volume and ultrasound to measure scar thickness. 
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These two devices are now utilized clinically in scar management and vascular anomaly 
clinics. 
9.4.3 Psychosocial support and education 
The research presented in Chapters 6 and 7 regarding partial thickness burn outcome and 
parent experiences has highlighted that patient and parent education on the burn healing 
process and outpatient care processes is needed. It is recommended as a result of research 
findings presented in this thesis that an educational tool be developed that could be given 
to parents new to the burns unit (e.g. on referral or in the waiting room). Such a tool (e.g. 
procedural preparation video, handout) would cover the outpatient burn care process (e.g. 
what to expect, what to bring, waiting times etc) and basic information on burn wounds and 
scarring. Psychosocial support should also be continued to be given to all parents regardless 
of burn severity as burn care has been shown be distressing for all parents. Given the 
possibility that some families may not initially appear to require referral for psychosocial 
support during burn wound care appointments or may not be seen by psychosocial service 
providers, including information on where to seek support in the educational tool would be 
of great benefit.  Parent experiences already reported in thesis demonstrate that it is likely 
that such a resource would benefit all parents and potentially alleviate feelings of anxiety 
and fear when coming to appointments. 
9.5 Future directions 
This thesis has provided a wealth of information regarding pediatric partial thickness burn 
care, however more information is still required to completely understand pediatric partial 
thickness burn care. 
9.5.1 Pediatric partial thickness burn research 
Further high level research on pediatric, partial thickness burns is required to improve health 
outcomes for this population of children. As was highlighted in this thesis, research on 
pediatric partial thickness burns ≤10% TBSA is low in comparison to severe burns despite 
this being the main type of pediatric burn seen in high-income countries. The replication of 
research in this thesis in an adult population would also be of interest to compare differences 
and similarities between the population groups. 
9.5.2 Silver dressings 
This thesis included one of the first randomized controlled trials to compare silver dressings 
in the pediatric population. While the dressings used for the trial are commonly used in 
Australia and New Zealand, there are other silver dressings available which are used in 
other parts of the world e.g. Aquacel Ag® or Mepilex Ag™ Transfer. It would be extremely 
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beneficial to continue the comparison of silver dressings by including all currently available 
dressings to determine if there is a superior dressing for children. Again, research on the 
efficacy of silver dressings for the adult population is required to determine the best dressing 
for this population, as the two populations are distinctly different in the challenges they 
present.  
Also of interest is the necessity of silver to treat clean, ≤10% TBSA partial thickness burns 
in children. Future research into the bacteriology of burn wounds treated with silver 
dressings compared to non-silver dressings would be important to determine the efficacy of 
silver treatments. Furthermore, the cytotoxicity and antimicrobial properties of silver 
dressings (fabric, foam, hydrofibre and alginate) on various gram positive and negative 
bacteria would be beneficial for clinical decision-making. The Centre for Children's Burns 
and Trauma Research laboratory team is currently in the process of testing the cytotoxicity 
of silver dressings compared in this thesis. 
There is also a preference from some consultants to prolong time between dressing changes 
for up to seven days to in order to minimize the disruption to the wound and child. Given that 
Mepilex Ag™ is indicated to be changed every 5-7 days and Acticoat 7™ can be changed 
weekly, conducting a similar RCT with less frequent dressing changes would be valuable in 
determining if longer times between dressing changes affects re-epithelialization time due 
to less disturbance of the wound. If dressings can be changed once a week compared to 
twice weekly this may also be a more cost-effective option for the healthcare system as less 
resources are being utilized. Additionally, it is recommended that future cost-analyses of 
burns treatments collect health-related quality of life measurements to undertake more 
rigorous cost-utility analyses and use a societal perspective to take into account the financial 
burden on families. 
9.5.3 Objective measures 
As was highlighted in Chapter 4, while 3D photography can reliably measure wound surface 
area in small, discrete wounds, larger and circumferential wounds require the stitching 
together of progressive photos and are significantly more technically difficult to measure. 
Therefore, as technology improves and measurement of these larger wounds becomes 
more user-friendly, the reliability and validity of the camera to measure such wounds will 
need to be reassessed to determine if this device is able to be used for all types of burn 
wounds. 
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9.5.4 Partial thickness burn outcome 
Chapter 6 of this thesis found evidence that skin pigmentation loss was more apparent in 
children with darker skin types, but the exact timeframe for a return to normal skin 
appearance is still not known. Further assessment of long-term scar assessment in 
children who sustain partial thickness burns should include a formal assessment of skin 
type using the Fitzpatrick skin type scale, objective measurement of burn depth acutely 
(i.e. laser Doppler imaging) and objective measurement of skin pigmentation. Skin colour 
and pigmentation was only a minor part of the outcomes measures initially, but resulted in 
an important finding and therefore slightly more focus was placed on these outcomes in 
this chapter. Such devices used to measure skin pigmentation (e.g. Colorimeter, Dermalab 
Combo, Scarbase Duo) were firstly not available for use and secondly not validated for 
use in burn scars at the time of the trial and thus could not be utilized. The validity of the 
Dermalab Combo and Scarbase Duo has now been established [147, 148], and validation 
of the Colorimeter is ongoing. Future use of such devices would certainly be of benefit in 
obtaining objective measures of pigmentation in burn scars. 
The scar outcome of children with partial thickness burns re-epithelializing within 2-3 weeks 
is still under-represented. A better understanding of the risk factors for scarring is required 
for better patient management and to provide more information for patients and their 
families.  
9.6 Conclusion 
This thesis has provided a comprehensive overview and examination of pediatric partial 
thickness burn care in the outpatient setting within the facets of treatment, outcome and 
parent experiences. Partial thickness burns in children are a significant burden on the 
healthcare system and should not be overlooked or disregarded. 
Research presented in this body of work has changed and improved clinical practice in 
Queensland with the identification of Mepilex Ag™ as a cost-effective alternative to both 
Acticoat™ and Acticoat™ with Mepitel™ for the treatment of partial thickness burns ≤10% 
TBSA in children. Additionally, the investigation and introduction of objective and non-
invasive burn wound and scar assessment tools (3D photography and ultrasound) has 
improved the ability to capture objective data and minimize unnecessary distress to children 
receiving treatment. A wealth of information has been obtained regarding the long term 
outcome from partial thickness burns, the subjective experiences of parents and the 
psychosocial implications of burn care.  
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Findings in this thesis have not only significantly improved clinical knowledge of pediatric 
partial thickness burns, but have provided clinicians with the tools and recommendations 
to improve burn care for children who sustain these injuries and their families.
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Appendices 
Appendix 1: Patient and Observer Scar Assessment Scale

Dressing type Dressing size Cost per sheet (A$) 
Mepilex Ag™ 10x10cm 8.40 
10x20cm 20.00 
15x15cm 21.75 
20x20cm 35.00 
Acticoat™ 5x5cm 10.24 
10x10cm 19.15 
10x20cm 28.75 
20x40cm 100.10 
Mepitel™ 5x7.5cm 5.20 
7.5x10cm 9.20 
10x18cm 17.80 
Scar management 
resources 
Size/Amount Cost for one (A$) 
Kelocote silicone gel 15 g tube 34.75 
Mepiform™ silicone sheet  5x7.5cm 9.00 
10x18cm 26.00 
Cicacare silicone sheet 6x12cm 40.99 
12x15cm 68.19 
Ezemix™ silicone moulds 50 moulds/tub Per tub: 350.98 
Per mould: 7.10 
Pressure garments Custom-made Range: $298 – 777.40 
Appendix 2: Breakdown of cost items (economic evaluation)
Queensland Health Wage Rates 2014 
Position Annual wage plus 25.85% on costs Cost/minute 
L26 (MO2) Consultant 246,290 2.08 
Clinical nurse consultant 129,133 1.09 
Clinical nurse 105,165 0.89 
Registered nurse 77,014 0.65 
Occupational therapist (HP3) 75,130 0.63 
Occupational therapist (HP4) 121,805 1.03 
Occupational therapist (HP5) 138,362 1.17 
Occupational therapist (HP6) 158,917 1.34 
Split skin grafting 
DRG code Cost  (A$) 
Y02B – Skin grafts for other burns w/o catastrophic or 
severe CC, Emergency 
17,131 
Negative pressure wound therapy  Cost (A$) 
Gauze dressing, dressing film and lease of canister 
and machine for 7 days 
408.09 
Analgesia Amount Dosage Cost per bottle (A$) 
Oxycodone 250mL 0.1mg/kg 9.76 
Paracetamol 20mL 15mg/kg 2.18 
For all paediatric burns 
1. Ensure adequate first aid is provided, 20 mins cool
running water up to 3hr post burn
2. Contact the LCCH Burns Registrar (07)30681111 prior
to dressing, or sending referral
3. Complete online referral
http://qheps.health.qld.gov.au/childrenshealth/reso
urces/clinforms/docs/500026.pdf
4. Email referral with photos to burns-
opd@health.qld.gov.au
5. We do not recommend the use of Silver
Sulphadiazine or ice.
6. All paediatric burns,  irrespective of size, should be
discussed with the Burn Registrar. However many
can be cared for in local centre under our
supervision.
TBSA 
SPT-DPT           
.   
FT 
Unclean first aid                                   
. 
Child unwell 
Total body surface area 
All partial thickness burns (superficial to 
deep partial) 
Full thickness 
eg water from creek/river, bore/ 
untreated/tank water, dirty water 
URTI, viral illness, etc 
 
 
Appendix 3: New silver dressing treatment protocol
Appendix 4: Burns centre staff perspective of dressings (ease of use Likert
scales)
1. How easy was it to REMOVE this dressing to the child? (please tick)
□ Extremely easy
□ Very easy
□ Somewhat easy
□ Not very easy
□ Not at all easy
2. How easy was it to APPLY this dressing to the child? (please tick)
□ Extremely easy
□ Very easy
□ Somewhat easy
□ Not very easy
□ Not at all easy
Appendix 5: Physical function while wearing dressings (Likert scale)
How easy is it move in the dressing?
□ Extremely easy
□ Very easy
□ Somewhat easy
□ Not very easy
□ Not at all easy
